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CHAPTER 5
Expedient Synthesis of 3-Hydroxyisoquinolines and 2-Hydroxy-1,4-
Naphthoquinones via One-Pot Aryne Acyl-Alkylation / Condensation
5.1 INTRODUCTION AND BACKGROUND
5.1.1 The Direct Acyl-Alkylation of Arynes†,1,2,3
Our research group first took an interest in the unique reactivity of benzyne in an
attempt to employ this species as an electrophilic arylating agent for the synthesis of α-
quaternary β-ketoesters (517) (Scheme 5.1).  Using a combination of the ortho-silyl aryl
triflate (71) previously developed by Kobayashi4 and an α-monosubstituted β-ketoester
such as ethyl 2-methylacetoacetate (514), it was envisioned that treatment with caesium
fluoride would accomplish both a fluoride-induced net elimination of TMSOTf from 71
to generate benzyne (1) and a deprotonation of the β-ketoester to generate a nucleophilic
enolate species (515).  Attack upon the electrophilic aryne and subsequent protonation of
the resulting aryl anion (516) would then furnish the desired α-arylated β-ketoester (517).
                                                 
† The discovery and development of the aryne acyl-alkylation reaction is the work of a former graduate
student in the Stoltz research group, Dr. Uttam K. Tambar.
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When this concept was put into practice, however, an interesting ortho-disubstituted
arene (518) was isolated in addition to the expected product.  Remarkably, this new
product constituted a formal insertion of benzyne into the α,β  C–C bond of the β-
ketoester.  Formation of the acyl-alkylated arene (518) presumably results through a
divergence from the anticipated path of reactivity.  If, instead of undergoing protonation,
aryl anion 516  undergoes nucleophilic addition to the proximal ketone, a
benzocyclobutenoxide intermediate (519) would be formed.  This species would then be
capable of decomposing to the acyl-alkylated arene (518) through fragmentation of the
strained four-membered ring and subsequent protonation.
Scheme 5.1. Discovery of the aryne acyl-alkylation reaction
CsF (2.5 equiv)
MeCN (0.2 M)




























Formal  aryne insertions into metal–metal,5 heteroatom–metal,6,7
heteroatom–heteroatom,8–13 carbon–metal,14 and carbon–heteroatom15,16 σ-bonds have
been reported previously.  However, the results of the experiment depicted above are
especially intriguing in that they represent the insertion of an aryne into a carbon–carbon
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σ-bond under mild conditions without prior formation of an anionic nucleophile.17–19
Inspired by this realization, our group initiated a more in-depth examination of the scope
of the aryne acyl-alkylation reaction.
Consideration was first given to the β-ketoester substrate.  It was reasoned that a β-
ketoester lacking substitution at the α-carbon would contain less steric bulk as the
corresponding aryl anion (516), and therefore display more rapid closure of the putative
benzocyclobutenoxide (519).  The expected benefits of this modification were two-fold:
the yield of the acyl-alkylated arene product (518) would likely increase, while the
incidence of α-arylation side product 517 would be suppressed.  A series of α -
unsubstituted β-ketoesters (520) bearing varied substitution at the γ-carbon were
therefore investigated (Table 5.1).  As anticipated, the reaction produced higher yields of
the ortho-disubstituted arenes (521) when substitution was omitted from the α-position.
Substrates bearing linear (entries 1 and 2) and branched (entry 3) alkyl chains, as well as
aryl substitution (entries 4 and 6) were all well tolerated.  Ether substitution could even
be incorporated, albeit in lower yield (entry 5).  On the other hand, modification of the
ester substituent enabled the preparation of acyl-alkylated products derived from more
complex alcohol precursors such as menthol (entry 7) and cholesterol (entry 8).
Importantly, this reaction has proven to be readily scalable for the production of multi-
gram quantities of acyl-alkylated arene 521a.3
Having confirmed that the aryne acyl-alkylation proceeds smoothly with a number of
differentially substituted β-ketoester substrates, attention was next given to an
examination of the second reaction partner, the aryne.  Methyl acetoacetate (520a) was
chosen as a model β-ketoester for its structural simplicity and employed in the acyl-
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Table 5.1. Acyl-alkylation of benzyne with substituted β-ketoesters
CsF (2.5 equiv)
MeCN (0.2 M)





















































































R = R =
521h
a Reaction performed with 1.25 equiv ortho-silyl aryl triflate 71 relative to β-ketoester 520.
b Reaction performed with 2 equiv ortho-silyl aryl triflate 71 relative to β-ketoester 520d.
Chapter 5 – One-Pot Aryne Acyl-Alkylation / Condensation 368
alkylation of the arynes derived from mono- and disubstituted ortho-silyl aryl triflates
(168)  (Table 5.2).  Gratifyingly, each of the three aryne precursors produced the
expected tri- (entries 1 and 2) and tetrasubstituted arenes (entry 3) in very good yield.
Furthermore, 3-methoxy-2-(trimethylsilyl)phenyl triflate (108) was found to react in a
completely regioselective manner, furnishing only the product isomer corresponding to
nucleophilic attack of the putative caesium enolate (e.g., 515) at C(1).20,21  As expected
from previous studies,20e however, the meta-alkyl substituted precursor (183) displayed a
weaker propensity for polarization of the reactive aryne bond and therefore afforded a
mixture of isomers (522b and 522c).


























































a Reaction performed with 2 equiv ortho-silyl aryl triflate 168 relative to β-ketoester 520a.
b Reaction performed with 1.25 equiv ortho-silyl aryl triflate 183 relative to β-ketoester 520a.
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In a final evaluation of the substrate scope, the aryne acyl-alkylation was
performed with a series of cyclic β-ketoesters (523) that, upon insertion of the aryne into
the α,β C–C bond, would undergo two-carbon ring expansion to generate benzannulated
medium-sized carbocycles (524) (Table 5.3).  In each of the substrates examined
(523a–e), the ester is oriented exo to a ketone-containing ring, thus constituting an
analogue of the α-monosubstituted β-ketoester originally examined (514).  A primary
concern was that these compounds would therefore display the same susceptibility
toward α-arylation that was observed in that first example.  While this indeed proved to
be the case with several of the substrates, the ring-expansive aryne acyl-alkylation
method was able to provide access to a number of benzannulated 7- (entries 1–3), 8-
(entry 4), and 9-membered polycycles (entry 5) in good yield from simple, readily
available starting materials.  In analogy to the previous screen of β-ketoester reactivity
(Table 5.1), the insertion proceeded smoothly when aryl substitution was introduced at
the γ-position (entries 2 and 4).  2-Indanone 523c performed equally well, suggesting that
α-aryl substitution of the β-ketoester has no additional negative effect upon reactivity.  In
full, this technique enables the construction of a number of synthetically useful medium-
sized ring-containing products featuring varying degrees of benzannulation around the
central ring.
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a Reaction performed with 1.25 equiv ortho-silyl aryl triflate 71 relative to β-ketoester 523.
b In most cases, the α-arylated β-ketoester was isolated as the major side product.
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5.1.2 Applications of Aryne Acyl-Alkylation in Natural Product Total
Synthesis
The aryne acyl-alkylation reaction is a powerful tool for the convergent assembly of
polycyclic arene-containing frameworks from simple starting materials.  As such, it is not
at all surprising that this technique has found ready use within the context of total
synthesis.  Over the past three years, our group has employed the acyl-alkylation reaction
as a key transformation in the asymmetric total syntheses of two natural products, (+)-
amurensinine (525) and (–)-curvularin (526), and we are currently investigating its
implementation as part of a synthetic approach toward integrastatins A (527) and B (528)
(Figure 5.1).  The following sections discuss each of these synthetic efforts in detail.

























5.1.2.1 Total Synthesis of (+)-Amurensinine†,2,22,23
The first natural product to be completed using the aryne acyl-alkylation reaction was
(+)-amurensinine (525), a member of the isopavine alkaloids (Scheme 5.2).24  The carbon
skeleton of 525 was recognized as being strikingly similar to structures previously
prepared using the ring-expansive aryne acyl-alkylation (524b and 524c, Table 5.3), so
                                                 
† The asymmetric total synthesis of (+)-amurensinine was carried out by two former graduate students in
the Stoltz research group, Drs. Uttam K. Tambar and David C. Ebner.
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much so that cyclic β-ketoester 523c was targeted as the precursor to the right
hemisphere of the natural product.  Construction of this intermediate started from
homoveratric acid (192), which was advanced to β-ketoester 529 through a four-step
procedure entailing conversion to the acid chloride, addition of Meldrum’s acid, thermal
decomposition of the resulting adduct to an α-ketoketene, and quenching with ethanol.
The β-ketoester was then treated with p-acetamidobenzenesulfonyl azide (p-ABSA) to
furnish α-diazo-β-ketoester 530, which underwent subsequent rhodium-catalyzed
insertion into the less hindered ortho-C–H bond to generate cyclic β-ketoester 523c.
Scheme 5.2. Total synthesis of (+)-amurensinine
(+)-Amurensinine (525)
• 18 linear steps •










1. SOCl2, DMF, benzene
2. Meldrum's acid, py
    CH2Cl2, 0 → 23 °C
3. aq HCl wash
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2. LiAlH4    THF, 0 °C





























    periodinane
    CH2Cl2, 0 → 23 °C
2. NaClO2, NaH2PO4•H2O
    2-methyl-2-butene
    t-BuOH, H2O
3. H2, Pd/C, EtOAc










99% ee (s > 47)
1. LiAlH4, THF, 65 °C
2. aq HCHO, NaBH3CN
    MeCN
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In the key transformation, this compound was combined with ortho-silyl aryl
triflate 155—a derivative of sesamol—and heated in the presence of caesium fluoride to
generate tetracycle 531.  Following assembly of the carbon framework, the ketone was
reduced with L-Selectride to set the trans relationship between the substituents at C(5)
and C(12), and the ester was reduced to a primary alcohol and selectively protected as the
silyl ether ((±)-532).  In order to impart asymmetry upon the synthetic sequence, an
oxidative kinetic resolution—a reaction methodology previously developed by our
research group—was carried out on this racemic material using Pd(sparteine)Cl2 (533) as
the chiral catalyst.25,26  Stereoselective oxidation of the undesired enantiomer of the
secondary alcohol (i.e., (+)-532) thereby furnished alcohol (–)-532 in 47% yield and
>99% ee (s > 47).27  Mitsunobu inversion using diphenylphosphoryl azide (DPPA) and
desilylation provided syn-azido alcohol 534, after which two-step oxidation to the
carboxylic acid and reduction of the azide resulted in spontaneous ring closure to form
the lactam (535).  The synthesis was completed through reduction of the lactam to a
benzazepine and installation of the N-methyl group via reductive amination, thus yielding
(+)-amurensinine (525) in a total of 18 linear steps.  Importantly, the completion of this
natural product marked the first application of both the aryne acyl-alkylation and the
oxidative kinetic resolution reactions in total synthesis.
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5.1.2.2 Total Synthesis of (–)-Curvularin†,28
The second natural product targeted was (–)-curvularin,29,30 a polyketide isolated from
the mold Curvularia that has recently been shown to inhibit human inducible nitric oxide
synthase expression.31  The primary objective of this synthesis was to examine the
feasibility of an aryne acyl-alkylation approach that employed a β-ketolactone—wherein
both the ester and ketone functionalities are contained within a single ring—in place of a
cyclic β-ketoester bearing an exocyclic ester (e.g., 523a–e, Table 5.3).
The synthesis of curvularin began from known (S)-heptenyl-6-acetate (536), which
was prepared as a single enantiomer through the addition of the Grignard reagent of 4-
bromo-1-butene to the terminus of (S)-propylene oxide followed by acetylation of the
resulting alcohol (Scheme 5.3).32  Aldol addition of the lithium enolate of 536 to acrolein
formed allylic alcohol 537.  This intermediate was then carried forward through
silylation, ring closing metathesis using ruthenium catalyst 538,33 and desilylation to
furnish unsaturated lactone 539 as a mixture of diastereomers and olefin isomers.
Hydrogenation of the olefin and oxidation of the secondary alcohol then generated β-
ketolactone 540, the substrate for the key aryne acyl-alkylation.  Heating this substrate
with dibenzyloxy ortho-silyl aryl triflate 54134 in the presence of caesium fluoride
produced the desired ring-expansion product in 30% yield, accompanied by a 20% yield
of the α-arylated isomer (not shown).  Hydrogenolysis of the benzyl protecting groups
then provided (–)-curvularin (526) in 7.2% yield over 6 linear steps from acetate 536.
                                                 
† The asymmetric total synthesis of (–)-curvularin was carried out by Pamela M. Tadross, a graduate
student in the Stoltz research group.
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Scheme 5.3. Total synthesis of (–)-curvularin
(–)-Curvularin (526)
• 6 linear steps •












HMDS, THF, 70 °C
then 538 (10 mol%)
benzene, reflux,










1. CsF, MeCN, 40 °C
2. H2, Pd/C
    MeOH / THF











1. H2, Pd/C, EtOH
2. Dess–Martin
    periodinane
    CH2Cl2





5.2.1.3 Progress Toward the Total Synthesis of Integrastatins A and B†
Our research group is currently pursuing the total syntheses of integrastatins A (527)
and B (528), isolates from an unidentified fungus found in New Mexico that have been
shown to inhibit the strand transfer reaction of recombinant HIV-1 integrase (IC50 = 1.1
and 2.5 µM, respectively).35  The present strategy calls for early construction of the left
and right hand arene rings as precursors to the key aryne acyl-alkylation, after which the
central bridging acetal will be assembled to complete the synthesis.  Beginning from
methyl gallate (542), selective mono-methylation, bromination, and installation of a
methylene dioxolane provided ester 544 (Scheme 5.4a).  Reduction to the primary
alcohol (545) and addition to diketene (546) then yielded β-ketoester 547.  Alternatively,
the aryne precursor can be prepared by diverting from alcohol 545  to generate
bromophenol 549 through conversion to the aldehyde (548), Baeyer–Villiger oxidation,
                                                 
† The total syntheses of integrastatins A and B are being pursued by Pradeep Bugga, a baccalaureate
researcher, and Pamela M. Tadross, a graduate student, both of whom are members of the Stoltz research
group.
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and deformylation (Scheme 5.4b).  Advancement to ortho-silyl aryl triflate 550 was
then accomplished through silylation of the phenol, lithium-halogen exchange, migration
of the silyl group from oxygen to the lithiated ortho-carbon, and quenching of the
resultant phenoxide with trifluoromethanesulfonic anhydride (Tf2O).36
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With β-ketoester 547 in hand, the aryne acyl-alkylation was first examined using
ortho-silyl aryl triflate 71 as a model substrate (Scheme 5.5a).  Because the β-ketoester
decomposes above room temperature in the presence of several fluoride sources, an
alternative set of conditions was developed to promote comparable reactivity at lower
temperatures.  Replacing caesium fluoride with potassium fluoride activated by a crown
ether promotes the reaction in tetrahydrofuran at 0 °C, thus suppressing thermal
decomposition of β-ketoester 547 and providing benzylic ester 551 in 56% yield.  When
this same reaction was attempted with ortho-silyl aryl triflate 550, however, the
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corresponding benzylic ester (552) could only be isolated in trace quantities (Scheme
5.5b).  Current efforts are therefore focused upon gaining a better understanding of the
shortcomings of this particular reaction in order to optimize the yield of 552.  With
greater quantities of this intermediate in hand, attention will be turned toward its
advancement to one of two α-hydroxyketones (553 or 554).  In the final steps, removal of
the two dioxolanes using boron trichloride will reveal a pair of catechols capable of
forming the central acetal to generate integrastatin B (528), or a silyl ether (555) one step
removed from integrastatin A (527).
Scheme 5.5. a) Model acyl-alkylation using ortho-silyl aryl triflate 71.  b) Aryne acyl-alkylation and



































































R = CH2OTBS 555
R = CH2OH
553, R = CHO
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5.2 EXPEDIENT SYNTHESIS OF 3-HYDROXYISOQUINOLINES AND 2-
HYDROXY-1,4-NAPHTHOQUINONES VIA ONE-POT ARYNE ACYL-
ALKYLATION / CONDENSATION37
5.2.1 Previous Synthetic Methods
Following our development of the fluoride-induced insertion reaction between β-
ketoesters and arynes derived from ortho-silyl aryl triflates,1 we began to investigate
avenues along which the acyl-alkylated arene products could be advanced toward more
complex ring systems.22  Our interest in nitrogen-containing heterocycles38 led us to a
communication by Bentley et al., which reported the synthesis of both 3-
hydroxyisoquinolines (558) and 2-hydroxy-1,4-naphthoquinones (559) through exposure
of 1,5-ketoesters such as 557—prepared by Friedel–Crafts acylation of homoveratric
esters (556)—to either aqueous ammonia or alkaline base under an ambient atmosphere,
respectively (Scheme 5.6a).39  We found this strategy particularly inspiring given that
traditional approaches to the incorporation of these aromatic groups within larger
molecular scaffolds typically rely upon transition metal-catalyzed cross coupling
reactions employing C(sp2)–X substrates.40  Select examples of such approaches include
Brown’s employment of a Suzuki coupling between isoquinoline chloride 560 and
naphthyl boronic acid 561 to prepare naphthyl isoquinoline 562,41 Knoechel’s synthesis
of arylisoquinline 565 via Negishi coupling,42 and the copper-catalyzed coupling between
naphthoquinone phenyliodonium ylide 566  and N-methylindole (567) utilized by
Spyroudis (Scheme 5.6b).43
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Scheme 5.6. a) Bentley’s synthesis of 3-hydroxyisoquinolines and 2-hydroxy-1,4-
naphthoquinones from 2-acylhomoveratric esters.  b) Selected previous syntheses of functionalized



































































5.2.2 Proof of Principle
The ability to extend our aryne acyl-alkylation technology to the preparation of
isoquinoline and naphthoquinone motifs would represent a new synthetic approach
employing materials ultimately derived from carboxylic acids.  Combining Bentley’s
condensation with our own aryne methodology, we found that treatment of a crude acyl-
alkylation reaction mixture containing methyl (2-acetylphenyl)acetate (521a) with
aqueous ammonium hydroxide furnished 1-methyl-3-hydroxyisoquinoline (569) in 84%
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yield directly from methyl acetoacetate (520a) and 2-(trimethylsilyl)phenyl triflate
(71) (Scheme 5.7).  Alternatively, the addition of sodium methoxide to intermediate 521a
with concomitant exposure to air generated lawsone (570)—an isolate from the henna
plant Lawsonia inermis44—in 78% yield.
Scheme 5.7. Aryne acyl-alkylation followed by condensation with ammonia or intramolecular





























5.2.3 Development of a One-Pot Aryne Acyl-Alkylation / Ammonia
Condensation Reaction Sequence for the Synthesis of 3-
Hydroxyisoquinolines
Focusing on the first of these two transformations, we investigated the reaction
between methyl acetoacetate (520a) and a number of functionalized aryne precursors
(168) (Table 5.4).  The sequence proved quite general, providing rapid access to a
number of 3-hydroxyisoquinoline products (571) featuring substitution at carbons 6, 7,
and 8.  The reaction proceeded well with both electron-rich (entries 1–4) and electron-
deficient arynes (entry 5), as well as with cyclohexyne45 (entry 6).  Notably, the use of
unsymmetrically substituted arynes (entries 1 and 2) provided single product isomers
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originating from regioselective addition of the β-ketoester to the inductively activated
carbon meta to the heteroatom.20,21










80 °C, 45–60 min,
then aq NH4OH
































































a Reaction performed with 1.25 equiv ortho-silyl aryl triflate 168 relative to β-ketoester 520a.
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Next, we considered alternative β-ketoesters for the introduction of substitution at
C(1) of the hydroxyisoquinoline scaffold (Table 5.5).  Though methyl acetoacetate and a
handful of other β-ketoesters are commercially available, we found it necessary to
prepare additional substrates in order to probe the scope of the reaction.  While there are
a number of methods known to generate β-ketoesters from the corresponding carboxylic
acids (574), we selected a procedure reported by Masamune et al., which employs the
addition of a magnesium monomethylmalonate to a preformed acyl imidazole.46  Both
simple and high yielding, this method facilitated the synthesis of a small library of
differentially substituted methyl β-ketoesters (575) from readily available carboxylic
acids in a single step.48
With a collection of substrates in hand, we set about testing the steric and
electronic tolerances of our acyl-alkylation/condensation reaction sequence.  Under
optimized conditions, the β-ketoester (575 ) and ortho-silyl aryl triflate (168) are
combined and heated in the presence of caesium fluoride.  Following formation of the
acyl-alkylated arene (e.g., 521a), ammonium hydroxide is added and heating is continued
in a sealed environment.  We were delighted to find that the reaction proceeds quite well
with a variety of alkyl (entries 1 and 2), aryl (entries 3–5), and heteroaryl groups (entries
6–8) located at the γ-position of the β-ketoester.  In addition, naphthyl isoquinoline (entry
9) and bis-isoquinoline  (entry 10) scaffolds—structures central to many ligand
frameworks—are accessible.47  Interestingly, this sequence proves quite effective at
rapidly appending isoquinoline motifs on to biological substrates such as arachidonic acid
(entry 11) and 3β-acetoxy-5-etienic acid (entry 12) without epimerization of existing
stereocenters.  The reaction can even be performed bidirectionally with a diacid to
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Table 5.5. Two-step synthesis of 3-hydroxyisoquinolines from carboxylic acids48
81%
79%
575a, R = CH2OMe 82%

















































































576g, R = H
576h, R = OMe
576d, R = H
576e, R = OCH2O
575b, R = c-Hex





































80 °C, 45–60 min
then aq NH4OH






























576a, R = CH2OMe
576b, R = c-Hex
576c, R = Ph
427
a Acyl-alkylation/condensation reaction performed with 1.25 equiv 168 relative to β-ketoester 575.
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generate a bis(3-hydroxyisoquinoline) product (entry 13).
The hydroxyl group on this molecular scaffold provides an excellent functional
handle for the introduction of additional substitution at C(3) of the isoquinoline.  As a
demonstration of this fact, we carried out the triflation of 3-hydroxyisoquinoline 576f
(Table 5.5, entry 6) followed by a palladium-catalyzed Suzuki coupling with 4-
methoxyphenylboronic acid (577) to furnish diarylisoquinoline 578 in high yield
(Scheme 5.8a).  Thus, this method provides avenues not only to C(1) functionalized
hydroxyisoquinolines, but toward 1,3-disubstituted isoquinolines as well.
As previously mentioned, our aryne acyl-alkylation/condensation reaction sequence
enables rapid assembly of structural motifs that are key to several chiral ligand
frameworks.  In particular, we envisioned that naphthyl isoquinoline 576i (Table 5.5,
entry 9) could be employed toward the synthesis of 1-(2'-diphenylphosphino-1'-
naphthyl)-isoquinoline (QUINAP, 582),49 an axially chiral P,N-ligand that has found
widespread application in asymmetric catalysis, including enantioselective
hydroboration,50 allylic alkylation,51 and hydrogenation52 (Scheme 5.8b).†  Having
developed an expedient method for the construction of naphthyl 3-hydroxyisoquinoline
576i, we set out to demonstrate the feasibility of our synthetic approach.  Following the
acyl-alkylation/condensation sequence, the resulting hydroxyisoquinoline (576i) was
subjected to triflation.  Next, reduction of triflate 579 yielded naphthyl isoquinoline 580,
which was subsequently brominated via nitrogen-directed palladium-catalyzed C–H
activation to furnish bromide 581.53  Finally, implementation of a modified version of
                                                 
† The synthesis of QUINAP was carried out by Boram D. Hong, a graduate student in the Stoltz research
group.
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B u c h w a l d ' s  phosphine–aryl bromide  coupling54 afforded the desired target, QUINAP
(582).  Whereas the majority of previous approaches to this ligand rely on transition
metal-catalyzed cross coupling reactions to form the axial C–C bond,55 our synthetic
route represents a novel disconnection that ultimately builds the isoquinoline ring system
on to the existing framework of naphthoic acid.








    0 → 23 °C
2. Pd(PPh3)4, Cs2CO3
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5.2.4 Development of a One-Pot Aryne Acyl-Alkylation / Intramolecular
Condensation Reaction Sequence for the Synthesis of 2-Hydroxy-1,4-
naphthoquinones
The second class of compounds we investigated comprised a series of 2-hydroxy-1,4-
naphthoquinones (586) (Scheme 5.9).  These compounds are generated via intramolecular
condensation of the acyl-alkylated arene (584 ) to form an intermediate 1,3-
naphthalenediol (585), which then autooxidizes under an ambient atmosphere.  We first
encountered these compounds while working toward 3-hydroxyisoquinolines when we
noticed that β-ketoester substrates bearing an acidic γ-methylene (583) preferentially
formed the hydroxynaphthoquinone, albeit in low yield, through the action of NH4OH as
a base.  When aqueous potassium carbonate was added in its place and the mixture was
heated while open to air, the reaction proceeded cleanly to provide exclusively the
hydroxynaphthoquinone (586).56
Scheme 5.9. Synthesis of 2-hydroxy-1,4-naphthoquinones via one-pot aryne acyl-alkylation,
























Using these optimized conditions, we are able to generate a variety of
hydroxynaphthoquinones (588) possessing alkoxy (entry 1), aryl (entries 2–5), and even
indole (entries 6 and 7) substitution at C(3) (Table 5.6).  However, having optimized the
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reaction for β-ketoesters bearing electron-withdrawing functionality at the γ-position,
it was necessary to select a stronger base in order to target alkyl substituted products
(588i–k).  Fortunately, sodium methoxide provided a suitable alternative in such cases,
giving rise to simple natural product scaffolds such as phthiocol57 (entry 9) and O-des-
methyl-stoechadone58 (entry 10), as well as a derivative of arachidonic acid (entry 11).
Under both conditions, differentially substituted arynes (entries 4, 8, and 10) and
cyclohexyne (entry 5) performed comparably to benzyne (derived from 71).
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588c, R = H
588d, R = OMe
588g, R = H
588h, R = OCH2O
588j, R = OMe
588i, R = H
583a, R = OMe









































80 °C, 45–60 min
then K2CO3, H2O, air


















588a, R = OMe







a Acyl-alkylation/condensation reaction performed with 1.25 equiv 168 relative to β-ketoester 583.
b NaOMe (5 equiv) in MeOH (1.0 M) was used in place of K2CO3 in H2O.
c Methyl 3-oxovalerate (583f) is commercially available.
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5.3 CONCLUSION
The aryne acyl-alkylation reaction has enabled the synthesis of a wide array of
structural motifs ranging from simple ortho-disubstituted arenes to complex polycyclic
benzannulated scaffolds.  This methodology has provided the key bond-forming
transformation in routes toward two separate natural products, and progress toward a
third target is currently underway.  In an effort to extend the synthetic utility of this
technology, we have developed an extremely concise procedure for the preparation of 3-
hydroxyisoquinolines and 2-hydroxy-1,4-naphthoquinones directly from β-ketoesters
using a novel one-pot aryne acyl-alkylation/condensation sequence.  By employing this
procedure in conjunction with a one-step synthesis of β-ketoesters from carboxylic acids,
we are able to build these bicyclic aromatic structures in only two steps from
commercially available materials.  Furthermore, this two-step sequence is capable of
joining a variety of differentially functionalized β-ketoester and ortho-silyl aryl triflate
substrates to generate products bearing sterically and electronically diverse substitution.
The utility of this approach has been demonostrated in the synthesis of the axially chiral
P,N-ligand, QUINAP.  Given the proven scalability of the aryne acyl-alkylation step, this
approach is expected to enable the preparation of multigram quantities of either of these
product structures.  Further investigation of this methodology, including its utilization
toward more complex natural product targets, is currently underway in our laboratories.
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5.4 EXPERIMENTAL SECTION
5.4.1 Materials and Methods
Unless stated otherwise, reactions were performed in flame-dried glassware under an
argon or nitrogen atmosphere using dry, deoxygenated solvents (distilled or passed over a
column of activated alumina).  Commercially obtained reagents were used as received.
3-Methoxy-2-(trimethylsilyl)phenyl triflate (1 0 8 ) ,59 3 ,5-dimethoxy-2-
(trimethylsilyl)phenyl triflate (572),34 4,5-dimethoxy-2-(trimethylsilyl)phenyl triflate
(184),60 6-(trimethylsilyl)benzo[d][1,3]dioxol-5-yl triflate (155),1 4,5-difluoro-2-
(trimethylsilyl)phenyl triflate (185),36 and 2-(trimethylsilyl)cyclohexene triflate (573)45
were prepared according to literature procedures.  Reaction temperatures were controlled
by an IKAmag temperature modulator.  Brine solutions are saturated aqueous sodium
chloride solutions.  Thin-layer chromatography (TLC) was performed using E. Merck
silica gel 60 F254 precoated plates (0.25 mm) and visualized by UV fluorescence
quenching, potassium permanganate, or ceric ammonium molybdate staining.  SiliaFlash
P60 Academic Silica gel (particle size 0.040–0.063 mm) was used for flash
chromatography.  1H and 13C NMR spectra were recorded on a Varian Inova 500 (at 500
MHz and 125 MHz, respectively) and are reported relative to Me4Si (δ 0.0).  Data for 1H
NMR spectra are reported as follows: chemical shift (δ  ppm) (multiplicity, coupling
constant (Hz), integration).  Data for 13C NMR spectra are reported in terms of chemical
shift relative to Me4Si (δ 0.0).  IR spectra were recorded on a Perkin Elmer Paragon 1000
Spectrometer and are reported in frequency of absorption (cm–1).  High resolution mass
spectra were acquired using an Agilent 6200 Series TOF with an Agilent G1978A
Multimode source in electrospray ionization (ESI), atmospheric pressure chemical
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ionization (APCI) or mixed (MM) ionization mode, or obtained from the Caltech
Mass Spectral Facility (FAB+).
5.4.2 Preparative Procedures and Spectroscopic Data















This procedure is based on the method of Masamune, et al.46  A flame-dried 50 mL
round-bottomed flask equipped with a magnetic stir bar was charged with magnesium
chloride (0.469 g, 4.93 mmol, 1.0 equiv) and potassium monomethyl malonate (427)
(1.02 g, 6.53 mmol, 1.3 equiv).  A reflux condenser was attached and the flask was
subsequently evacuated and back-filled with argon.  Tetrahydrofuran (7.5 mL) was added
and the suspension was heated to 65 °C for 3 h.  After the above reaction had proceeded
for 2 h, a separate flame-dried 25 mL round-bottomed flask equipped with a magnetic stir
bar was charged with isoquinoline-1-carboxylic acid (574h) (0.852 g, 4.92 mmol, 1.0
equiv) and tetrahydrofuran (5 mL).  To this solution was added carbonyl diimidazole
(0.957 g, 5.90 mmol, 1.2 equiv) in portions, allowing for effervescence to subside
between additions.  Warning: vigorous gas evolution.  The reaction was stirred at 23 °C
until bubbling ceased (30 min), and then heated to 40 °C (at which point bubbling
renewed) for an additional 30 min.  The magnesium malonate suspension was cooled to
30 °C and the acyl-imidazole solution was added dropwise via syringe (NOTE: a white
precipitate forms rapidly during this addition; vigorous stirring is necessary to avoid
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clumping).  The resulting milky white suspension was stirred at 30 °C for 24 h.  The
reaction was cooled to 0 °C when TLC analysis showed complete consumption of the
intermediate acyl imidazole.  The reaction was quenched by the addition of 1.0 N HCl
(15 mL) and extracted with EtOAc (3 × 40 mL).  The combined organic layers were
sequentially washed with water (80 mL), saturated aqueous sodium bicarbonate (80 mL),
and brine (80 mL).  The organic layer was then dried over MgSO4, filtered, and
concentrated under reduced pressure.  The crude residue was purified via flash
chromatography over silica gel.





β-Ketoester 575h (Table 5.5, Entry 10)
Purified via flash chromatography (SiO2, 10:90 EtOAc/hexanes) to yield a clear colorless
oil (64% yield).  R f = 0.70 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 9.14–9.11 (m, 1H), 8.59 (d, J = 5.4 Hz, 1H), 7.89 (dd, J = 5.9, 2.4 Hz, 1H), 7.86 (dd, J
= 5.9, 1.0 Hz, 1H), 7.76–7.70 (comp m, 2H), 4.38 (s, 2H), 3.74 (s, 3H); 13C NMR (125
MHz, CDCl3) δ 196.6, 169.0, 150.5, 141.0, 137.1, 130.5, 129.6, 127.0, 126.7, 126.3,
125.4, 52.2, 46.8; IR (Neat Film, NaCl) 3055, 2952, 1744, 1698, 1580, 1436, 1323, 1104,
1089 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C13H11NO3 [M+H]+: 230.0812, found
230.0815.




β-Ketoester 575i (Table 5.5, Entry 11)
Purified via flash chromatography (SiO2, 5:95 → 8:92 EtOAc/hexanes) to yield a waxy
white solid (90% yield).  Rf = 0.64 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 5.45–5.32 (comp m, 8H), 3.75 (s, 3H), 3.45 (s, 2H), 2.84 (comp m, 6H), 2.56 (t, J = 7.3
Hz, 2H), 2.10 (dt, J = 7.3, 6.6 Hz, 2H), 2.07 (dt, J = 7.1, 7.1 Hz, 2H), 1.69 (tt, J = 7.6, 7.3
Hz, 2H), 1.41–1.26 (comp m, 6H), 0.90 (t, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3)
δ 202.5, 167.6, 130.5, 129.0, 128.9, 128.6, 128.3, 128.1, 127.8, 127.5, 52.3, 49.0, 42.3,
31.5, 29.3, 27.2, 26.3, 25.7, 25.6, 25.6, 23.2, 22.6, 14.1; IR (Neat Film, NaCl) 3434,
2928, 2858, 1743, 1716, 1438, 1321, 1175, 1083, 1002 cm-1; HRMS (MM: ESI–APCI)







β-Ketoester 575j (Table 5.5, Entry 12)
Purified via flash chromatography (SiO2, 5:95 → 10:90 EtOAc/hexanes) to yield a white
solid (96% yield).  Rf = 0.42 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 5.37
(d, J = 5.1 Hz, 1H), 4.64–4.57 (m, 1H), 3.73 (s, 3H), 3.45 (s, 2H), 2.62 (t, J = 9.0 Hz,
1H), 2.33 (dd, J = 3.7, 1.5 Hz, 1H), 2.31 (dd, J = 2.7, 2.2 Hz, 1H), 2.22–2.15 (m, 1H),
2.05–2.00 (comp m, 2H), 2.03 (s, 3H), 1.98 (td, J = 5.4, 2.0 Hz, 1H), 1.87 (app dd, J =
9.3, 2.4 Hz, 2H), 1.76–1.67 (comp m, 2H), 1.66–1.54 (comp m, 4H), 1.54–1.44 (comp m,
2H), 1.28–1.12 (comp m, 3H), 1.02 (s, 3H), 0.68 (s, 3H); 13C NMR (125 MHz, CDCl3)
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δ 203.5, 170.5, 167.7, 139.7, 122.2, 73.8, 63.1, 56.8, 52.2, 50.4, 49.8, 44.5, 38.6, 38.1,
37.0, 36.6, 31.9, 31.7, 27.7, 24.4, 23.1, 21.4, 21.0, 19.3, 13.4; IR (Neat Film, NaCl) 2945,
2903, 1748, 1732, 1709, 1438, 1374, 1310, 1245, 1032 cm-1; HRMS (MM: ESI–APCI)






β-Ketoester 575k (Table 5.5, Entry 13)62
Purified via flash chromatography (SiO2, 15:85 → 25:75 EtOAc/hexanes) to yield a clear
colorless oil (92% yield).  Rf = 0.20 (25:75 EtOAc/hexanes); product is isolated as a
1:0.8:0.3 mixture of bis(β-ketoester), E-mono-enolized, and Z-mono-enolized tautomers,
respectively.  1H NMR (500 MHz, CDCl3) δ 12.54 (s, 0.8H), 12.52 (s, 0.3H), 8.50 (t, J =
1.8 Hz, 1H), 8.35 (t, J = 1.8 Hz, 0.8H), 8.19 (dd, J = 7.5, 1.8 Hz, 2H), 8.03 (tt, J = 7.5,
1.8 Hz, 1H), 8.02 (tt, J = 7.5, 1.8 Hz, 0.8H), 7.88 (dd, J = 7.5, 1.8 Hz, 0.3H), 7.65 (t, J =
8.1 Hz, 1H), 7.57 (t, J = 7.8 Hz, 0.8H), 7.49 (t, J = 7.8 Hz, 0.3H), 5.75 (s, 0.8H), 5.74 (s,
0.3H), 4.06 (s, 4H), 4.05 (s, 1.6H), 3.83 (s, 2.4H), 3.83 (s, 0.9H), 3.78 (s, 6H), 3.77 (s,
2.4H), 3.77 (s, 0.9H); 13C NMR (125 MHz, CDCl3) bis(β-ketoester): δ 191.5, 167.5,
133.3, 131.0, 129.6, 128.5, 52.6, 45.7; combination of E - and Z-mono-enolized
tautomers: δ 191.8, 173.3, 170.5, 169.8, 167.7, 167.1, 136.5, 136.3, 134.2, 133.9, 130.9,
129.2, 128.9, 128.7, 126.1, 123.8, 88.1, 87.7, 52.6, 52.5, 51.6, 51.5, 48.7, 45.7; IR (Neat
Film, NaCl) 2955, 1742, 1689, 1654, 1625, 1438, 1327, 1268, 1199, 1150, 1012 cm-1;
HRMS (MM: ESI–APCI) m/z calc’d for C14H14O6 [M+H]+: 279.0863, found 279.0863.
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O (1.25 equiv), CsF (2.5 equiv)
MeCN (0.2 M), 80 °C, 1h,








A flame-dried 10 mL Schlenk flask with a septum-covered side arm equipped with a
magnetic stir bar was charged with cesium fluoride (0.152 g, 1.00 mmol, 2.5 equiv).  The
flask was evacuated and back-filled with argon (×2).  Acetonitrile (2 mL), methyl
acetoacetate (520a) (0.043 mL, 0.4 mmol, 1.0 equiv) and 2-(trimethylsilyl)phenyl
trifluoromethanesulfonate (71) (0.121 mL, 0.498 mmol, 1.25 equiv) were sequentially
added.  The screw valve was sealed and the reaction was heated to 80 °C while stirring
for 1 h.  The reaction was cooled to room temperature when TLC analysis showed
complete consumption of methyl acetoacetate (520a) (NOTE: at this point, the major
component of the reaction is the acyl-alkylated arene).  The screw valve was removed
under positive argon pressure and aqueous ammonium hydroxide (28% w/w, 2 mL) was
added via syringe.  The screw valve was replaced and tightened, and the reaction was
heated to 60 °C while stirring for 8 h.  The reaction was cooled to room temperature
when TLC analysis showed complete consumption of the intermediate acyl-alkylated
arene.  The mixture was diluted with brine (5 mL) and extracted with EtOAc (2 × 15
mL).  The aqueous layer was neutralized to pH 7 with 2.0 N HCl and extracted again
with EtOAc (2 × 15 mL).  The aqueous layers were discarded and the combined organic
layers were extracted with 2.0 N HCl (3 × 20 mL) (NOTE: this process separates nitrogen
containing products capable of forming HCl salts (in aqueous phase) from other organic
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products (in organic phase)).  The organic layers were discarded and the combined
aqueous layers were neutralized to pH 7 with 2.0 N NaOH and extracted with EtOAc (3 ×
20 mL).  The combined organic layers were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The residue was purified either by recrystallization or flash
chromatography over silica gel.





Purified via recrystallization from boiling EtOAc to yield a yellow solid (84% yield).  1H
NMR (500 MHz, DMSO-d6) δ 11.18 (br s, 1H), 7.99 (dd, J = 8.5, 1.0 Hz, 1H), 7.62 (d, J
= 8.5 Hz, 1H), 7.51 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H), 7.26 (ddd, J = 8.3, 6.8, 1.0 Hz, 1H),
6.67 (s, 1H), 2.77 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 159.8, 157.2, 140.4, 130.6,
126.3, 126.1, 123.5, 122.1, 99.2, 21.3; IR (Neat Film, NaCl) 3384, 3244, 2641, 1668,
1627, 1454, 1382, 1234 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C10H9NO [M+H]+:
160.0757, found 160.0765.





3-Hydroxyisoquinoline 571a (Table 5.4, Entry 1)
Purified via recrystallization from boiling EtOAc to yield a yellow solid (70% yield).  1H
NMR (500 MHz, DMSO-d6) δ 10.94 (br s, 1H), 7.33 (dd, J = 8.1, 7.6 Hz, 1H), 7.08 (d, J
= 8.1 Hz, 1H), 6.59 (d, J = 7.6 Hz, 1H), 6.52 (s, 1H), 3.88 (s, 3H), 2.87 (s, 3H); 13C NMR
(125 MHz, DMSO-d6) δ 159.7, 158.6, 155.5, 143.7, 131.2, 118.4, 114.1, 102.4, 100.2,
56.0, 26.6; IR (Neat Film, NaCl) 2590, 1651, 1627, 1587, 1502, 1438, 1388 cm-1; HRMS






3-Hydroxyisoquinoline 571b (Table 5.4, Entry 2)64
Purified via recrystallization from boiling EtOAc to yield a yellow solid (81% yield).  1H
NMR (500 MHz, DMSO-d6) δ 6.40 (s, 1H), 6.29 (s, 1H), 6.10 (s, 1H), 3.83 (s, 3H), 3.80
(s, 3H), 2.76 (s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 161.8, 160.2, 160.0, 159.9,
157.9, 140.8, 122.2, 106.7, 98.8, 56.1, 55.7, 20.1; IR (Neat Film, NaCl) 2921, 2719,
1666, 1641, 1624, 1560, 1497, 1430, 1178 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for
C12H13NO3 [M+H]+: 220.0968, found 220.0963.





3-Hydroxyisoquinoline 571c (Table 5.4, Entry 3)65
Purified via recrystallization from boiling EtOAc to yield a yellow solid (75% yield).  1H
NMR (500 MHz, CDCl3) δ 6.83 (s, 1H), 6.64 (s, 1H), 6.58 (s, 1H), 4.00 (s, 3H), 3.95 (s,
3H), 2.82 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 162.2, 155.1, 147.7, 146.4, 142.0,
113.5, 104.8, 102.9, 102.5, 56.3, 56.1, 17.5; IR (Neat Film, NaCl) 3251, 2939, 2836,
1645, 1488, 1433, 1245, 1161, 1029 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for





3-Hydroxyisoquinoline 571d (Table 5.4, Entry 4)64
Purified via recrystallization from boiling EtOAc to yield a yellow solid (77% yield).  1H
NMR (500 MHz, DMSO-d6) δ 7.25 (s, 1H), 6.96 (s, 1H), 6.50 (s, 1H), 6.08 (s, 2H), 2.60
(s, 3H); 13C NMR (125 MHz, DMSO-d6) δ 159.6, 151.3, 145.7, 139.9, 131.6, 106.9,
105.0, 101.8, 101.4, 101.1, 20.8; IR (Neat Film, NaCl) 3306, 2918, 1658, 1651, 1620,
1478, 1433, 1231 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C11H9NO3 [M+H]+:
204.0655, found 204.0656.





3-Hydroxyisoquinoline 571e (Table 5.4, Entry 5)
Purified via recrystallization from boiling EtOAc to yield a pale yellow solid (73% yield).
1H NMR (500 MHz, DMSO-d6) δ 10.86 (br s, 1H), 8.04 (dd, J = 12.0, 8.3 Hz, 1H), 7.71
(dd, J = 12.0, 8.1 Hz, 1H), 6.73 (s, 1H), 2.74 (s, 3H); 13C NMR (125 MHz, DMSO-d6)
δ 160.3 (d, JC–F = 2.3 Hz), 153.5 (d, JC–F = 16.6 Hz), 151.5 (d, JC–F = 16.6 Hz), 148.0 (d,
JC–F = 16.6 Hz), 146.1 (d, JC–F = 16.6 Hz), 138.3 (d, JC–F = 9.7 Hz), 113.1 (d, JC–F = 15.2
Hz), 111.8 (d, JC–F = 17.5 Hz), 99.2, 21.7; 19F NMR (282 MHz, DMSO-d6) δ –132.5 (app
quintet, J = 11.0 Hz), –140.5 (app q, J = 11.0 Hz); IR (Neat Film, NaCl) 2613, 1679,
1656, 1516, 1488, 1454, 1336 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C10H7F2NO




3-Hydroxyisoquinoline 571f (Table 5.4, Entry 6)66
Purified via flash chromatography (SiO2, 20:80 EtOAc/hexanes) to yield a white solid
(54% yield).  1H NMR (500 MHz, CDCl3) δ 6.18 (s, 1H), 2.64 (t, J = 6.1 Hz, 2H), 2.44 (t,
J = 6.5 Hz, 2H), 2.27 (s, 3H), 1.80–1.74 (comp m, 2H), 1.73–1.67 (comp m, 2H); 13C
NMR (125 MHz, CDCl3) δ 164.2, 154.3, 142.3, 114.3, 114.2, 30.2, 24.2, 23.0, 22.2, 16.5;
IR (Neat Film, NaCl) 2942, 1651, 1609, 1536, 1450, 1251, 1172, 1103 cm-1; HRMS
(MM: ESI–APCI) m/z calc’d for C10H13NO [M+H]+: 164.1070, found 164.1065.




3-Hydroxyisoquinoline 576a (Table 5.5, Entry 1)
Purified via flash chromatography (SiO2, 40:60 →  50:50 EtOAc/hexanes) to yield a
yellow solid (82% yield).  Rf = 0.20 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 8.10 (dd, J = 8.8, 1.0 Hz, 1H), 7.64 (d, J = 8.6 Hz, 1H), 7.53 (ddd, J = 8.5, 6.8, 1.2 Hz,
1H), 7.29 (ddd, J = 8.8, 6.8, 1.2 Hz, 1H), 6.99 (s, 1H), 5.02 (s, 2H), 3.51 (s, 3H); 13C
NMR (125 MHz, CDCl3) δ 159.8, 153.3, 141.8, 131.0, 126.1, 125.6, 123.9, 121.2, 104.0,
71.5, 58.7; IR (Neat Film, NaCl) 2929, 2670, 2595, 1629, 1562, 1514, 1457, 1326, 1103




3-Hydroxyisoquinoline 576b (Table 5.5, Entry 2)
Purified via flash chromatography (SiO2, 15:85 EtOAc/hexanes) to yield a yellow solid
(81% yield).  Rf = 0.20 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.89 (d, J
= 8.8 Hz, 1H), 7.45 (d, J = 8.6 Hz, 1H), 7.37 (ddd, J = 8.5, 6.6, 1.0 Hz, 1H), 7.09 (ddd, J
= 8.8, 6.6, 1.0 Hz, 1H), 6.73 (s, 1H), 3.46 (tt, J = 11.8, 3.4 Hz, 1H), 2.04–1.76 (comp m,
7H), 1.54–1.42 (comp m, 3H); 13C NMR (125 MHz, CDCl3) δ 160.7, 159.8, 143.2, 131.0,
126.3, 125.1, 122.5, 117.5, 104.4, 39.8, 31.5, 26.7, 25.6; IR (Neat Film, NaCl) 3208,
2930, 2855, 1694, 1651, 1602, 1452, 1374, 1258, 1066 cm-1; HRMS (MM: ESI–APCI)
m/z calc’d for C15H17NO [M+H]+: 228.1383, found 228.1382.
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3-Hydroxyisoquinoline 576c (Table 5.5, Entry 3)67
Purified via flash chromatography (SiO2, 40:60 EtOAc/hexanes) to yield a yellow solid
(79% yield).  Rf = 0.27 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.81 (dd, J
= 8.8, 1.0 Hz, 1H), 7.61 (t, J = 7.8 Hz, 1H), 7.61–7.58 (m, 2H), 7.56–7.52 (comp m, 3H),
7.49 (ddd, J = 8.8, 6.6, 1.2 Hz, 1H), 7.18 (ddd, J = 8.8, 6.6, 1.2 Hz, 1H), 6.93 (s, 1H); 13C
NMR (125 MHz, CDCl3) δ 160.0, 157.1, 142.0, 136.4, 130.7, 130.0, 129.2, 128.4, 127.8,
125.9, 123.7, 121.2, 103.1; IR (Neat Film, NaCl) 3151, 3058, 2883, 1662, 1639, 1552,






3-Hydroxyisoquinoline 576d (Table 5.5, Entry 4)
Purified via flash chromatography (SiO2, 30:70 EtOAc/hexanes) to yield a yellow solid
(68% yield).  Rf = 0.14 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.93 (dd, J
= 8.5, 1.0 Hz, 1H), 7.63 (d, J = 8.5 Hz, 1H), 7.50 (ddd, J = 8.5, 6.6, 1.2 Hz, 1H), 7.19
(ddd, J = 8.5, 6.6, 1.0 Hz, 1H), 6.93 (s, 1H), 6.80 (s, 2H), 3.95 (s, 3H), 3.83 (s, 6H); 13C
NMR (125 MHz, CDCl3) δ 160.1, 156.0, 153.0, 142.4, 138.8, 131.1, 130.9, 127.7, 126.0,
123.7, 120.5, 107.3, 103.5, 60.9, 56.1; IR (Neat Film, NaCl) 3191, 2940, 1711, 1694,
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1679, 1640, 1585, 1505, 1454, 1414, 1354, 1335, 1236, 1127 cm-1; HRMS (MM:







3-Hydroxyisoquinoline 576e (Table 5.5, Entry 5)
Purified via flash chromatography (SiO2, 40:60 →  80:20 EtOAc/hexanes) to yield a
yellow-orange solid (73% yield).  Rf = 0.15 (70:30 EtOAc/hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.10 (s, 1H), 6.80 (s, 1H), 6.72 (app s, 3H), 6.01 (s, 2H), 3.92 (s, 3H), 3.82 (s,
6H); 13C NMR (125 MHz, CDCl3) δ 160.4, 153.1, 152.1, 150.5, 146.4, 142.6, 138.7,
130.2, 115.7, 106.9, 105.5, 101.8, 101.5, 100.6, 60.9, 56.1; IR (Neat Film, NaCl) 3181,
2938, 1643, 1612, 1584, 1455, 1236, 1126 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for




3-Hydroxyisoquinoline 576f (Table 5.5, Entry 6)
Purified via flash chromatography (SiO2, 25:75 → 35:65 EtOAc/hexanes) to yield a red-
orange solid (85% yield).  Rf = 0.13 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 8.47 (d, J = 8.8 Hz, 1H), 7.66 (s, 1H), 7.61 (d, J = 8.3 Hz, 1H), 7.49 (t, J = 7.6 Hz, 1H),
7.28 (d, J = 7.3 Hz, 1H), 7.18 (d, J = 3.4 Hz, 1H), 6.97 (s, 1H), 6.60 (dd, J = 3.4, 1.2 Hz,
1H); 13C NMR (125 MHz, CDCl3) δ 159.8, 150.3, 144.4, 144.1, 142.5, 130.8, 126.9,
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126.1, 124.4, 119.7, 114.0, 112.1, 104.6; IR (Neat Film, NaCl) 3057, 2893, 1634,
1551, 1444, 1300, 1152 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C13H9NO2




3-Hydroxyisoquinoline 576g (Table 5.5, Entry 7)
Purified via flash chromatography (SiO2, 40:60 →  70:30  EtOAc/hexanes) to yield a
yellow solid (72% yield).  Rf = 0.20 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 8.81 (ddd, J = 4.9, 1.0, 0.7 Hz, 1H), 8.22 (dd, J = 8.7, 0.7 Hz, 1H), 7.90 (td, J = 7.6, 1.7
Hz, 1H), 7.85 (dt, J = 7.8, 1.0 Hz, 1H), 7.65 (d, J = 8.6 Hz, 1H), 7.51 (ddd, J = 8.6, 6.6,
1.0 Hz, 1H), 7.44 (ddd, J = 7.6, 4.9, 1.2 Hz, 1H), 7.27 (ddd, J = 8.9, 6.6, 1.0 Hz, 1H),
7.03 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 159.4, 155.2, 154.0, 149.3, 142.1, 136.8,
130.7, 127.4, 125.9, 125.4, 124.5, 123.7, 121.4, 104.3; IR (Neat Film, NaCl) 3056, 2665,
1626, 1587, 1555, 1445, 1312, 1132 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for




3-Hydroxyisoquinoline 576h (Table 5.5, Entry 8)
Purified via flash chromatography (SiO2, 60:40 EtOAc/hexanes →  80:15:5
EtOAc/hexanes/CH2Cl2) to yield a yellow solid (94% yield).  Rf = 0.13 (70:30
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EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.62 (dd, J = 5.1, 0.7 Hz, 1H), 7.73
(td, J = 7.6, 1.7 Hz, 1H), 7.39 (d, J = 7.8 Hz, 1H), 7.32 (t, J = 7.8 Hz, 1H), 7.30 (ddd, J =
7.3, 4.9, 1.0 Hz, 1H), 7.06 (d, J = 8.5 Hz, 1H), 6.70 (br s, 1H), 6.38 (d, J = 7.6 Hz, 1H),
3.46 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 159.5, 156.9, 148.3, 144.2, 135.3, 131.6,
130.1, 124.0, 122.8, 121.6, 118.4, 115.0, 113.0, 102.3, 55.2; IR (Neat Film, NaCl) 3062,
2937, 1643, 1638, 1556, 1434, 1390, 1281, 1147 cm-1; HRMS (MM: ESI–APCI) m/z
calc’d for C15H12N2O2 [M+H]+: 253.0972, found 253.0843.
N
OH
3-Hydroxyisoquinoline 576i (Table 5.5, Entry 9)
Purified via flash chromatography (SiO2, 20:80 EtOAc/hexanes →  80:10:10
EtOAc/hexanes/CH2Cl2) to yield a yellow solid (69% yield).  Rf = 0.15 (25:75
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.03 (d, J = 8.6 Hz, 1H), 7.97 (d, J = 8.3
Hz, 1H), 7.65 (d, J = 8.5 Hz, 1H), 7.64 (dd, J = 8.5, 7.1 Hz, 1H), 7.58 (dd, J = 7.1, 1.5
Hz, 1H), 7.52 (ddd, J = 8.3, 6.6, 1.5 Hz, 1H), 7.48 (ddd, J = 8.5, 6.6, 1.0 Hz, 1H), 7.41
(dd, J = 7.8, 0.5 Hz, 1H), 7.37 (dd, J = 6.6, 1.2 Hz, 1H), 7.35 (dd, J = 8.1, 0.5 Hz, 1H),
7.05 (ddd, J = 8.6, 6.6, 1.2 Hz, 1H), 6.96 (s, 1H); 13C NMR (125 MHz, CDCl3) δ 159.3,
156.4, 141.5, 134.2, 133.6, 132.0, 130.9, 129.5, 128.4, 127.8, 126.7, 126.2, 125.8, 125.7,
125.1, 123.8, 122.8, 105.0, 103.0; IR (Neat Film, NaCl) 2968, 2665, 2582, 1626, 1601,
1558, 1449, 1317 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C19H13NO [M+H]+:
272.1070, found 272.1082.




3-Hydroxyisoquinoline 576j (Table 5.5, Entry 10)
Purified via flash chromatography (SiO2, 50:50 →  60:40 EtOAc/hexanes) to yield a
yellow solid (68% yield).  Rf = 0.30 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 8.74 (d, J = 5.9 Hz, 1H), 7.97 (d, J = 8.3 Hz, 1H), 7.85 (dd, J = 5.9, 1.0 Hz, 1H), 7.72
(ddd, J = 8.3, 6.6, 1.0 Hz, 1H), 7.70 (d, J = 8.6 Hz, 1H), 7.64 (dd, J = 8.6, 1.0 Hz, 1H),
7.52 (ddd, J = 8.5, 6.6, 1.0 Hz, 1H), 7.47 (ddd, J = 8.5, 6.8, 1.2 Hz, 1H), 7.44 (dd, J = 8.5,
1.0 Hz, 1H), 7.15 (ddd, J = 8.6, 6.8, 1.2), 7.02 (d, J = 0.5 Hz, 1H); 13C NMR (125 MHz,
CDCl3) δ 158.9, 156.4, 155.4, 142.2, 141.2, 136.6, 130.7, 130.5, 127.7, 127.6, 127.2,
127.0, 126.9, 125.9, 124.4, 123.4, 121.4, 102.7; IR (Neat Film, NaCl) 3053, 2665, 2586,
1624, 1554, 1448, 1318, 1136 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C18H12N2O
[M+H]+: 273.1022, found 273.1033.
N
OH
3-Hydroxyisoquinoline 576k (Table 5.5, Entry 11)
Purified via flash chromatography (SiO2, 15:85 EtOAc/hexanes) to yield a pale yellow oil
(81% yield).  Rf = 0.16 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.81 (dd, J
= 8.8, 1.0 Hz, 1H), 7.48 (d, J = 8.5 Hz, 1H), 7.40 (ddd, J = 8.5, 6.6, 1.0 Hz, 1H), 7.12
(ddd, J = 8.8, 6.6, 1.0 Hz, 1H), 6.76 (s, 1H), 5.49–5.31 (comp m, 8H), 3.26 (dd, J = 8.1,
7.8 Hz, 2H), 2.86–2.78 (comp m, 6H), 2.28 (dd, J = 7.1, 6.8 Hz, 2H), 2.05 (dd, J = 7.1,
7.1 Hz, 2H), 1.92 (tt, J = 7.8, 7.6 Hz, 2H), 1.38–1.24 (comp m, 6H), 0.88 (t, J = 6.8 Hz,
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3H); 13C NMR (125 MHz, CDCl3) δ 161.7, 156.4, 143.1, 131.3, 130.5, 129.1, 129.0,
128.6, 128.2, 128.1, 127.9, 127.6, 126.1, 125.7, 122.7, 118.3, 104.6, 31.5, 31.3, 30.4,
29.4, 27.2, 27.1, 25.7, 25.6, 25.5, 22.6, 14.1; IR (Neat Film, NaCl) 3265, 2930, 1697,







3-Hydroxyisoquinoline 576l (Table 5.5, Entry 12)
Purified via flash chromatography (SiO2, 15:85 →  50:50 EtOAc/hexanes) to yield a
yellow oil (62% yield).  Rf = 0.20 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 7.91 (d, J = 8.8 Hz, 1H), 7.45 (d, J = 8.5 Hz, 1H), 7.36 (ddd, J =  8.5, 6.6, 1.0 Hz, 1H),
7.05 (ddd, J = 8.8, 6.6, 1.2 Hz, 1H), 6.72 (s, 1H), 5.42 (d, J = 5.1 Hz, 1H), 4.62 (dddd, J =
5.9, 5.6, 5.4, 4.1 Hz, 1H), 3.72 (app t, J = 9.5 Hz, 1H), 2.67 (ddd, J = 11.2, 9.5, 2.5 Hz,
1H), 2.38–2.28 (comp m, 2H), 2.14–2.02 (comp m, 2H), 2.05 (s, 3H), 1.96–1.81 (comp
m, 3H), 1.71–1.40 (comp m, 8H), 1.32 (app qd, J = 12.5, 4.8 Hz, 1H), 1.14 (app td, J =
13.4, 3.9 Hz, 1H), 1.06 (app td, J = 12.0, 4.8 Hz, 1H), 0.99 (s, 3H), 0.66 (s, 3H); 13C
NMR (125 MHz, CDCl3) δ 171.3, 170.6, 159.9, 154.9, 143.0, 139.7, 130.9, 126.1, 122.4,
122.3, 119.9, 104.7, 73.8, 57.2, 50.5, 50.1, 47.0, 38.6, 38.1, 37.0, 36.7, 32.2, 31.9, 27.7,
26.4, 25.0, 21.5, 21.0, 19.3, 13.5; IR (Neat Film, NaCl) 3221, 2943, 1729, 1711, 1600,
1438, 1375, 1365, 1249, 1033 cm-1; HRMS (FAB+) m/z calc’d for C30H37NO3 [M+H]+:
460.2846, found 460.2845.
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3-Hydroxyisoquinoline 576m (Table 5.5, Entry 13)68
Purified via flash chromatography (SiO2, 50:50 →  75:25 EtOAc/hexanes) to yield a
yellow solid (66% yield).  Rf = 0.46 (70:30 EtOAc/hexanes); 1H NMR (500 MHz,
CD3OD) δ 7.93 (t, J = 8.5 Hz, 2H), 7.91 (t, J = 1.2 Hz, 1H), 7.85 (dd, J = 8.1, 1.2 Hz,
2H), 7.79 (dd, J = 8.5, 7.1 Hz, 1H), 7.70 (d, J = 8.5 Hz, 2H), 7.56 (ddd, J = 8.5, 6.8, 1.2
Hz, 2H), 7.27 (ddd, J = 8.5, 6.6, 1.2 Hz, 2H), 6.95 (s, 2H); 13C NMR (125 MHz, DMSO-
d6) δ 167.9, 160.0, 141.1, 139.1, 131.5, 130.6, 130.4, 128.6, 127.2, 126.4, 124.6, 122.0,
100.5; IR (Neat Film, NaCl) 3181, 3063, 2958, 1671, 1639, 1624, 1555, 1446, 1343,
1281, 1152, 1024 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C24H16N2O2 [M+H]+:
365.1285, found 365.1293.
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A flame-dried 1 dram vial equipped with a magnetic stir bar and a screw cap with
PTFE septum was charged with 3-hydroxyisoquinoline 576f (0.028 g, 0.133 mmol) and
pyridine (0.7 mL).  The mixture was cooled to 0 °C in an ice bath while stirring, and Tf2O
(0.033 mL, 0.196 mmol, 1.5 equiv) was then added dropwise via syringe. The reaction
was stirred at 0 °C for 5 minutes, after which the ice bath was removed.  The resulting
brown solution was allowed to warm to room temperature while stirring for 11 hours.
When TLC analysis showed complete consumption of the 3-hydroxyisoquinoline 576f,
the reaction was quenched by the addition of saturated aqueous sodium bicarbonate (1
mL) and extracted with EtOAc (3 × 10 mL).  The combined organic layers were washed
with brine (15 mL), dried over MgSO4, filtered, and concentrated under reduced pressure.
The crude residue was purified via flash chromatography over silica gel (SiO2, 10:90
EtOAc/hexanes) to yield triflate A5-1 as a pale yellow oil (0.040 g, 88% yield). Rf = 0.70
(25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 9.80 (dd, J = 8.6, 0.7 Hz, 1H),
7.89 (d, J = 8.1 Hz, 1H), 7.77 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.75 (d, J = 0.73 Hz, 1H),
7.70 (ddd, J = 8.6, 6.8, 1.5 Hz, 1H), 7.44 (s, 1H), 7.40 (dd, J = 3.4, 0.7 Hz, 1H), 6.67 (dd,
J = 3.4, 1.7 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 153.6, 151.0, 148.2, 144.9, 140.3,
131.3, 128.5, 127.5, 127.4, 124.8, 118.8 (q, JC–F = 320.8 Hz), 115.0, 112.4, 109.4; 19F
NMR (282 MHz, CDCl3) δ –72.8; IR (Neat Film, NaCl) 3141, 3077, 2923, 1593, 1547,
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1484, 1420, 1321, 1224, 1212, 1139, 1109, 1016 cm-1; HRMS (EI+) m/z calc’d for
















A flame-dried 1 dram vial equipped with a magnetic stir bar and a screw cap with a
PTFE septum was charged with Pd(PPh3)4 (0.0035 g, 0.003 mmol, 0.05 equiv), caesium
carbonate (0.0220 g, 0.068 mmol, 1.2 equiv), and 4-methoxyphenylboronic acid (577)
(0.0142 g, 0.093 mmol, 1.6 equiv).  The vial was evacuated and backfilled with argon
(×2).  Isoquinoline triflate A5-1 (0.020 g, 0.058 mmol) in toluene (0.6 mL) was added via
syringe followed by ethanol (0.06 mL).  The vial was sealed and heated to 100 °C.  After
stirring for 18 h, the reaction was cooled to room temperature and filtered through a plug
of silica under EtOAc elution.  The solvents were removed under vacuum and the crude
yellow residue was purified via flash chromatography (SiO2, 3:97 EtOAc/hexanes) to
yield 1,3-diarylisoquinoline 578 as a colorless oil (0.0169 g, 97% yield).  Rf = 0.37 (15:85
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.86 (dd, J = 8.5, 1.0 Hz, 1H), 8.18 (d, J
= 8.8 Hz, 2H), 7.94 (s, 1H), 7.87 (ddd, J = 8.1, 0.7, 0.5 Hz, 1H), 7.74 (dd, J = 1.7, 0.7 Hz,
1H), 7.67 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.58 (ddd, J = 8.5, 6.8, 1.5 Hz, 1H), 7.37 (dd, J
= 3.4, 0.7 Hz, 1H), 7.05 (d, J = 9.0 Hz, 2H), 6.67 (dd, J = 3.4, 2.0 Hz, 1H), 3.90 (s, 3H);
13C NMR (125 MHz, CDCl3) δ 160.2, 155.0, 149.8, 148.4, 143.7, 138.3, 132.0, 130.0,
128.2, 127.4, 127.0, 126.9, 124.2, 114.9, 114.1, 112.6, 111.8, 55.4; IR (Neat Film, NaCl)
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3052, 2958, 2933, 2835, 1607, 1554, 1514, 1487, 1439, 1334, 1289, 1249, 1173,
1033, 1012 cm-1; HRMS (EI+) m/z  calc’d for C20H15NO2 [M•]+: 301.1103, found
301.1099.
5.4.2.6 Synthesis of QUINAP
Spectroscopic data is provided only for those compounds that have not been
previously reported in the literature (i.e., 579).  Spectroscopic data for compounds 580,69









A flame-dried 10 mL round-bottomed flask equipped with a magnetic stir bar was
charged with 3-hydroxyisoquinoline 576i (0.053 g, 0.195 mmol) and pyridine (1.2 mL).
The mixture was cooled to 0 °C in an ice bath while stirring, and Tf2O (0.056 mL, 0.333
mmol, 1.7 equiv) was then added dropwise via syringe. The reaction was stirred at 0 °C
for 5 minutes, after which the ice bath was removed.  The resulting orange brown
solution was allowed to warm to room temperature while stirring for 12 hours. When
TLC analysis showed complete consumption of the 3-hydroxyisoquinoline 576i, the
reaction was quenched by the addition of water (10 mL) and extracted with EtOAc (3 ×
10 mL).  The combined organic layers were dried over MgSO4, filtered, and concentrated
under reduced pressure.  The crude residue was purified via flash chromatography over
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silica gel (SiO2, 5:95 → 10:90 EtOAc/hexanes) to yield triflate 579 as a colorless oil
(0.0782 g, 99% yield). Rf = 0.70 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ
8.04 (d, J = 8.1 Hz, 1H), 8.01 (d, J = 8.3 Hz, 1H), 7.97 (d, J = 8.3 Hz, 1H), 7.78 (ddd, J =
8.3, 6.8, 1.2 Hz, 1H), 7.72 (dd, J = 8.5, 1.0 Hz, 1H), 7.69 (d, J = 0.7 Hz, 1H), 7.63 (dd, J
= 7.0, 8.1 Hz, 1H), 7.58 (dd, J = 7.1, 1.5 Hz, 1H), 7.52 (ddd, J = 8.3, 6.8, 1.2 Hz, 1H),
7.49 (ddd, J = 8.5, 6.8, 1.0 Hz, 1H), 7.45 (dd, J = 8.6, 1.0 Hz, 1H), 7.38 (ddd, J = 8.6, 6.8,
1.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 161.0, 151.3, 139.2, 134.7, 133.7, 131.9,
131.6, 129.7, 128.4, 128.3, 128.2, 128.2, 127.3, 126.7, 126.2, 125.6, 125.0, 118.8 (q, J =
320.8 Hz), 110.4; 19F (282 MHz, CDCl3) δ –72.9; IR (Neat Film, NaCl) 3066, 1622,
1594, 1553, 1509, 1504, 1422, 1321, 1244, 1227, 1212, 1138, 1110 cm-1; HRMS (EI+)









A flame-dried 1 dram vial equipped with a magnetic stir bar and a screw cap with a
PTFE septum was charged with 1-(1’-naphthyl)-3-(trifluoromethanesulfonyloxy)-
isoquinoline 579 (0.020 g, 0.0496 mmol) and DMF (0.6 mL).  The mixture was stirred
for approximately 5 minutes at room temperature, after which Pd(PPh3)2Cl2 (0.075 g,
0.0107 mmol, 20 mol%), Et3N (0.040 mL, 0.287 mmol, 5.8 equiv), and formic acid
(0.020 mL, 0.530 mmol, 10.6 equiv) were added sequentially.  The resulting mixture was
heated to 110 °C for 90 minutes.  The reaction was then cooled to room temperature
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when TLC analysis showed complete consumption of triflate 579, diluted with water
(2 mL), and extracted with EtOAc (3 × 10 mL). The combined organic layers were dried
over MgSO4, filtered, and concentrated under reduced pressure. The crude residue was
purified via flash chromatography over silica gel (SiO2, 5:95 → 20:80 EtOAc/hexanes) to
yield napthyl isoquinoline 580 as a white solid (0.0087 g, 70% yield).  Spectroscopic data









This procedure is based on the method of Sanford et al.53b  A flame-dried 1 dram vial
equipped with a magnetic stir bar and a screw cap with a PTFE septum was charged with
naphthyl isoquinoline 580 (0.021 mg, 0.081 mmol), Pd(OAc)2 (0.063 g, 0.028 mmol, 35
mol%), NBS (0.016 g, 0.090 mmol, 1.1 equiv), and AcOH (0.8 mL).  The vial was sealed
with a Teflon-lined screw cap, and the mixture was heated to 120 °C while stirring for 17
hours.  The solvent was then evaporated under reduced pressure and the crude residue
was purified by flash chromatography over silica gel (SiO2, 5:95 →  20:80
EtOAc/hexanes) to yield bromonaphthyl isoquinoline 581 as a colorless film (0.0039 g,
15% yield).  Spectroscopic data matched those reported in the literature.55b













This procedure is based on our previously reported variant of Buchwald’s copper-
catalyzed phosphine–aryl halide coupling reaction.54  A flame-dried 1 dram vial equipped
with a magnetic stir bar and a screw cap with a PTFE septum was charged with copper(I)
iodide (0.0022 g, 0.012 mmol, 70 mol%), diphenylphosphine (0.0061 mL, 0.035 mmol,
2.1 equiv), N,N’-dimethylethylenediamine (0.002 mL,  0.019 mmol, 1.1 equiv), and
toluene (0.1 mL).  The mixture was stirred for 30 minutes at room temperature.
Following this, caesium carbonate (0.0221 g, 0.068 mmol, 4 equiv), 1-(2-bromo-1-
naphthyl)isoquinoline (581) (0.0055 g, 0.017 mmol, 1 equiv), and toluene (0.15 mL)
were added, and the vial was sealed and heated to 110 °C.  After stirring for 14 hours, the
reaction mixture was allowed to cool to room temperature and filtered through celite
under dichloromethane elution (20 mL).  The solution was concentrated under reduced
pressure and the crude residue was purified via flash chromatography (SiO2, 5:95 →
10:90 EtOAc/hexanes) to yield QUINAP (582) as a colorless film (0.0075 g, 99% yield).
Spectroscopic data matched those reported in the literature.55a
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O (1.25 equiv), CsF (2.5 equiv)
MeCN (0.2 M), 80 °C, 1 h,
then K2CO3, H2O, air





A flame-dried 15 mL reaction tube equipped with a magnetic stir bar was charged
with cesium fluoride (0.152 g, 1.00 mmol, 2.5 equiv).  The reaction tube was sealed with
a rubber septum, evacuated, and back-filled with argon (×2).  Acetonitrile (2 mL), methyl
3-oxo-4-phenylbutanoate (583b ) (0.077 g, 0.4 mmol, 1.0 equiv) and 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate (71) (0.121 mL, 0.498 mmol, 1.25
equiv) were sequentially added.  The reaction was then heated to 80 °C while stirring for
1 h.  The reaction was cooled to room temperature when TLC analysis showed complete
consumption of methyl 3-oxo-4-phenylbutanoate (583b) (NOTE: at this point, the major
component of the reaction is the acyl-alkylated arene).  Potassium carbonate (0.276 g, 5.0
equiv) in water (2 mL) was added via syringe and the biphasic mixture was vigorously
stirred at room temperature for 30 min.  The septum was then removed and the reaction
was heated to 60 °C while open to air for 12 h.  The reaction was cooled to room
temperature when TLC analysis showed complete consumption of the acyl-alkylated
arene intermediate.  The reaction was diluted with EtOAc (10 mL) and extracted with 1.0
N K2CO3 (5 × 15 mL).  The organic layer was discarded.  The combined aqueous layers
were acidified to pH 1 with 2.0 N HCl (Warning: vigorous gas evolution) and extracted
with EtOAc (3 × 40 mL).  The combined organic layers were washed with brine (50 mL)
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and dried over MgSO4.  After filtration, the solvent was removed under reduced
pressure and the residue was purified via flash chromatography over silica gel.





2-Hydroxy-1,4-naphthoquinone 588a (Table 5.6, Entry 1)70
Purified via flash chromatography (SiO2, 40:60 EtOAc/hexanes) to yield an orange solid
(86% yield).  Rf = 0.11 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.11 (ddd,
J = 7.6, 1.5, 0.5 Hz, 1H), 8.06 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H), 7.74 (td, J = 7.6, 1.5 Hz,
1H), 7.69 (td, J = 7.6, 1.5 Hz, 1H), 6.91 (br s, 1H), 4.20 (s, 3H); 13C NMR (125 MHz,
CDCl3) δ 182.2, 181.1, 142.5, 140.5, 134.7, 133.4, 131.3, 129.1, 126.8, 126.1, 60.7; IR
(Neat Film, NaCl) 3370, 2967, 1673, 1639, 1592, 1461, 1276, 1203 cm-1; HRMS (MM:




2-Hydroxy-1,4-naphthoquinone 588b (Table 5.6, Entry 2)71
Purified via flash chromatography (SiO2, 10:90 EtOAc/hexanes) to yield a bright yellow
solid (92% yield).  Rf = 0.37 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.22
(dd, J = 7.8, 1.5 Hz, 1H), 8.17 (dd, J = 7.8, 1.5 Hz, 1H), 7.83 (td, J = 7.6, 1.5 Hz, 1H),
7.76 (td, J = 7.6, 1.5 Hz, 1H), 7.60 (br s, 1H), 7.52 (d, J = 7.1 Hz, 2H), 7.48 (t, J = 7.3
Hz, 2H), 7.42 (tt, J = 7.3, 1.5 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 183.9, 182.1,
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152.4, 135.5, 133.4, 133.1, 130.9, 130.2, 129.5, 128.9, 128.2, 127.5, 126.4, 122.4; IR
(Neat Film, NaCl) 3345, 3057, 1651, 1594, 1365, 1332, 1282, 1000 cm-1; HRMS (MM:






2-Hydroxy-1,4-naphthoquinone 588c (Table 5.6, Entry 3)72
Purified via flash chromatography (SiO2, 15:85 → 25:75 EtOAc/hexanes) to yield a dark
red solid (78% yield).  Rf = 0.45 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ
8.21 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H), 8.16 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H), 7.82 (td, J = 7.6,
1.2 Hz, 1H), 7.74 (td, J = 7.6, 1.2 Hz, 1H), 7.61 (br s, 1H), 7.17 (dd, J = 8.3, 2.2 Hz, 1H),
7.12 (d, J = 2.2 Hz, 1H), 6.98 (d, J = 8.3 Hz, 1H), 3.94 (s, 3H), 3.92 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 184.0, 181.8, 151.9, 149.4, 148.4, 135.2, 133.1, 132.9, 129.3, 127.3,
126.1, 124.0, 122.4, 121.9, 114.0, 110.6, 56.0, 55.9; IR (Neat Film, NaCl) 3363, 2938,
1712, 1655, 1594, 1516, 1364, 1260, 1145, 1026 cm-1; HRMS (MM: ESI–APCI) m/z
calc’d for C18H14O5 [M+H]+: 311.0914, found 311.0914.






2-Hydroxy-1,4-naphthoquinone 588d (Table 5.6, Entry 4)
Purified via flash chromatography (SiO2, 30:70 → 70:30 EtOAc/hexanes) to yield a dark
red solid (84% yield).  Rf = 0.10 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ
7.83 (dd, J = 7.6, 1.2 Hz, 1H), 7.67 (dd, J = 8.6, 7.6 Hz, 1H), 7.39 (dd, J = 8.6, 1.0 Hz,
1H), 7.13 (dd, J = 8.1, 1.5 Hz, 1H), 7.11 (d, J = 1.5 Hz, 1H), 6.95 (d, J = 8.1 Hz, 1H),
4.01 (s, 3H), 3.93 (s, 3H), 3.91 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 183.7, 182.2,
159.9, 150.5, 149.3, 148.2, 134.1, 131.6, 124.1, 123.4, 122.9, 120.1, 119.9, 119.0, 114.2,
110.5, 56.6, 56.0, 55.9; IR (Neat Film, NaCl) 3347, 2937, 2838, 1650, 1585, 1516, 1472,







2-hydroxy-5,6,7,8-tetrahydronaphtha-1,4-quinone 588e (Table 5.6, Entry 5)
Purified via flash chromatography (SiO2, 20:80 EtOAc/hexanes) to yield a red solid (61%
yield).  Rf = 0.53 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.25 (br s, 1H),
7.07 (dd, J = 8.6, 2.0 Hz, 1H), 7.03 (d, J = 2.0 Hz, 1H), 6.94 (d, J = 8.6 Hz, 1H), 3.92 (s,
3H), 3.89 (s, 3H), 2.52 (ddd, J = 12.5, 4.4, 2.0 Hz, 4H), 1.75 (comp m, 4H); 13C NMR
(125 MHz, CDCl3) δ 186.6, 183.6, 149.5, 149.2, 148.3, 145.3, 138.1, 123.7, 122.4, 118.7,
113.9, 110.6, 55.9, 55.8, 23.4, 22.1, 21.2, 21.0; IR (Neat Film, NaCl) 3347, 2937, 1639,
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1516, 1346, 1257, 1143, 1026 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for




2-Hydroxy-1,4-naphthoquinone 588f (Table 5.6, Entry 6)73
Purified via flash chromatography (SiO2, 50:50 → 70:30 EtOAc/hexanes) to yield a red-
orange solid (70% yield).  Rf = 0.37 (70:30 EtOAc/hexanes); 1H NMR (500 MHz,
CD3OD) δ 8.15 (dd, J = 7.3, 1.5 Hz, 1H), 8.12 (dd, J = 8.3, 1.0 Hz, 1H), 8.07 (dd, J = 7.6,
1.5 Hz, 1H), 7.83 (td, J = 7.5, 1.5 Hz, 1H), 7.79 (td, J = 7.5, 1.5 Hz, 1H), 7.74 (td, J =
7.6, 1.2 Hz, 1H), 7.60 (td, J = 7.6, 1.5 Hz, 1H), 7.57 (dd, J = 7.6, 1.5 Hz, 1H); 13C NMR
(125 MHz, DMSO-d6) δ 183.0, 181.5, 151.3, 149.3, 135.5, 134.2, 133.7, 133.5, 132.2,
130.5, 129.9, 127.0, 126.6, 126.5, 124.6, 105.0; IR (Neat Film, NaCl) 3325, 2923, 1674,
1639, 1523, 1363, 1303, 1286, 1263 cm-1; HRMS (FAB+) m/z calc’d for C16H9NO5
[M+H]+: 296.0553, found 296.0564.





2-Hydroxy-1,4-naphthoquinone 588g (Table 5.6, Entry 7)74
Purified via flash chromatography (SiO2, 5:95 → 15:85 EtOAc/hexanes) to yield a dark
blue solid (84% yield).  Rf = 0.17 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ
8.22 (ddd, J = 7.6, 1.5, 0.5 Hz, 1H), 8.16 (ddd, J = 7.6, 1.5, 0.5 Hz, 1H), 7.79 (td, J = 7.6,
1.5 Hz, 1H), 7.73 (td, J = 7.6, 1.2 Hz, 1H), 7.68 (br s, 1H), 7.65 (dt, J = 7.6, 1.0 Hz, 1H),
7.64 (s, 1H), 7.38 (dt, J = 8.3, 1.0 Hz, 1H), 7.29 (ddd, J = 8.3, 7.1, 1.2 Hz, 1H), 7.20
(ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 3.90 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 184.4, 181.2,
150.4, 136.9, 134.7, 133.2, 133.1, 133.0, 129.8, 127.2, 126.8, 125.9, 122.4, 122.1, 120.1,
118.1, 109.6, 104.2, 33.3; IR (Neat Film, NaCl) 3350, 3052, 2928, 1651, 1627, 1525,
1474, 1362, 1332, 1287, 1240, 1104 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for







2-Hydroxy-1,4-naphthoquinone 588h (Table 5.6, Entry 8)
Purified via flash chromatography (SiO2, 15:85 → 20:80 EtOAc/hexanes) to yield a dark
blue solid (88% yield).  Rf = 0.60 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 7.64 (br s, 1H), 7.63 (d, J = 8.1 Hz, 1H), 7.61 (s, 1H), 7.58 (s, 1H), 7.53 (s, 1H), 7.37
(d, J = 8.3 Hz, 1H), 7.28 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.19 (ddd, J = 8.1, 7.1, 1.0 Hz,
1H), 6.17 (s, 2H), 3.89 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 183.5, 180.1, 153.1, 151.6,
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150.1, 136.8, 132.8, 130.6, 126.8, 126.0, 122.3, 122.0, 120.0, 116.9, 109.5, 107.2,
105.4, 104.1, 102.7, 33.2; IR (Neat Film, NaCl) 3346, 2911, 1706, 1647, 1595, 1478,





2-Hydroxy-1,4-naphthoquinone 588i (Phthiocol) (Table 5.6, Entry 9)75,76
Purified via flash chromatography (SiO2, 10:90 →  15:85 EtOAc/hexanes) to yield a
yellow solid (80% yield).  Rf = 0.37 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 8.14 (ddd, J = 7.8, 1.2, 0.5 Hz, 1H), 8.09 (ddd, J = 7.6, 1.5, 0.5 Hz, 1H), 7.76 (td, J =
7.8, 1.5 Hz, 1H), 7.69 (td, J = 7.6, 1.2 Hz, 1H), 7.31 (br s, 1H), 2.12 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 185.0, 181.2, 153.1, 134.8, 133.0, 132.9, 129.4, 126.7, 126.1, 120.5,
8.9; IR (Neat Film, NaCl) 3336, 1658, 1592, 1395, 1349, 1305, 1278, 1208, 1181, 1072
cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C11H8O3 [M+H]+: 189.0546, found
189.0539.







(O-des-methyl-Stoechadone) (Table 5.6, Entry 10)75,77
Purified via flash chromatography (SiO2, 15:85 →  25:75 EtOAc/hexanes) to yield a
yellow-orange solid (63% yield).  Rf = 0.63 (50:50 EtOAc/hexanes); 1H NMR (500 MHz,
CDCl3) δ 7.56 (s, 1H), 7.48 (s, 1H), 7.28 (br s, 1H), 4.03 (s, 3H), 4.01 (s, 3H), 2.07 (s,
3H); 13C NMR (125 MHz, CDCl3) δ 184.8, 180.5, 154.3, 152.9, 152.5, 128.1, 123.5,
119.2, 108.7, 107.6, 56.6, 56.5, 8.6; IR (Neat Film, NaCl) 3371, 2964, 1638, 1579, 1375,





2-Hydroxy-1,4-naphthoquinone 588k (Table 5.6, Entry 11)75
Purified via flash chromatography (SiO2, 5:95 EtOAc/hexanes) to yield a yellow oil (66%
yield).  Rf = 0.33 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.13 (ddd, J =
7.6, 1.5, 0.5 Hz, 1H), 8.09 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H), 7.76 (td, J = 7.6, 1.2 Hz, 1H),
7.69 (td, J = 7.6, 1.5 Hz, 1H), 7.35 (br s, 1H), 5.50 (ddt, J = 18, 7.5, 1.5 Hz, 1H),
5.45–5.27 (comp m, 7H), 2.85–2.77 (comp m, 6H), 2.70 (app t, J = 7.5 Hz, 2H), 2.36 (dt,
J = 7.3, 7.1 Hz, 2H), 2.05 (dt, J = 7.3, 6.8 Hz, 2H), 1.38–1.24 (comp m, 6H), 0.88 (t, J =
6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 184.6, 181.4, 153.2, 134.9, 132.9, 132.8,
130.5, 129.4, 128.9, 128.8, 128.5, 128.2, 128.1, 127.9, 127.6, 126.8, 126.1, 123.8, 31.5,
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29.3, 27.2, 25.9, 25.6, 25.6, 25.5, 23.3, 22.6, 14.1; IR (Neat Film, NaCl) 3377, 3012,
2928, 2857, 1774, 1664, 1648, 1594, 1371, 1348, 1276, 1216 cm-1; HRMS (MM:
ESI–APCI) m/z calc’d for C28H34O3 [M+H]+: 419.2581, found 419.2580.
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APPENDIX 5
Spectra Relevant to Chapter 5:
Expedient Synthesis of 3-Hydroxyisoquinolines and 2-Hydroxy-1,4-
Naphthoquinones via One-Pot Aryne Acyl-Alkylation / Condensation
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Figure A5.1.3  13C NMR (125 MHz, CDCl3) of β-ketoester 575h
(Table 5.5, entry 10).
Figure A5.1.2  Infrared spectrum (thin film/NaCl) of β-ketoester 575h
(Table 5.5, entry 10).
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Figure A5.2.3  13C NMR (125 MHz, CDCl3) of β-ketoester 575i
(Table 5.5, entry 11).
Figure A5.2.2  Infrared spectrum (thin film/NaCl) of β-ketoester 575i
(Table 5.5, entry 11).
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Figure A5.3.3  13C NMR (125 MHz, CDCl3) of β-ketoester 575j
(Table 5.5, entry 12).
Figure A5.3.2  Infrared spectrum (thin film/NaCl) of β-ketoester 575j
(Table 5.5, entry 12).
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Figure A5.4.2  Infrared spectrum (thin film/NaCl) of β-ketoester 575k
(Table 5.5, entry 13).
Figure A5.4.3  13C NMR (125 MHz, CDCl3) of β-ketoester 575k
(Table 5.5, entry 13).
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Figure A5.5.3  13C NMR (125 MHz, DMSO-d6) of 3-hydroxyisoquinoline 569.
Figure A5.5.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 569.
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Figure 6.3  13C NMR (125 MHz, DMSO-d6) of 3-hydroxyisoquinoline 571a
(Table 5.4, entry 1).
Figure A5.6.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 571a
(Table 5.4, entry 1).
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Figure A5.7.3  13C NMR (125 MHz, DMSO-d6) of 3-hydroxyisoquinoline 571b
(Table 5.4, entry 2).
Figure A5.7.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 571b
(Table 5.4, entry 2).
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Figure A5.8.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 571c
(Table 5.4, entry 3).
Figure A5.8.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 571c
(Table 5.4, entry 3).
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Figure A5.9.3  13C NMR (125 MHz, DMSO-d6) of 3-hydroxyisoquinoline 571d
(Table 5.4, entry 4).
Figure A5.9.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 571d
(Table 5.4, entry 4).
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Figure A5.10.3  13C NMR (125 MHz, DMSO-d6) of 3-hydroxyisoquinoline 571e
(Table 5.4, entry 5).
Figure A5.10.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 571e
(Table 5.4, entry 5).
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Figure A5.11.3  13C NMR (125 MHz, CDCl3) of 3-hydroxy-5,6,7,8-
tetrahydroisoquinoline 571f (Table 5.4, entry 6).
Figure A5.11.2  Infrared spectrum (thin film/NaCl) of 3-hydroxy-
5,6,7,8-tetrahydroisoquinoline 571f (Table 5.4, entry 6).
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Figure A5.12.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576a
(Table 5.5, entry 1).
Figure A5.12.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576a
(Table 5.5, entry 1).
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Figure A5.13.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576b
(Table 5.5, entry 2).
Figure A5.13.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576b
(Table 5.5, entry 2).
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Figure A5.14.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576c
(Table 5.5, entry 3).
Figure A5.14.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576c
(Table 5.5, entry 3).
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Figure A5.15.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576d
(Table 5.5, entry 4).
Figure A5.15.2  Infrared spectrum (thin film/NaCl) of of 3-hydroxyisoquinoline 576d
(Table 5.5, entry 4).
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Figure A5.16.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576e
(Table 5.5, entry 5).
Figure A5.16.2  Infrared spectrum (thin film/NaCl) of of 3-hydroxyisoquinoline 576e
(Table 5.5, entry 5).
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Figure A5.17.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576f
(Table 5.5, entry 6).
Figure A5.17.2  Infrared spectrum (thin film/NaCl) 3-hydroxyisoquinoline 576f
(Table 5.5, entry 6).
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Figure A5.18.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576g
(Table 5.5, entry 7).
Figure A5.18.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576g
(Table 5.5, entry 7).
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Figure A5.19.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576h
(Table 5.5, entry 8).
Figure A5.19.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576h











































Figure A5.20.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576i
(Table 5.5, entry 9).
Figure A5.20.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline  576i
(Table 5.5, entry 9).
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Figure A5.21.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576j
(Table 5.5, entry 10).
Figure A5.21.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576j
(Table 5.5, entry 10).
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Figure A5.22.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576k
(Table 5.5, entry 11).
Figure A5.22.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576k
(Table 5.5, entry 11).
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Figure A5.23.3  13C NMR (125 MHz, CDCl3) of 3-hydroxyisoquinoline 576l
(Table 5.5, entry 12).
Figure A5.23.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576l
(Table 5.5, entry 12).
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Figure A5.24.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576m
(Table 5.5, entry 13).
Figure A5.24.2  Infrared spectrum (thin film/NaCl) of 3-hydroxyisoquinoline 576m
(Table 5.5, entry 13).
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Figure A5.25.2  Infrared spectrum (thin film/NaCl) of isoquinoline triflate A5-1.
Figure A5.25.3  13C NMR (125 MHz MHz, CDCl3) of isoquinoline triflate A5-1.

































Appendix 5 – Spectra Relevant to Chapter 5 485
Figure A5.26.3  13C NMR (125 MHz, CDCl3) of 1,3-diarylisoquinoline 578.
Figure A5.26.2  Infrared spectrum (thin film/NaCl) of 1,3-diarylisoquinoline 578.
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Figure A5.27.2  Infrared spectrum (thin film/NaCl) of isoquinoline triflate 579.
Figure A5.27.3  13C NMR (125 MHz, CDCl3) of isoquinoline triflate 579.
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Figure A5.28.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588a (Table 5.6, entry 1).
Figure A5.28.2  Infrared spectrum (thin film/NaCl) 2-hydroxy-1,4-naphthaquinone
588a (Table 5.6, entry 1).
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Figure A5.29.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588b (Table 5.6, entry 2).
Figure A5.29.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588b (Table 5.6, entry 2).
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Figure A5.30.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588c (Table 5.6, entry 3).
Figure A5.30.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588c (Table 5.6, entry 3).
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Figure A5.31.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588d (Table 5.6, entry 4).
Figure A5.31.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588d (Table 5.6, entry 4).
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Figure A5.32.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-5,6,7,8-
tetrahydronaphtha-1,4-quinone 588e (Table 5.6, entry 5).
Figure A5.32.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-
5,6,7,8-tetrahydronaphtha-1,4-quinone 588e (Table 5.6, entry 5).
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Figure A5.33.3  13C NMR (125 MHz, DMSO-d6) of 2-hydroxy-1,4-naphthaquinone
588f (Table 5.6, entry 6).
Figure A5.33.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588f (Table 5.6, entry 6).
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Figure A5.34.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588g (Table 5.6, entry 7).
Figure A5.34.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588g (Table 5.6, entry 7).
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Figure A5.35.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588h (Table 5.6, entry 8).
Figure A5.35.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588h (Table 5.6, entry 8).











































Appendix 5 – Spectra Relevant to Chapter 5 505
Figure A5.36.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588i (Table 5.6, entry 9).
Figure A6.36.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588i (Table 5.6, entry 9).
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Figure A5.37.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588j (Table 5.6, entry 10).
Figure A5.37.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588j (Table 5.6, entry 10).
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Figure A5.38.3  13C NMR (125 MHz, CDCl3) of 2-hydroxy-1,4-naphthaquinone
588k (Table 5.6, entry 11).
Figure A5.38.2  Infrared spectrum (thin film/NaCl) of 2-hydroxy-1,4-naphthaquinone
588k (Table 5.6, entry 11).
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CHAPTER 6
Multicomponent Aryne Reactions
6.1 INTRODUCTION AND BACKGROUND
6.1.1 Introduction to Multicomponent Reactions
Multicomponent reactions are processes involving sequential reactions among three
or more compounds that co-exist within the same reaction mixture.1  While the products
of these reactions comprise the whole or fragments of each of the constituent substrates,
the mechanisms responsible for their formation involve a series of bimolecular processes.
As such, each individual component must be compatible with all others, participating
only along the desired mechanistic pathway and only in the proper order.  The past 160
years have witnessed the discovery and development of a tremendous number of such
reactions, the first example of which was reported by Laurent and Gerhardt in 1838.  By
treating bitter almond oil (containing amygdalin 589) with ammonia, the authors were
able to accomplish a three-component synthesis of α-aminobenzonitrile (591) by
coupling benzaldehyde (590) with ammonia and hydrogen cyanide (Scheme 6.1).2,3
Since then, the field of multicomponent organic synthesis has evolved to encompass a
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wide variety of product structures originating from the combination of anywhere
between three and seven distinct substrates.



















+ NH3 + HCN
Traditional approaches to multistep synthesis require a significant input of time and
energy to advance starting materials to products along a linear path (Scheme 6.2a).  In
comparison, multicomponent reactions minimize the time spent and material lost by
providing a convergent approach to the assembly of complex structures in a single step
(Scheme 6.2b).  Coupled with the fact that most of these reactions are performed at mild
temperatures with few reagents other than the participating substrates, multicomponent
strategies are becoming increasingly popular in the realm of natural product total
synthesis.4  Furthermore, the number of obtainable product structures increases
exponentially with the addition of new substrates.  For example, a four-component
reaction comprising n individual substrates of each component type (A–D) would give
rise to n4 distinct product structures.  The addition of a single substrate to any one of the
four component types would then provide an additional n3 products.  Not surprisingly,
this has led to an abundant use of multicomponent chemistry in the preparation of
combinatorial libraries for bioactivity screening and pharmaceutical discovery (Scheme
6.2c).5
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Scheme 6.2. a) Linear synthesis of a product containing four components.  b) One-step
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Four-component reaction with n types of each component
n = 5 (20 substrates)
n = 10 (40 substrates)
n = 50 (200 substrates)
→  625 products
→  10,000 products
→  6,250,000 products
6.1.2 Multicomponent Aryne Reactions
Benzyne is ideally suited to multicomponent synthesis given its ability to function as
an intermediary between nucleophiles and electrophiles.  By effectively relaying
electronic charge between the two species, this strategy provides ready access to 1,2-
disubstituted arenes (592) (Scheme 6.3, eq 1).  When the initiating nucleophile and
terminating electrophile are contained within the same molecule, several relay species
can be employed in concert to extend this method to the synthesis of polycycles (593) (eq
2).  Along these lines, recent attention has been given to carbene equivalents—in
particular, isocyanides—for the synthesis of benzannulated five-membered rings (594)
(eq 3).  The following sections of this chapter provide examples of recent advances in
multicomponent aryne chemistry.  The methods described are divided based on the
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number of reactive components—either three or four—and further delineated by the
number of aryne equivalents present in the final product.  Separate consideration is given
to those reactions that are catalyzed by transition metals, which thus far incorporate only
three components.  Finally, examples of multicomponent aryne reactions employed in
total synthesis are discussed.











Benzyne as a relay species
in a three-component reaction
Multiple relay species for the
synthesis of rings

















Only a handful of three-component aryne reactions were reported prior to
Kobayashi’s development of the ortho-silyl aryl triflate precursor to benzyne.6  The
earliest recorded observation was made by Bachmann and Clarke in 1927 and consisted
of an unintentional cyclotrimerization of benzyne to form triphenylene.7  However, it was
not until 1940 that benzyne was deliberately used in a three-component reaction.  In an
attempt to probe the existence of a zwitterionic phenylene intermediate (prior to Roberts’
studies), Wittig added phenyllithium to benzyne generated from fluorobenzene and
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quenched the resulting biaryl anion with benzophenone.8,9  Forty years later, Meyers
et al. reported the preparation of ortho-oxazoline-substituted arynes (596) from aryl
chlorides (595) under anionic conditions, followed by the addition of alkyl lithium
species.10–12  Nucleophilic attack at the ortho position was found to occur, counter to the
regioselectivity predicted by inductive polarization of the aryne bond.  This unexpected
result was attributed to coordination of the incoming lithium species to the oxazoline
nitrogen to favor a directed attack.  Quenching the resulting aryl lithium intermediate
(597) with one of a number of electrophiles and then hydrolyzing the oxazoline product
provided a handful of 2,3-disubstituted benzoic acid derivatives (598a–f) in good yield.
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The vast majority of research directed toward the discovery of new multicomponent
aryne reactions has taken place within the past decade.  The simplest cases involve
reactions between two equivalents of an aryne and a third reagent.  One such example,
reported in 2002 by Pawlas and Begtrup features a synthesis of functionalized
phenanthridines (601) from aryl fluorides (17) and nitriles (600) (Scheme 6.5).13  Upon
treatment with n-butyllithium, the aryl fluoride undergoes ortho-deprotonation to form a
transient ortho-fluoroaryllithium (66), which decomposes to benzyne (1).  Reaction with
a second equivalent of 66 then forms fluorobiaryllithium 599.  Nucleophilic addition to
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the nitrile (600) is then followed by cyclization to close the central ring, yielding
phenanthridine 601.
The research group led by Yoshida and Kunai at Hiroshima University has been an
active contributor to the body of knowledge concerning multicomponent aryne
transformations over the past six years.  This group first entered the field in 2004 by
publishing a method to generate 9-arylxanthenes (605a–c) from aldehydes (602) and
ortho-silyl aryl triflates (71).14  In the presence of solubilized potassium fluoride, 71
forms benzyne in situ, which undergoes a formal [2 + 2] cycloaddition with the aldehyde
to form benzoxetane 603.  A retro-[2 + 2] cycloaddition opens the four-membered ring to
reveal ortho-quinone methide 604, an intermediate capable of participating in a [4 + 2]
cycloaddition with a second equivalent of benzyne to form the xanthene (605).  The
group went on to show that the reaction proceeds with most electron-rich, electron-
deficient, and polycyclic aryl aldehydes to provide the corresponding 9-arylxanthenes in
17–70% yield.


































605a, Ar = Ph
605b, Ar = PMP
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Following the first reports of the early 2000’s, newer multicomponent aryne
reactions began to feature three distinct reaction partners.  Coincident with their previous
communication, Yoshida et al. reported the synthesis of both iminoisobenzofurans15
(608a–c) and iminoisoindoles16 (610a–c) from ortho-silyl aryl triflates (71), isocyanides
(606), and either aldehydes (602) or aldimines (609), respectively (Scheme 6.6).17  As a
carbene equivalent, the isocyanide functions as both a nucleophile and an electrophile.
Addition to the aryne generates an intermediate zwitterion (607),18 the anion of which
adds to the carbonyl species to effectively relay the electron pair through these two
additional atoms.  Closure of the five-membered ring is then achieved through addition of
the resulting oxygen-centered anion to the N-alkyl nitrilium ion to generate the product
(608 or 610).  While the majority of substrates were derivatives of benzaldehyde, both
propionaldehyde and pivaldehyde were shown to participate in the three-component
reaction to form alkyl-substituted iminoisobenzofurans.
In 2006, Jeganmohan and Cheng developed a three-component coupling of arynes,
isoquinolines (611), and nitriles (612).19  In this particular case, the aryne functions as an
arylating agent, producing N-aryl isoquinolinium ion 614 after deprotonating the nitrile.
Addition of the resulting anion (613) to the activated heteroaromatic system then yields
an N-aryl dihydroisoquinoline (615a–c) bearing various substitution at C(1).  The group
also demonstrated that similar reactivity could be achieved using 2- and 4-substituted
pyridines in place of the isoquinoline.20
More recently, the three-component synthesis of pyrido[2,1-a]isoindolines (619) was
accomplished independently by the labs of Zhang21 and Huang22 by coupling arynes, α-
bromoacetophenones (616), and pyridines (617).  The groups each propose an initial
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condensation between pyridine and the bromoketone, followed by deprotonation to
form betaine 618.  A 1,3-dipolar cycloaddition between this intermediate and benzyne (1)
then forms the nitrogen-containing tricycle (619a–c).  While most examples featured
substituted para-substituted acetophenones, Huang et al. also successfully employed
bromoacetone and ethyl bromoacetate.  Furthermore, each group was able to replace
pyridine with isoquinoline in order to generate tetracyclic product scaffolds.




















606 608a, Ar = 1-naphthyl
608b, Ar = Ph




















606 610a, Ar = 1-naphthyl
610b, Ar = Ph
















613 615a, R = H
615b, R = Me






















619a, R = OMe
619b, R = Cl
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While the work performed by these four groups does not comprise the entirety of
three-component aryne technology, it provides an accurate representation of the product
structures attainable using this general strategy.  Additional studies carried out between
2006 and 2008 accomplished the synthesis of benzoxazinones,23 naphthalenes,24
anthranilic acids,25 and ortho-aminobenzyl alcohols26 and amines.27  Notably, each of
these studies employed Kobayashi’s ortho-silyl aryl triflate (71), further underscoring the
versatility of this important aryne precursor.6
In addition to the metal-free multicomponent aryne reactions discussed above, there
have been a number of transition metal-catalyzed transformations reported in recent
years.28–30  In comparison to non-catalytic variants, which typically require a heteroatom
or carbanion nucleophile to initiate the reaction, these processes can be performed with
simple alkyl and aryl halides, olefinic species, and terminal alkynes.  Furthermore, metal-
catalyzed aryne reactions often take place primarily, if not exclusively, at carbon centers.
In 2006, Greaney et al. developed a catalytic approach to styrenyl diesters (622) by
coupling arynes with α-bromoesters (620) and acrylates (358) (Scheme 6.7).31  Beginning
with oxidative insertion into the C–Br bond of 620, the resulting alkylpalladium
intermediate undergoes two sequential Heck-type migratory insertions, the first of which
occurs across the aryne triple bond to form arylpalladium 621.  A second migratory
insertion across the acrylate olefin followed by β-hydride elimination furnishes styrene
621.  Based on previous work by Yamamoto,32 the authors also demonstrated that the
bromoester could be replaced by allyl chloride, though purification of the resulting ortho-
allylstyrene was complicated by the presence of phenanthrene side products derived from
the combination of allyl chloride and two equivalents of the aryne.33
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In a continuing effort to develop new transition metal-catalyzed multicomponent
aryne reactions, the Cheng research group at Tsing Hua University has reported a number
of methods for preparing 1,2-disubstituted arenes by coupling arylpalladium
intermediates similar to 621 with alkynyl,34 allenyl,35 and aryl stannanes.36  In 2008, the
group devised a cooperative palladium- and copper-catalyzed process for the synthesis of
ortho-allyl phenylacetylenes (627) from arynes, allylic epoxides (623), and terminal
alkynes (624).37  Having proven the efficacy of this strategy in previous coupling
reactions utilizing allyl chlorides and acetates,38,39 the authors were confident that allylic
epoxides could be used to build products bearing terminal alcohols.  In terms of the
mechanism, copper(I) iodide is envisioned to form a copper acetylide, which undergoes
addition to benzyne to form arylcopper intermediate 6 2 5 .  Transmetallation to
allylpalladium complex 626 and subsequent reductive elimination then forms the
observed product and regenerates the catalyst.
Although less commonly used than palladium, nickel is beginning to appear in
several multicomponent aryne reactions.40  In 2009, Qiu and Xie reported a three-
component coupling of arynes, acrylates (358), and alkynes (628) catalyzed by nickel(0)
cyclooctadiene to form trisubstituted dihydronaphthalenes (630).41  The proposed
mechanism involves cyclometallation with the aryne and acrylate to form metalloindane
629.  Insertion of the alkyne and reductive elimination then forms the six-membered ring.
The reaction is shown to proceed in good yield with a number of substituted arynes,
though the two remaining substrates are limited to unsubstituted acrylates and internal
alkynes.
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629 630, 76% yield
6.1.2.2 Four-Component Reactions
In comparison to the array of three-component aryne reactions described above, the
field of four-component transformations is still very much in its infancy.  To date, only
three examples have been reported, two of which were developed as synthetic methods
and the third as the key step in a total synthesis.  The former are discussed below and the
latter will be discussed in the following section.
Each of the four-component methodologies forms compounds derived from multiple
equivalents of the aryne.  The first involves a one-pot synthesis of N -a ry l
anthracenamines (635) reported in 2007 by Xie and Zhang (Scheme 6.8).42  In the
presence of excess quantities of benzyne, N-substituted imidazoles (631) will undergo a
[4 + 2] cycloaddition to form a benzannulated diazabicyclo[2.2.1]heptene (632).
Expulsion of hydrogen cyanide via retro-[4 + 2] cycloaddition then forms a reactive 2H-
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isoindole (633), which undergoes another [4 + 2] cycloaddition with a second
equivalent of benzyne to form a nitrogen-bridged tetracycle (634).  Rearrangement to
aromatize the central ring and subsequent addition of the amine to a third equivalent of
benzyne then furnishes the polyaromatic product (635a–c).  Based on the substitution
pattern of imidazole 641, products bearing various substitution at nitrogen and C(10) can
be achieved in good yield.
The second four-component method was designed by Sha and Huang in 2009 as a
novel approach to polyfunctionalized isoquinolines (642) using arynes, isocyanides, and
terminal alkynes.43  The mechanism of formation is proposed to begin with an addition of
isocyanide 636 to benzyne to form zwitterion 638.  Deprotonation of the alkyne is then
followed by addition to the nitrilium ion to generate propargylic imine 639, which is
envisioned to be in equilibrium with allene 640.  This intermediate undergoes a [4 + 2]
cycloaddition with a second equivalent of benzyne to form dihydroisoquinoline 641,
which equilibrates to the isolated product (642).  The authors also found that if the alkyne
component was used in excess, the second [4 + 2] cycloaddition took place with this
substrates to give rise to pyridine products.
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635a, R1 = Bn, R2 = H
635b, R1 = Me, R2 = Me




















































642a, R = 4-EtC6H4
642b, R = 4-ClC6H4










6.1.2.3 Multicomponent Aryne Reactions in Total Synthesis
Despite the advantages in speed and convergence afforded by multicomponent aryne
reactions, approaches utilizing these transformations have only been applied to the total
synthesis of two natural products—ent-clavilactone B44 (651) and dehydroaltenuene B45
(658)—both of which were completed by the Barrett group at Imperial College London
(Scheme 6.9). The first synthesis featured a three-component relay addition of isobutenyl
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Grignard 645 to aryne 644, followed by an addition of the resulting aryl Grignard
(646) to aldehyde 647 to form diastereomeric benzylic alcohols 648a and 648b.  While
the reaction proceeded with low diastereoselectivity to produce the alcohols in a ratio of
only 1.6:1, the authors were able to quickly advance each of these products to a single
diastereomer of epoxylactone 646.  In the last two steps, the macrocycle was then formed
via ruthenium-catalyzed ring-closing metathesis and the hydroquinone was oxidized to
furnish ent-clavilactone B (652) in 14% overall yield through a maximum of 13 steps.
With the success of this first synthesis, Barrett et al. turned to the development of a
four-component reaction sequence for the synthesis of dehydroaltenuene B (658).  The
key step began in a manner similar to the previous, with the addition of cyclohexenyl
Grignard 654 to aryne 653.  Aryl Grignard 655 was then exposed to carbon dioxide to
carboxylate the aromatic ring, after which treatment with molecular iodine promoted
iodolactonization of the magnesium carboxylate (656) to form tricycle 657.  Having thus
assembled the core of the natural product in the first step, the authors then advanced this
material through six additional steps to complete the first total synthesis of
dehydroaltenuene B (658) in 19% overall yield.
Chapter 6 – Multicomponent Aryne Reactions 524
Scheme 6.9. a) Three-component synthesis of alcohols 648a and 648b  en route to ent-




























• 7 linear steps •















































2 steps from 648a
3 steps from 648b
70% yield from 648a










PCy31. 650 (40 mol%)
    tetrafluorobenzoquinone
    (80 mol%), toluene, 80 °C
2. CAN, MeCN / H2O
    (48% yield, 2 steps)
ent-Clavilactone B (651)
• 12 or 13 linear steps •
• 14% overall yield •
a)
b)
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6.2 SYNTHESIS OF PHENOXY IMINOISOBENZOFURANS AND
IMINOINDENONES VIA A THREE-COMPONENT COUPLING OF ARYNES,
ISOCYANIDES, AND ESTERS OR ALKYNES†
6.2.1 Outline of Approach and Initial Studies
We decided to approach the task of designing a novel multicomponent aryne reaction
by considering the mechanisms involved in more classical multicomponent
transformations.  In particular, we were interested in the Passerini reaction, a method
used to prepare α-acyloxyamides (665) through the three-component coupling of
aldehydes (659), isocyanides (660), and carboxylic acids (661) (Scheme 6.10).46  The
reaction proceeds through an initial combination of the aldehyde and isocyanide
substrates to form a hydroxy nitrilium intermediate (662).47  Nucleophilic addition of the
carboxylate (663) then produces a neutral imidate (664), which undergoes acyl migration
to the free alcohol to form the amide product (665).

























Upon closer examination of this mechanism, we recognized that the aldehyde
component plays roles as both an electrophile and a nucleophile (in the form of an
                                                 
† This work was performed in collaboration with Christopher D. Gilmore, a fellow graduate student in the
Stoltz research group.
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intermediate alcohol) during the course of the reaction.  Based on the established
tendency of benzyne to act in a similar capacity as a relay species in multicomponent
transformations, we envisioned an analogue of the Passerini reaction in which benzyne
would take the place of the aldehyde to generate ortho-ketobenzamides (669) (Scheme
6.11).  Considering the mechanism in a stepwise sense, we anticipated an initial addition
of the isocyanide (660) to benzyne (1) to form zwitterion 667.18  Then, nucleophilic
addition of a carboxylate salt (666) to the nitrilium ion would produce ortho-metallated
acyl imidate 668.  The specific use of the carboxylate salt was viewed as a necessity in
light of the expectation that a carboxylic acid would simply protonate the aromatic ring.
In the final step, acyl migration from oxygen to carbon in a manner analogous to the
anionic ortho-Fries rearrangement48 would produce ortho-ketobenzamide 669.  In line
with our previous development of the aryne acyl-alkylation reaction,49 we expected this
method would provide a useful new addition to the arsenal of aryne 1,2-disubstitution
reactions.
































Chapter 6 – Multicomponent Aryne Reactions 527
Our first attempts to accomplish an aryne analogue of the Passerini three-
component coupling reaction featured ortho-silyl aryl triflate 71, tert-butyl isocyanide
(670), and various alkali salts of acetic and benzoic acid (666) (Scheme 6.12).  We
combined these reagents in tetrahydrofuran using tetra-n-butylammonium
difluorotriphenylsilicate (TBAT) as the fluoride source and performed the reaction at
temperatures between 23 °C and 60 °C.  However, in all cases, the only product isolated
from the reaction mixture was N-tert-butyl benzamide (672), presumably resulting from
addition of the isocyanide to benzyne followed by quenching of the nitrilium (671) with
adventitious water.  Suspecting that the lack of carboxylate addition was due to the
insolubility of the salt, we added the appropriate crown ethers.  Unfortunately, these
additives had little effect upon the outcome, often resulting only in a lower yield of 672.
Scheme 6.12. Attempted three-component coupling of benzyne, tert-butyl isocyanide, and
carboxylate salts
R = Me, Ph
M = Li, Na, K

























6.2.2 Synthesis of Phenoxy Iminoisobenzofurans
Given our lack of success in utilizing carboxylate salts, we chose to modify our initial
mechanistic proposal to employ the aryl anion nucleophile (667) prior to attack at the
nitrilium ion (Scheme 6.13).  Replacing the salt with a carboxylic ester (673), we
envisioned nucleophilic addition of the anion to the carbonyl to generate a tetrahedral
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intermediate (674).  Expulsion of the alkoxide (676) followed by recombination with
the nitrilium ion (675) would then furnish a neutral imidate (677).  Finally, this
compound could be hydrolyzed upon work-up or in a subsequent step in order to
intercept the originally targeted ortho-ketobenzamide (669).
Scheme 6.13. Revised approach to the synthesis of ortho-ketobenzamides via three-component









































Adapting the reaction conditions to this new proposal proved straightforward.  Ethyl
acetate (678) was chosen for the first trial due to its availability as an organic solvent
(Scheme 6.14a).  Unfortunately, when the reaction was performed according to the
previous conditions at 40 °C, none of the desired ketobenzamide was observed.  Given
that similar additions had been established with aldehydes15,26 and aldimines,16,27 we
endeavored to employ a more electrophilic ester.  Based on the knowledge that phenyl
esters possess lower pK a values than the corresponding ethyl and tert-butyl
esters50—presumably due to electron withdrawal from the aryl ring—we reasoned that
phenyl acetate (679) would display greater electrophilicity than ethyl acetate (Scheme
6.14b).  When the reaction was performed under identical conditions, however, we were
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surprised to find that instead of generating the expected ketobenzamide (681) or its
related imidate, phenoxy iminoisobenzofuran 680 was isolated in 60% yield.  The
formation of this product most likely occurs through intramolecular attack of alkoxide
674 upon the nitrilium ion, suggesting that closure of the five-membered ring occurs
faster than expulsion of the alkoxide.  To our knowledge, this method represents the first
preparation of a stable ether-substituted iminoisobenzofuran.51
Scheme 6.14. a) Attempted three-component coupling of benzyne, tert-butyl isocyanide, and ethyl








































Having discovered this unexpected new reaction, we decided to ascertain the optimal
conditions for the formation of phenoxy iminoisobenzofuran 680 (Table 6.1).  In the first
experiment, we had established the aryne as the limiting reagent.  A greater excess of the
phenyl ester was employed relative to the isocyanide in light of the previous difficulties
we had encountered while attempting to stimulate the reactivity of the carbonyl
component.  Subsequent trials were performed using the original stoichiometric ratios at
room temperature (entry 2) and 60 °C (entry 3), though neither provided 680 in greater
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than 60% yield.  We then evaluated conditions in which the isocyanide (entry 4) and
the phenyl ester (entry 5) were each used in limiting quantities.  Although neither trial
proved more effective than the first, we were intrigued to find that using the phenyl ester
as the limiting reagent had nearly the same effect on the yield as did the aryne (entry 1).
Considering this method from the standpoint of multistep synthesis, we anticipated that
the ester would likely represent the most valuable component.  As such, we decided to
pursue conditions in which this substrate would be used in limiting quantities.  In
accordance with the previous optimization of our aryne annulation technology,52 we
diluted the reaction solution to 0.1 M (entry 6).  While this had a modest retarding effect
on the reaction, it was accompanied by an appreciable increase in yield.  Further attempts
to decrease the reaction temperature (entry 7) and the amount of excess material used
(entry 8) met only with lesser yields.
Table 6.1. Optimization of reaction conditions for the three-component coupling of benzyne, tert-
butyl isocyanide, and phenyl acetate
40%11 11 0.1 40 12
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Having devised an optimal set of conditions to prepare the phenoxy
iminoisobenzofuran (683), we were determined to gain a better understanding of the
synthetic capabilities of this reaction.  We began by examining a number of differentially
substituted phenyl esters prepared from the corresponding carboxylic acids in a single
step (Table 6.2).  Esters bearing linear (680 and 683a), branched (683b), and cyclic
(683c) aliphatic substituents performed well under the established reaction conditions.
Benzoic esters faired equally well, though we found that electron-withdrawing
substituents (683f–h) promoted greater reactivity than electron-donating substituents
(683e).  Despite concerns that an α-haloester would react with tert-butyl isocyanide
(670), phenyl chloroacetate produced the expected three-component adduct (683i) in
comparable yield.  Even dihydrocoumarin and phenyl carbonate gave rise to interesting
spirocyclic (683j) and masked orthoester products (683k), respectively.  Next, we
evaluated the isocyanide component, replacing tert-butyl isocyanide (670) with 4-
methoxyphenyl isocyanide (683l and 683m) and 2-benzyloxyethyl isocyanide (683n) to
form novel N-functionalized imidate structures.  We also prepared and tested the ortho-
(dimethoxyethyl)phenyl isocyanide designed by Kobayashi as a convertible functional
handle for Ugi reactions,53 which produced iminoisobenzofuran 683o in a reasonable
yield given the increased steric bulk of the nucleophile.  Finally, we performed the three-
component coupling with a series of heteroatom-functionalized aryne precursors to
generate aryl-substituted adducts 683p–u.  Importantly, when unsymmetrical arynes were
employed, the products (683p–r) were isolated as single isomers derived from the
expected addition of tert-butyl isocyanide to the inductively activated position meta to the
heteroatom.54,55
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Table 6.2. Synthesis of phenoxy iminoisobenzofurans via three-component coupling of arynes,
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680, 83% 683a, 79% 683b, 72%a 683c, 75%a 683d, 91%
683p, 75%a
683r, 68%a 683s, 85% 683t, 76%
683e, 64%
































683m, 62% 683n, 67%a 683o, 58%a
R1
a Reaction performed at 60 °C
Our original structural assignment of the phenoxy iminoisobenzofurans was based
primarily on analogy to Yoshida’s earlier work with iminoisobenzofurans15 and
iminoisoindoles.16  However, we recognized the potential for a structural rearrangement
pathway uniquely available to our products based on the presence of the phenyl ether.
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Donation of an electron pair from the oxygen of the phenoxy substituent would result
in ring opening to generate an intermediate oxocarbenium species (684) (Scheme 6.15a).
Bond rotation and addition of the imidate nitrogen to the activated carbonyl would then
lead to the isomeric isoindolinone (685).  Given the close structural similarity between
iminoisobenzofuran 683  and lactam 685 , we were hesitant to make a definitive
assignment based solely on NMR and IR data.  We therefore obtained a crystal of adduct
683p  suitable for X-ray diffraction (Scheme 6.15b).  The structure obtained
unambiguously confirmed our original assignment as the phenoxy iminoisobenzofuran.
Scheme 6.15. a) Potential equilibration between iminoisobenzofuran and isoindolinone isomers.  b)


























While considering the possibility of structural rearrangement, we realized that the
phenoxy iminoisobenzofurans could potentially be converted to our original
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targets—ortho-ketobenzamides (e.g., 669)—by intercepting a ring-opened
intermediate such as 684 with an equivalent of water.  We therefore began examining
conditions under which the three-component adducts might be hydrolyzed in situ to
generate ortho-ketobenzamides (Table 6.3).  A thorough screen of protic acids (e.g., HCl,
HF, H2SO4, AcOH, TFA) eventually yielded oxalic acid as the optimal additive.  Upon
completion of the three-component coupling, a saturated aqueous solution of oxalic acid
is added to the crude reaction and the biphasic mixture is allowed to stir a room
temperature until the phenoxy iminoisobenzofuran is fully consumed.  In this way, we are
able to generate di- (669b, d, and e), tri- (669c), and tetrasubstituted (669a, f, and g)
ortho-ketobenzamides in good yield in a single step from readily available ortho-silyl
aryl triflate (168), isocyanide (660), and phenyl ester (682) starting materials.56
















































+R1 R2 NC R1 O
R3 OPh
N R2
(2 equiv) (2 equiv)
sat aq
oxalic acid
23 °C, 4–8 h R3
a Reaction performed at 60 °C.
In an effort to demonstrate the utility of the ortho-ketobenzamides, we sought to
achieve an intramolecular coupling between the amide nitrogen and the aryl bromide of
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2-(ortho-bromobenzoyl)benzamides 669e–g to generate caprolactams (Scheme 6.16).
Unfortunately, preliminary attempts employing 669e in the presence of several different
palladium57 and copper58 complexes failed to produce the desired seven-membered ring,
most likely due to the steric bulk of the tert-butyl amide.  We eventually discovered that
copper(I) iodide in the absence of an added ligand effectively catalyzed the reaction in
N,N-dimethylformamide at 150 °C, providing dibenzoketocaprolactams 669a–c in
61–85% yield  The structural similarity that these products share with natural isolates
such as silvaticamide59 (688) suggests that this method may prove useful in the realm of
total synthesis.

















71, R = H
184, R = OMe















669e, R = H
669f, R = OMe
669g, R = OCH2O
687a, R = H
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6.2.3 Synthesis of Iminoindenones
During the course of our efforts to develop an aryne analogue of the Passerini
reaction, we had uncovered a novel three-component synthesis of unusual phenoxy
iminoisobenzofuran structural motifs.  Further investigations demonstrated the broad
scope of this reaction, both alone and in tandem with a hydrolysis step en route to ortho-
ketobenzamides.  Seeking to harness this general mode of reactivity, we began to
examine substrates other than phenyl esters capable of fulfilling the role as a relay
species.  Based on our results, as well as those of Rigby,18 Yoshida,14,15 and Huang,43 we
were confident that the first step of the reaction mechanism involved addition of the
isocyanide (660) to benzyne to form zwitterion 667 (Scheme 6.17a).  The aryl anion then
added to the relay component, through which the negative charge was conveyed back to
the nitrilium ion.  It occurred to us that a conjugate acceptor (689) should fill this role
adequately, acting as both an β-electrophile and an α-nucleophile.  Thus, we tested a
series of α,β-unsaturated carbonyl compounds under the optimized coupling conditions
in the hope of generating carbocyclic adducts (690).  Eventually, we found that methyl
propiolate (452) furnished iminoindenone 691 in 88% yield after 12 h, a result that was
all the more significant in light of the fact that compounds 692–696 failed to react
(Scheme 6.17b).
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Scheme 6.17. a) Proposed three-component coupling of arynes, isocyanides, and a two-carbon








































With our initial result in hand, we performed a more in-depth analysis of the substrate
tolerances of our newly discovered three-component coupling reaction (Table 6.4).
Introducing substitution at the β-position of the propiolate framework provided access to
2,3-disubstituted iminoindenone 698a without significantly impacting the yield.  The
reaction also proved amenable to the replacement of tert-butyl isocyanide with
Kobayashi’s ortho-(dimethoxyethyl)phenyl isocyanide,53 generating compounds 698b
and 698c in 66% and 91% yield, respectively.  Finally, we examined the effects of aryne
substitution upon product distribution.  As in the previous synthesis of phenoxy
iminoisobenzofurans, we found that both symmetrical and unsymmetrical heteroatom-
functionalized arynes formed the expected three-component adducts (698d–g) in good
yield as single isomers.
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698d, 66% 698e, 79%
O
O
698f, 54% 698g, 56%
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3
Once again, we endeavored to hydrolyze the product of our three-component reaction
(698a), this time to reveal an indenone (699) (Scheme 6.18a).  The ubiquity of this
bicyclic framework in bioactive natural products such as pauciflorol F (700) ,60
quadrangularin A (701),61 caraphenol C (702),62 and the Virola sebifera isolate 70363
suggested that the development of a facile method for hydrolysis of our products could
provide a novel approach to the construction of medicinally relevant small molecules
(Scheme 6.18b).  Gratifyingly, conversion of iminoindenone 698a to indenone 699
proved exceedingly straightforward, as this transformation could be achieved simply by
stirring the substrate in wet ethyl acetate at 40 °C in the presence of silica gel.  In this
way, we were able to generate the desired indenone (699) in nearly quantitative yield in
as little as 30 min.
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6.2.4 Quinones as Relay Components
At present, our efforts are focused upon the discovery of new relay species for the
synthesis of additional three-component products.  We were particularly interested in
quinones, given that they represent electrophiles capable of undergoing either 1,2- (path
A) or 1,4-addition (path B) of the aryl anion to generate either fused (704) or spirocyclic
(705) tricycles (Scheme 6.19).  In a preliminary experiment, 1,4-benzoquinone (706) was
employed as the relay species in combination with ortho-silyl aryl triflate 71 and tert-
butyl isocyanide (670).  Under standard conditions, spirocyclic hemiquinone 707 was
isolated in 60% yield, thereby confirming the 1,2-addition pathway.64  Additional
experiments with 1,4-naphthoquinone (708) and 9,10-phenanthrenequinone (710) yielded
similar products (709 and 711, respectively) resulting from addition directly to the
quinone carbonyl.  Further research within this class of substrates is ongoing and we
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anticipate that the results of these studies will provide greater insight into the
synthetic capabilities of the three-component aryne coupling reactions.




































































We entered the forum of multicomponent synthesis with the intention of applying
classical mechanistic understanding to the development of new aryne methodologies.
However, in the course of our efforts to employ arynes in a modern analogue of the
Passerini reaction, we discovered a novel three-component coupling of arynes,
isocyanides, and phenyl esters that forms unusual phenoxy iminoisobenzofuran products.
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Given that stable versions of these products had not been prepared prior to our work,
we were eager to demonstrate their synthetic utility.  By adding a saturated aqueous
solution of oxalic acid to the reaction mixture, we are able to hydrolyze the three-
component adducts to accomplish a one-pot synthesis of ortho-ketobenzamides and thus
generate the original targets of our work toward the modified Passerini reaction.
Furthermore, we have been able to advance certain of these compounds through a copper-
catalyzed intramolecular coupling reaction to construct interesting
dibenzoketocaprolactams.  In an attempt to translate the general mechanism of the three-
component coupling reaction to the formation of additional adducts, we examined a
number of α,β-unsaturated carbonyl compounds.  These studies led to the discovery that
activated alkynes participated in a similar transformation to yield iminoindenones.  As
before, a method for the hydrolysis of these products was uncovered, and with it, a route
to indenone frameworks relevant to the assembly of resveratrol-derived natural products.
Ongoing efforts are directed toward the investigation of additional relay species for the
synthesis of novel spirocyclic compounds.
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6.4 EXPERIMENTAL SECTION
6.4.1 Materials and Methods
Unless stated otherwise, reactions were performed in flame-dried glassware under an
argon or nitrogen atmosphere using dry, deoxygenated solvents (distilled or passed over a
column of activated alumina).  Commercially obtained reagents were used as received.
Tetra-n-butylammonium difluorotriphenylsilicate (TBAT) was azeotropically dried from
acetonitrile prior to use.  3-Methoxy-2-(trimethylsilyl)phenyl triflate (108),65 3,5-
dimethoxy-2-(trimethylsilyl)phenyl triflate (572),66 4 ,5-d imethoxy-2-
(trimethylsilyl)phenyl triflate (184),67 6-(trimethylsilyl)benzo[d][1,3]dioxol-5-yl triflate
(155),68 and 4,5-difluoro-2-(trimethylsilyl)phenyl triflate (185)69 were prepared according
to literature procedures.  Reaction temperatures were controlled by an IKAmag
temperature modulator.  Thin-layer chromatography (TLC) was performed using E.
Merck silica gel 60 F254 precoated plates (0.25 mm) and visualized by UV fluorescence
quenching, potassium permanganate, or ceric ammonium molybdate staining.  SiliaFlash
P60 Academic Silica gel (particle size 0.040-0.063 mm) was used for flash
chromatography.  1H and 13C NMR spectra were recorded on a Varian Inova 500 (at 500
MHz and 125 MHz, respectively) and are reported relative to Me4Si (δ 0.0).  Data for 1H
NMR spectra are reported as follows: chemical shift (δ  ppm) (multiplicity, coupling
constant (Hz), integration).  Data for 13C NMR spectra are reported in terms of chemical
shift relative to Me4Si (δ 0.0).  IR spectra were recorded on a Perkin Elmer Paragon 1000
Spectrometer and are reported in frequency of absorption (cm-1).  High resolution mass
spectra were acquired using an Agilent 6200 Series TOF with an Agilent G1978A
Multimode source in electrospray ionization (ESI), atmospheric pressure chemical
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ionization (APCI) or mixed (MM) ionization mode, or obtained from the Caltech
Mass Spectral Facility (EI+ or FAB+).
6.4.2 Preparative Procedures and Spectroscopic Data
6.4.2.1 Representative Procedure for the Three-Component Synthesis of Phenoxy
















(2 equiv) (2 equiv)
A flame-dried 50 mL round bottomed flask with a magnetic stir bar was charged with
TBAT (1.70 g, 3.15 mmol, 2.0 equiv) and THF (16 mL).  To this solution was added
phenyl acetate (6 7 9 ) (0.20 mL, 1.57 mmol), 2-(trimethylsilyl)phenyl
trifluoromethanesulfonate (71) (0.765 mL, 3.15 mmol, 2.0 equiv), and tert-
butylisocyanide (670) (0.356 mL, 3.15 mmol, 2.0 equiv), each via syringe.  The reaction
was heated to 40 °C under argon for 12 h, at which point TLC analysis showed complete
consumption of phenyl acetate.  The reaction was cooled to room temperature and passed
over a plug of silica (3 cm diam. x 5 cm length) eluting with 15:85 EtOAc/hexanes in
order to remove excess TBAT from solution.  The solvents were removed under reduced
pressure and the crude residue was purified by flash chromatography over silica gel.
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Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(83% yield).  Rf = 0.46 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.65 (dt, J
= 7.6, 1.0 Hz, 1H), 7.49 (d, J = 1.0 Hz, 1H), 7.48 (dd, J = 2.0, 1.0 Hz, 1H), 7.39 (ddd, J =
8.3, 5.1, 3.2 Hz, 1H), 7.12 (dd, J = 8.3, 7.3 Hz, 2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.92
(dd, J = 8.8, 1.2 Hz, 2H), 1.97 (s, 3H), 1.43 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 153.8,
152.7, 143.6, 136.6, 132.9, 131.4, 130.1, 129.1, 128.3, 124.4, 123.4, 122.8, 122.3, 110.6,
54.1, 30.4, 26.3; IR (Neat Film, NaCl) 2968, 1778, 1704, 1662, 1490, 1215, 1114 cm-1;





Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(79% yield).  Rf = 0.43 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J
= 7.6 Hz, 1H), 7.50–7.42 (comp m, 2H), 7.37 (dt, J = 7.8, 2.0 Hz, 1H), 7.08 (t, J = 7.6 Hz,
2H), 6.94 (t, J = 7.3 Hz, 1H), 6.86 (d, J = 7.6 Hz, 2H), 2.42 (ddd, J = 13.9, 12.0, 4.6 Hz,
1H), 2.20 (ddd, J = 13.9, 12.0, 4.6 Hz, 1H), 1.51–1.40 (m, 1H), 1.44 (s, 9H), 1.39–1.26
(m, 2H), 1.22–1.11 (m, 1H), 0.88 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3)
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δ 153.7, 153.0, 142.5, 136.6, 130.0, 129.0, 128.3, 124.3, 123.4, 122.9, 122.6, 112.8,
54.0, 39.2, 30.4, 25.7, 22.8, 14.2; IR (Neat Film, NaCl) 2963, 2871, 1706, 1592, 1491,






Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98
EtOAc/hexanes) to yield a colorless oil (72% yield).  Rf = 0.54 (15:85 EtOAc/hexanes);
1H NMR (500 MHz, CDCl3) δ 7.61 (dt, J = 7.6, 1.0 Hz, 1H), 7.43 (dd, J = 4.4, 1.2 Hz,
1H), 7.41 (d, J = 5.1 Hz, 1H), 7.34 (ddd, J = 7.8, 6.1, 2.4 Hz, 1H), 7.03 (dd, J = 8.3, 7.3
Hz, 2H), 6.90 (tt, J = 7.3, 1.2 Hz, 1H), 6.78 (dd, J = 8.8, 1.2 Hz, 2H), 2.62 (septet, J = 6.8
Hz, 1H), 1.42 (s, 9H), 1.22 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.8 Hz, 3H); 13C NMR (125
MHz, CDCl3) δ 153.9, 153.4, 141.6, 134.1, 131.2, 130.0, 129.0, 124.2, 123.3, 123.0,
122.9, 114.9, 54.0, 37.4, 30.4, 17.3, 16.8; IR (Neat Film, NaCl) 2968, 1706, 1592, 1491,
1214, 1070 cm-1; HRMS (FAB+) m/z calc’d for C21H25NO2 [M+H]+: 324.1964, found
324.1959.





Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98
EtOAc/hexanes) to yield a colorless oil (75% yield).  Rf = 0.46 (15:85 EtOAc/hexanes);
1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 7.6 Hz, 1H), 7.43–7.40 (comp m, 2H), 7.34
(dd, J = 7.8, 2.4 Hz, 1H), 7.03 (t, J = 7.6 Hz, 2H), 6.90 (t, J = 7.3 Hz, 1H), 6.78 (d, J = 7.6
Hz, 2H), 2.29 (td, J = 12.0, 3.2 Hz, 2H), 1.86 (br d, J = 12.9 Hz, 1H), 1.71 (br s, 1H),
1.50–1.41 (m, 1H), 1.43 (s, 9H), 1.38–1.14 (comp m, 5H); 13C NMR (125 MHz, CDCl3)
δ 153.8, 153.3, 141.7, 136.6, 134.1, 131.1, 129.9, 129.0, 128.3, 124.2, 123.3, 123.0,
122.9, 114.3, 54.0, 47.0, 30.4, 27.2, 26.8, 26.6, 26.3, 26.2; IR (Neat Film, NaCl) 2931,






Purified by flash chromatography (SiO2, 3:97 EtOAc/hexanes) to yield a white solid
(91% yield).  Rf = 0.40 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.71 (dt, J
= 7.6, 1.0 Hz, 1H), 7.64 (dd, J = 7.1, 1.5 Hz, 2H), 7.45-7.33 (comp m, 6H), 7.13 (dd, J =
8.5, 7.3 Hz, 2H), 6.99 (dd, J = 7.6, 1.2 Hz, 2H), 6.95 (t, J = 7.3 Hz, 1H), 1.47 (s, 9H); );
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13C NMR (125 MHz, CDCl3) δ 154.1, 152.8, 144.5, 139.8, 131.8, 131.7, 130.1, 129.2,
129.0, 128.9, 126.0, 123.6, 123.5, 123.3, 121.5, 110.4, 54.3, 30.5; IR (Neat Film, NaCl)







Purified by flash chromatography (SiO2, 4:96 EtOAc/hexanes) to yield a colorless oil
(64% yield).  Rf = 0.30 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.71 (d, J
= 7.6 Hz, 1H), 7.55 (d, J = 8.8 Hz, 2H), 7.44 (dd, J = 7.3, 6.6 Hz, 1H), 7.41–7.36 (comp
m, 2H), 7.13 (dd, J = 8.5, 7.3 Hz, 2H), 6.99 (d, J = 7.8 Hz, 2H), 6.95 (t, J = 7.3 Hz, 1H),
6.90 (d, J = 8.8 Hz, 2H), 3.80 (s, 3H), 1.47 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 160.1,
154.1, 152.9, 144.7, 131.9, 131.7, 131.3, 130.0, 129.1, 128.7, 127.4, 126.9, 123.6, 123.2,
121.6, 114.2, 55.5, 54.3, 30.5; IR (Neat Film, NaCl) 2967, 1708, 1661, 1513, 1490, 1254,
1213, 1173 cm-1; HRMS (FAB+) m/z calc’d for C25H25NO3 [M+H]+: 388.1913, found
388.1923.






Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(86% yield).  Rf = 0.43 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.71 (dt, J
= 7.3, 1.0 Hz, 1H), 7.61 (dd, J = 9.0, 5.1 Hz, 2H), 7.45 (td, J = 7.3, 1.2 Hz, 1H), 7.40 (dd,
J = 7.3, 1.2 Hz, 1H), 7.38 (tt, J = 7.3, 1.0 Hz, 1H), 7.13 (dd, J = 8.8, 7.1 Hz, 2H), 7.07 (t, J
= 8.8 Hz, 2H), 6.97 (d, J = 7.1 Hz, 2H), 6.96 (tt, J = 7.1, 1.2 Hz, 1H), 1.47 (s, 9H); 13C
NMR (125 MHz, CDCl3) δ 163.9, 161.9, 153.6, 152.1, 143.9, 136.4, 131.7, 131.5, 130.1,
129.9, 129.0, 128.1, 127.8 (d, JC–F = 8.6 Hz), 123.6 (d, JC–F = 21.9 Hz), 123.0, 121.5,
115.6 (d, JC–F = 21.5 Hz), 109.9, 54.1, 30.2; 19F NMR (282 MHz, CDCl3) d –113.0 (app
septet, J = 5.1 Hz); IR (Neat Film, NaCl) 2968, 1710, 1590, 1509, 1491, 1211, 1158 cm-1;






Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a white solid
(90% yield).  Rf = 0.37 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.26 (d, J
= 9.0 Hz, 2H), 7.83 (d, J = 9.0 Hz, 2H), 7.76 (dt, J = 7.6, 1.0 Hz, 1H), 7.47 (td, J = 7.3,
1.2 Hz, 1H), 7.42 (td, J = 7.6, 1.2 Hz, 1H), 7.38 (d, J = 7.6 Hz, 1H), 7.15 (dd, J = 8.5, 7.3
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Hz, 2H), 7.00 (tt, J = 7.3, 1.2 Hz, 1H), 6.97 (d, J = 7.6 Hz, 2H), 1.49 (s, 9H); 13C
NMR (125 MHz, CDCl3) δ 153.2, 151.6, 148.2, 146.6, 142.9, 135.1, 131.8, 130.5, 129.2,
127.9, 127.0, 124.1, 124.0, 123.8, 123.0, 121.6, 109.3, 54.4, 30.3; IR (Neat Film, NaCl)
2969, 1712, 1590, 1525, 1490, 1350, 1210 cm-1; HRMS (FAB+) m/z calc’d for






Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(77% yield).  Rf = 0.40 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.09 (dd,
J = 8.1, 1.7 Hz, 1H), 7.67 (d, J = 7.6 Hz, 1H), 7.62 (td, J = 7.9, 1.2 Hz, 2H), 7.46 (td, J =
7.9, 1.2 Hz, 1H), 7.45–7.38 (comp m, 2H), 7.25 (td, J = 7.6, 1.7 Hz, 1H), 7.11 (t, J = 7.3
Hz, 2H), 6.97 (t, J = 7.3 Hz, 1H), 6.90 (d, J = 7.6 Hz, 2H), 1.40 (s, 9H); 13C NMR (125
MHz, CDCl3) δ 152.9, 152.4, 142.5, 137.2, 136.4, 135.4, 135.0, 131.2, 130.5, 130.1,
129.7, 128.8, 128.1, 127.9, 127.2, 123.9, 123.1, 123.0, 122.5, 109.5, 54.2, 30.3; IR (Neat
Film, NaCl) 2968, 1711, 1589, 1490, 1429, 1289, 1209 cm-1; HRMS (MM: ESI–APCI)
m/z calc’d for C24H22BrNO2 [M+H]+: 438.0889, found 438.0881.






Purified by flash chromatography (SiO2, 3:97 EtOAc/hexanes) to yield a pale yellow oil
(76% yield).  Rf = 0.55 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.67 (d, J
= 7.6 Hz, 1H), 7.56 (dt, J = 7.6, 1.0 Hz, 1H), 7.48 (dt, J = 7.6, 1.0 Hz, 1H), 7.42 (dt, J =
7.6, 1.0 Hz, 1H), 7.10 (t, J = 7.6 Hz, 2H), 6.98 (tt, J = 7.3, 1.0 Hz, 1H), 6.90 (dd, J = 7.6,
1.0 Hz, 2H), 4.14 (d, J = 11.7 Hz, 1H), 4.07 (d, J = 11.7 Hz, 1H), 1.43 (s, 9H); 13C NMR
(125 MHz, CDCl3) δ 153.2, 151.7, 139.7, 134.1, 131.5, 130.8, 129.3, 124.9, 123.6, 123.2,
122.7, 109.6, 54.4, 47.9, 30.3; IR (Neat Film, NaCl) 2968, 1788, 1709, 1591, 1490, 1210






Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a white solid
(86% yield).  Rf = 0.37 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.86 (d, J
= 7.6 Hz, 1H), 7.55 (dd, J = 7.3, 1.5 Hz, 1H), 7.51 (ddd, J = 7.3, 1.5, 1.2 Hz, 1H), 7.39
(td, J = 7.3, 1.2 Hz, 1H), 7.21 (d, J = 7.6 Hz, 1H), 7.17 (t, J = 8.1 Hz, 1H), 7.00 (td, J =
7.3, 1.2 Hz, 1H), 6.87 (dd, J = 8.1, 1.2 Hz, 1H), 3.29 (ddd, J = 13.7, 13.4, 5.6 Hz, 1H),
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2.95 (ddd, J = 16.4, 5.6, 1.7 Hz, 1H), 2.43 (td, J = 13.7, 5.9 Hz, 1H), 2.19 (ddd, J =
13.4, 5.9, 2.0 Hz, 1H), 1.34 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 168.7, 152.7, 143.7,
136.1, 135.0, 131.4, 130.3, 129.2, 127.7, 123.6, 121.7, 121.5, 117.0, 105.9, 54.1, 30.0,
28.0, 22.0; IR (Neat Film, NaCl) 2967, 1706, 1586, 1489, 1362, 1228, 1044 cm-1; HRMS





Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(71% yield).  Rf = 0.43 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.79 (dd,
J = 7.6, 1.0 Hz, 1H), 7.62 (d, J = 8.1, 1.5 Hz, 2H), 7.48 (tt, J = 7.3, 1.5 Hz, 1H), 7.43 (dd,
J = 6.8, 1.2 Hz, 1H), 7.38 (td, J = 7.6, 1.0 Hz, 1H), 7.20 (dd, J = 8.5, 7.6 Hz, 2H), 7.12
(td, J = 7.6, 1.2 Hz, 1H), 7.05 (ddd, J = 7.3, 1.2, 1.0 Hz, 2H), 6.94 (dd, J = 8.5, 1.0 Hz,
2H), 6.36 (dt, J = 7.6, 1.0 Hz, 1H), 1.77 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 167.8,
153.6, 139.1, 138.2, 136.4, 134.2, 132.4, 132.3, 131.6, 131.1, 130.3, 130.1, 129.1, 128.1,
124.1, 123.2, 123.0, 121.9, 121.3, 113.4, 57.1, 28.4; IR (Neat Film, NaCl) 2966, 1713,
1589, 1489, 1357, 1323, 1202, 1128, 1016 cm-1; HRMS (FAB+) m/z calc’d for
C24H23NO3 [M+H]+: 374.1756, found 374.1763.






Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98 →  4:96
EtOAc/hexanes) to yield a white solid (68% yield).  Rf = 0.35 (15:85 EtOAc/hexanes); 1H
NMR (500 MHz, CDCl3) δ 7.85 (ddd, J = 7.6, 1.2, 1.0 Hz, 1H), 7.65 (ddd, J = 8.1, 1.2
Hz, 2H), 7.50–7.45 (comp m, 3H), 7.49 (d, J = 9.0 Hz, 2H), 7.42–7.35 (comp m, 3H),
7.12 (dd, J = 8.8, 7.3 Hz, 2H), 6.98 (dd, J = 8.8, 1.2 Hz, 2H), 6.97 (dd, J = 6.1, 1.0 Hz,
1H), 6.92 (d, J = 9.3 Hz, 2H), 3.84 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 157.0, 153.9,
153.6, 144.4, 138.9, 138.6, 135.0, 131.9, 131.2, 130.2, 130.1, 129.0, 129.0, 128.7, 127.9,
125.9, 125.9, 123.8, 123.5, 123.3, 121.8, 113.9, 55.4; IR (Neat Film, NaCl) 3062, 2928,
2833, 1685, 1591, 1506, 1488, 1292, 1245, 1208, 1030 cm-1; HRMS (MM: ESI–APCI)







Purified by flash chromatography (SiO2, 2:98→ 4:96 EtOAc/hexanes) to yield a white
solid (62% yield).  Rf = 0.37 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.16
(dd, J = 7.8, 1.5 Hz, 1H), 7.77 (dd, J = 7.3, 1.0 Hz, 1H), 7.62 (dd, J = 7.8, 1.2 Hz, 1H),
7.51 (td, J = 7.3, 1.2 Hz, 1H), 7.47 (dd, J = 7.3, 1.2 Hz, 1H), 7.44–7.41 (comp m, 2H),
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7.43 (d, J = 9.0 Hz, 2H), 7.26 (ddd, J = 0.5, 1.7, 8.1 Hz, 1H), 7.09 (dd, J = 8.6, 7.3 Hz,
2H), 6.99 (ddd, J = 7.3, 1.2, 1.0 Hz, 1H), 6.90 (d, J = 9.0 Hz, 2H), 6.87 (dd, J = 8.6, 1.2
Hz, 2H), 3.83 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 156.9, 154.3, 152.4, 142.7, 138.7,
136.4, 135.4, 135.0, 133.3, 131.7, 130.7, 130.4, 130.1, 129.6, 128.9, 127.9, 127.3, 125.6,
124.4, 123.2, 123.1, 123.0, 121.4, 113.9, 55.4; IR (Neat Film, NaCl) 3062, 2928, 2833,
1692, 1590, 1506, 1490, 1466, 1293, 1244, 1202, 1034 cm-1; HRMS (MM: ESI–APCI)





Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98→ 8:92
EtOAc/hexanes) to yield a pale yellow solid (67% yield).  Rf = 0.30 (25:75
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.74 (dt, J = 7.8, 1.0 Hz, 1H), 7.65–7.62
(comp m, 2H), 7.46 (dd, J = 6.8, 1.0 Hz, 1H), 7.44 (dd, J = 7.6, 0.7 Hz, 1H), 7.41 (ddd, J
= 7.6, 1.7, 1.0 Hz, 1H), 7.40–7.37 (comp m, 2H), 7.36–7.33 (comp m, 5H), 7.28 (tt, J =
7.3, 1.0, 1H), 7.10 (dd, J = 8.8, 7.3 Hz, 2H), 6.99 (dd, J = 7.6, 1.2 Hz, 2H), 6.94 (tt, J =
7.3, 1.2 Hz, 1H), 4.64 (s, 2H), 3.98 (dt, J = 13.7, 6.3 Hz, 1H), 3.88 (ddd, J = 13.7, 6.3, 5.4
Hz, 1H), 3.80 (ddd, J = 6.6, 6.3, 1.2 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 157.0,
153.5, 144.9, 138.9, 138.5, 135.3, 131.6, 130.3, 129.9, 128.9, 128.8, 128.5, 128.3, 127.7,
127.4, 125.8, 123.7, 123.2, 123.1, 121.8, 73.0, 70.1, 47.8; IR (Neat Film, NaCl) 3057,
2858, 1707, 1589, 1490, 1449, 1293, 1208, 1100 cm-1; HRMS (FAB+) m/z calc’d for
C29H25NO3 [M+H]+: 436.1907, found 436.1893.







Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98 →  5:95
EtOAc/hexanes) to yield a yellow oil (58% yield).  Rf = 0.40 (25:75 EtOAc/hexanes); 1H
NMR (500 MHz, CDCl3) δ 8.46 (dd, J = 7.3, 1.0 Hz, 1H), 7.74 (ddd, J = 7.3, 1.2, 1.0 Hz,
1H), 7.65 (dd, J = 8.1, 1.5 Hz, 2H), 7.57 (ddd, J = 7.6, 1.5, 1.0 Hz, 1H), 7.45 (dd, J = 7.3,
1.5 Hz, 2H), 7.40 (ddd, J = 7.57, 1.5, 1.2 Hz, 2H), 7.27 (m, 1H), 7.26 (tt, J = 7.3, 1.5 Hz,
1H), 7.22 (dd, J = 7.8, 7.3 Hz, 2H), 7.12 (dd, J = 7.8, 1.2 Hz, 2H), 6.99 (dd, J = 7.8, 1.0
Hz, 1H), 6.82 (td, J = 7.6, 1.2 Hz, 1H), 6.62 (td, J = 8.1, 1.5 Hz, 1H), 5.23 (dd, J = 7.8,
1.2 Hz, 1H), 3.66 (t, J = 5.4 Hz, 1H), 3.01 (s, 6H), 2.98 (t, J = 5.4 Hz, 1H); 13C NMR (125
MHz, CDCl3) δ 168.6, 144.7, 142.9, 138.1, 138.0, 135.8, 135.6, 134.7, 133.5, 133.2,
131.2, 130.2, 130.1, 129.8, 128.8, 128.6, 128.5, 127.9, 127.6, 127.4, 127.3, 125.0, 124.2,
121.4, 102.9, 51.7, 31.3; IR (Neat Film, NaCl) 3067, 2935, 1617, 1597, 1429, 1303,
1121, 1068, 1048 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C30H27NO4 [M+H]+:
466.2013, found 466.2008.






Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98 →  4:96
EtOAc/hexanes) to yield a white solid (75% yield).  X-ray diffraction crystals were
grown via slow evaporation of a solution of the white solid (20 mg) in CDCl3 (0.6 mL)
on the bench top at 23 °C over 3 days; mp 101–104 °C.  Rf = 0.30 (15:85
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 6.6 Hz, 2H), 7.40–7.34
(comp m, 3H), 7.32 (t, J = 7.8 Hz, 2H), 7.11 (dd, J = 8.6, 7.1 Hz, 2H), 7.06 (dd, J = 7.6,
1.2 Hz, 2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.83 (d, J = 8.6 Hz, 1H), 3.78 (s, 3H), 1.47 (s,
9H); 13C NMR (125 MHz, CDCl3) δ 154.6, 154.0, 153.1, 139.2, 135.1, 134.6, 132.3,
130.6, 129.0, 128.7, 128.1, 126.9, 124.4, 122.4, 115.5, 113.6, 55.7, 54.3, 30.4; IR (Neat
Film, NaCl) 2967, 1699, 1612, 1489, 1271, 1213, 1049 cm-1; HRMS (FAB+) m/z calc’d







Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98 →  6:94
EtOAc/hexanes) to yield a pale yellow solid (96% yield).  Rf = 0.10 (15:85
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.23 (d, J = 9.0 Hz, 2H), 7.84 (d, J = 9.0
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Hz, 2H), 7.36 (t, J = 7.8 Hz, 1H), 7.28 (dd, J = 7.8, 0.7 Hz, 1H), 7.13 (dd, J = 8.5, 7.3
Hz, 2H), 7.02 (dd, J = 8.8, 1.2 Hz, 2H), 6.99 (ddd, J = 7.3, 1.2, 1.0 Hz, 1H), 6.84 (d, J =
8.1 Hz, 1H), 3.79 (s, 3H), 1.46 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 154.3, 153.2,
151.6, 147.9, 146.1, 134.4, 132.7, 129.2, 128.9, 127.8, 124.7, 123.2, 122.2, 115.4, 113.4,
109.8, 55.5, 54.2, 30.2; IR (Neat Film, NaCl) 2968, 1700, 1613, 1524, 1490, 1349, 1271,








Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 2:98 →  4:96
EtOAc/hexanes) to yield a white solid (68% yield).  Rf = 0.27 (15:85 EtOAc/hexanes); 1H
NMR (500 MHz, CDCl3) δ 7.65 (dd, J = 7.8, 1.7 Hz, 2H), 7.36 (dd, J = 7.8, 1.7 Hz, 2H),
7.35 (tt, J = 7.8, 1.7 Hz, 1H), 7.12 (dd, J = 8.3, 7.3 Hz, 2H), 7.04 (dd, J = 8.3, 1.2 Hz,
2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.72 (d, J = 2.0 Hz, 1H), 6.38 (d, J = 2.0 Hz, 1H), 3.80
(s, 3H), 3.74 (s, 3H), 1.45 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 163.3, 155.1, 153.8,
152.9, 139.4, 135.5, 128.7, 128.4, 128.1, 127.8, 126.5, 124.1, 123.8, 122.4, 102.7, 97.0,
55.8, 55.4, 54.0, 30.2; IR (Neat Film, NaCl) 2964, 1695, 1619, 1599, 1355, 1204, 1146,
1037 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C26H27NO4 [M+H]+: 418.2013, found
418.2020.







Purified by flash chromatography (SiO2, 5:95 → 10:90 EtOAc/hexanes) to yield a white
solid (85% yield).  Rf = 0.23 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 7.62 (d, J = 6.8 Hz, 2H), 7.40 (dd, J = 7.1, 6.8 Hz, 2H), 7.35 (tt, J = 7.1, 1.5 Hz, 1H),
7.14 (dd, J = 8.5, 7.1, 2H), 7.12 (s, 1H), 7.00–6.95 (comp m, 3H), 6.77 (s, 1H), 3.92 (s,
3H), 3.88 (s, 3H), 1.45 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 153.8, 153.0, 152.6, 151.0,
139.8, 137.4, 129.8, 128.9, 128.7, 128.6, 128.2, 125.7, 123.5, 121.5, 104.5, 104.4, 56.3,
56.2, 54.0, 30.3; IR (Neat Film, NaCl) 2966, 1701, 1595, 1501, 1491, 1317, 1214 cm-1;







Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(76% yield).  Rf = 0.30 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.60 (d, J
= 7.1 Hz, 2H), 7.39 (dd, J = 7.6, 6.8 Hz, 2H), 7.34 (tt, J = 7.1, 1.0 Hz, 1H), 7.16 (dd, J =
8.5, 7.6 Hz, 2H), 7.06 (s, 1H), 7.00 (dd, J = 8.5, 1.0 Hz, 2H), 6.98 (t, J= 7.3 Hz, 1H), 6.74
(s, 1H), 6.02 (d, J = 1.2 Hz, 1H), 5.97 (d, J = 1.2 Hz, 1H), 1.44 (s, 9H); 13C NMR (125
MHz, CDCl3) δ 153.8, 152.2, 151.2, 149.7, 139.7, 139.3, 136.0, 135.0, 129.0, 128.8,
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128.7, 125.7, 123.4, 121.4, 102.8, 102.6, 102.2, 53.9, 30.3; IR (Neat Film, NaCl)
2967, 1707, 1473, 1307, 1213, 1059, 1037 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for







Purified by flash chromatography (SiO2, 0:100 → 2:98 EtOAc/hexanes) to yield a pale
yellow oil (62% yield).  Rf = 0.50 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ
7.59 (dd, J = 6.6, 1.5 Hz, 2H), 7.48 (dd, J = 8.8, 7.1 Hz, 1H), 7.40 (d, J = 7.6 Hz, 2H),
7.39 (dd, J = 8.3, 6.8 Hz, 1H), 7.17 (tt, J = 7.6, 1.5 Hz, 1H), 7.15 (d, J = 7.6 Hz, 2H), 6.99
(t, J = 7.6 Hz, 1H), 6.98 (dd, J = 7.6, 7.1 Hz, 2H), 1.45 (s, 9H); 13C NMR (125 MHz,
CDCl3) δ 154.0 (d, J C–F = 14.7 Hz), 153.5, 153.1 (d, J C–F = 14.3 Hz), 151.9 (d, J C–F =
14.3 Hz), 151.1 (d, J C–F = 14.3 Hz), 150.3, 140.3, 138.8, 129.2, 129.1, 128.9, 125.6,
123.8, 121.3, 111.0 (dd, J C–F = 19.8, 4.1 Hz), 109.4, 54.3, 30.1; 19F NMR (282 MHz,
CDCl3) δ –130.3 (ddd, J = 18.9, 7.9, 7.6 Hz), –133.7 (ddd, J = 18.9, 7.1, 6.8 Hz); IR
(Neat Film, NaCl) 2968, 1711, 1498, 1451, 1343, 1211 cm-1; HRMS (MM: ESI–APCI)
m/z calc’d for C24H21F2NO2 [M–H]–: 392.1468, found 392.1479.
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6.4.2.3 Representative Procedure for the One-Pot Synthesis of Ortho-







THF (0.1 M), 40 °C, 12 h
then sat aq oxalic acid














A flame-dried 15 mL long reaction tube with a magnetic stir bar was charged with
TBAT (0.545 g, 1.01 mmol, 2 equiv), phenyl benzoate (A6-1) (0.100 g, 0.504 mmol),
and THF (5 mL).  To this solution was added silyl aryl triflate 184 (0.362 g, 1.01 mmol, 2
equiv) and tert-butylisocyanide (670) (0.114 mL, 1.01 mmol, 2 equiv), each via syringe.
The reaction was heated to 40 °C under argon for 12 h, at which point TLC analysis
showed complete consumption of phenyl benzoate (A6-1) (NOTE: at this point, the
major component of the reaction is phenoxy iminoisobenzofuran 683s).  The reaction was
cooled to room temperature and a saturated aqueous solution of oxalic acid (5 mL) was
added via syringe.  The mixture was vigorously stirred at room temperature for 4 h, at
which point TLC analysis showed complete comsumption of the intermediate
iminoisobenzofuran.  The reaction was quenched by the slow addition of a saturated
aqueous solution of NaHCO3 (10 mL).  The mixture was stirred until bubbling ceased and
then extracted with EtOAc (3 x 25 mL).  The combined organic layers were washed with
brine (40 mL), dried over MgSO4, filtered, and concentrated under reduced pressure.  The
residue was purified by flash chromatography over silica gel.
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Purified by flash chromatography (SiO2, 15:85 → 40:60 EtOAc/hexanes) to yield a white
solid (81% yield).  Rf = 0.37 (50:50 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.80
(dd, J = 8.3, 1.2 Hz, 2H), 7.57 (tt, J = 7.6, 1.2 Hz, 1H), 7.45 (dd, J = 8.1, 7.6 Hz, 2H),
7.24 (s, 1H), 6.95 (s, 1H), 5.59 (br s, 1H), 4.00 (s, 3H), 3.92 (s, 3H), 1.05 (s, 9H); 13C
NMR (125 MHz, CDCl3) δ 197.6, 166.7, 150.4, 150.3, 137.5, 133.5, 130.7, 129.8, 128.6,
127.8, 111.1, 110.7, 56.3, 56.2, 51.8, 28.0; IR (Neat Film, NaCl) 3318, 2965, 1654, 1648,
1596, 1502, 1449, 1348, 1293, 1273, 1215 1084 cm-1; HRMS (MM: ESI–APCI) m/z






Purified by flash chromatography (SiO2, 10:90 → 25:75 EtOAc/hexanes) to yield a white
solid (75% yield).  Rf = 0.10 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 7.49–7.42 (comp m, 4H), 7.12–7.08 (comp m, 2H), 6.88 (dd, J = 8.5, 1.2 Hz, 1H), 6.84
(td, J = 7.3, 1.2 Hz, 1H), 5.72 (br s, 1H), 3.26 (t, J = 6.4 Hz, 2H), 3.02 (t, J = 6.4 Hz, 2H),
1.45 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 206.0, 168.4, 154.5, 138.5, 136.8, 131.1,
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130.4, 130.2, 129.9, 127.6, 127.5, 127.3, 120.5, 117.2, 52.2, 43.2, 28.6, 24.2; IR
(Neat Film, NaCl) 3315, 2970, 1681, 1644, 1593, 1532, 1456, 1366, 1230 cm-1; HRMS








Purified by flash chromatography (SiO2, 10:90 →  30:70 EtOAc/hexanes) to yield a
yellow solid (84% yield).  Rf = 0.10 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 8.51 (d, J = 11.7 Hz, 1H), 8.33 (d, J = 1.7 Hz, 1H), 7.88 (m, 1H), 7.45 (d, J = 9.0 Hz,
2H), 7.28 (br s, 1H), 7.04 (d, J = 8.9 Hz, 2H), 6.90 (d, J = 9.0 Hz, 2H), 6.87 (d, J = 9.0
Hz, 2H), 3.81 (s, 3H), 3.80 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 163.0, 158.8, 157.7,
156.7, 129.9, 129.5, 121.8, 121.7, 114.9, 114.2, 55.6, 55.5; IR (Neat Film, NaCl) 3270,
3127, 3062, 1684, 1603, 1512, 1412, 1301, 1247, 1032 cm-1; HRMS (MM: ESI–APCI)






Reaction performed at 60 °C.  Purified by flash chromatography (SiO2, 5:95 → 15:85
EtOAc/hexanes) to yield a white solid (59% yield).  Rf = 0.27 (25:75 EtOAc/hexanes); 1H
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NMR (500 MHz, CDCl3) δ 7.58 (dd, J = 8.1, 1.5 Hz, 2H), 7.48 (td, J = 7.3, 1.5 Hz,
1H), 7.45 (ddd, J = 7.3, 1.5, 0.5 Hz, 1H), 7.39 (dd, J = 5.1, 1.5 Hz, 1H), 7.38–7.31 (comp
m, 7H), 7.29 (dd, J = 8.1, 1.5 Hz, 2H), 6.09 (t, J = 5.4 Hz, 1H), 4.38 (s, 2H), 3.15 (t, J =
5.1 Hz, 2H), 2.97 (dt, J = 5.4, 5.1 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 192.1, 169.4,
143.2, 139.2, 138.0, 136.1, 135.7, 134.0, 129.8, 129.7, 129.0, 128.5, 127.8, 127.7, 127.6,
126.6, 72.9, 68.4, 39.4; IR (Neat Film, NaCl) 3284, 3067, 2860, 1634, 1631, 1536, 1427,







Purified by flash chromatography (SiO2, 20:80 →  30:70 EtOAc/hexanes) to yield a
colorless oil (77% yield).  Rf = 0.20 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 7.63 (dd, J = 7.8, 1.2 Hz, 1H), 7.56–7.54 (comp m, 2H), 7.49 (dd, J = 7.6, 2.0 Hz, 1H),
7.46–7.44 (comp m, 2H), 7.38 (td, J = 7.6, 1.5 Hz, 1H), 7.34 (td, J = 7.8, 2.0 Hz, 1H),
5.74 (br s, 1H), 1.34 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 196.1, 167.9, 139.4, 138.7,
137.3, 133.8, 132.3, 131.8, 131.7, 130.3, 129.6, 127.9, 127.3, 120.8, 51.9, 28.5; IR (Neat
Film, NaCl) 3320, 2969, 1663, 1534, 1452, 1297, 1248, 1220 cm-1; HRMS (MM:
ESI–APCI) m/z calc’d for C18H18BrNO2 [M+H]+: 360.0594, found 360.0594.















Purified by flash chromatography (SiO2, 10:90 →  30:70 EtOAc/hexanes) to yield a
colorless oil (69% yield). Rf = 0.10 (25:75 EtOAc/hexanes).  Product was isolated as a 2:1
mixture of inseparable ketobenzamide and cyclic imidate isomers.  1H and 13C NMR data
are reported for individual isomers; IR and HRMS data are reported for the mixture.
ortho-Ketobenzamide: 1H NMR (500 MHz, CDCl3) δ 7.64 (dd, J = 7.8, 1.2 Hz, 1H),
7.46 (dd, J = 7.3, 2.0 Hz, 1H), 7.40 (td, J = 7.6, 1.5 Hz, 1H), 7.34 (td, J = 7.8, 2.0 Hz,
1H), 7.08 (s, 1H), 6.96 (s, 1H), 5.70 (br s, 1H), 3.99 (s, 3H), 3.83 (s, 3H), 1.28 (s, 9H); 13C
NMR (125 MHz, CDCl3) δ 195.0, 167.6, 151.9, 149.4, 139.7, 135.2, 133.8, 133.1, 132.2,
131.5, 127.4, 120.7, 113.1, 111.2, 56.3, 56.2, 51.9, 28.3.
Cyclic imidate: 1H NMR (500 MHz, CDCl3) δ 8.32 (dd, J = 8.1, 1.7 Hz, 1H), 7.50 (dd, J
= 7.8, 1.2 Hz, 1H), 7.43 (ddd, J = 8.1, 7.3, 1.2 Hz, 1H), 7.23 (s, 1H), 7.19 (ddd, J = 7.8,
7.3, 1.7 Hz, 1H), 6.37 (s, 1H), 3.94 (s, 3H), 3.77 (s, 3H), 2.87 (br s, 1H), 1.45 (s, 9H); 13C
NMR (125 MHz, CDCl3) δ 169.7, 153.0, 150.7, 140.4, 139.0, 129.9, 129.7, 129.0, 127.3,
126.0, 121.0, 104.3, 103.6, 91.8, 57.0, 56.3, 56.2, 28.8.
IR (Neat Film, NaCl) 3357, 2966, 2936, 1664, 1593, 1507, 1502, 1463, 1349, 1289,
1272, 1212, 1089 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C20H22BrNO4 [M+H]+:
420.0805, found 420.0817.








Purified by flash chromatography (SiO2, 5:95 → 20:80 EtOAc/hexanes) to yield a white
solid (64% yield).  Rf = 0.10 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.62
(dd, J = 7.8, 1.2 Hz, 1H), 7.47 (dd, J = 7.6, 2.0 Hz, 1H), 7.39 (td, J = 7.6, 1.2 Hz, 1H),
7.33 (td, J = 7.8, 2.0 Hz, 1H), 7.01 (s, 1H), 6.86 (s, 1H), 6.07 (s, 2H), 5.63 (br s, 1H),
1.31 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 194.5, 167.4, 150.5, 148.3, 139.7, 135.1,
133.6, 132.1, 131.3, 127.4, 121.4, 120.5, 110.4, 108.7, 102.3, 51.9, 28.4; IR (Neat Film,
NaCl) 3317, 2969, 2907, 1654, 1650, 1607, 1503, 1482, 1453, 1367, 1285, 1259, 1226,
1035 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C19H18BrNO4 [M+H]+: 404.0492,
found 404.0505.














A flame-dried 1.5 dram vial containing a magnetic stir bar and sealed with a
PTFE/silicone septum and screw cap was charged with copper(I) iodide (0.005 g, 0.028
mmol, 0.5 equiv) and potassium carbonate (0.019 g, 0.137 mmol, 2.5 equiv). The vial
was evacuated and backfilled with argon twice.  Then ketobenzamide 669e (0.020 g,
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0.056 mmol) in DMF (0.6 mL) was added and the mixture was heated to 150 °C.  The
solution started as a pale yellow and became progressively brighter yellow over the
course of the reaction.  After stirring for 24 h, the reaction was cooled to room
temperature and filtered through a pad of silica under EtOAc elution.  The solvents were
removed under reduced pressure and the resulting yellow residue was purified via flash
chromatography over silica gel.





Purified by flash chromatography (SiO2, 5:95 → 10:90 EtOAc/hexanes) to yield a white
solid (85% yield).  Rf = 0.50 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.09
(ddd, J = 7.8, 1.2, 0.7 Hz, 1H), 7.57 (ddd, J = 7.8, 6.4, 2.5 Hz, 1H), 7.53 (d, J = 1.7 Hz,
1H), 7.52 (dd, J = 7.6, 1.2 Hz, 1H), 7.42–7.37 (comp m, 2H), 7.40 (dd, J = 6.1, 1.5 Hz,
1H), 7.31–7.27 (m, 1H), 1.52 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 196.7, 166.9, 142.1,
141.1, 137.3, 133.5, 132.2, 131.9, 131.8, 130.1, 127.9, 127.3, 126.0, 125.8, 60.9, 30.0; IR
(Neat Film, NaCl) 2974, 1689, 1647, 1592, 1483, 1446, 1340, 1280, 1188 cm-1; HRMS
(MM: ESI–APCI) m/z calc’d for C18H17NO2 [M+H]+: 280.1332, found 280.1340.







Purified by flash chromatography (SiO2, 5:95 → 10:90 EtOAc/hexanes) to yield a pale
yellow oil (61% yield).  Rf = 0.30 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3)
δ 7.62 (s, 1H), 7.44 (ddd, J = 7.6, 1.5, 0.5 Hz, 1H), 7.42 (ddd, J = 7.6, 1.7, 1.5 Hz, 1H),
7.39 (app td, J = 6.8, 1.7 Hz, 1H), 7.29 (ddd, J = 7.6, 6.8, 1.7 Hz, 1H), 7.08 (s, 1H), 3.97
(s, 3H), 3.96 (s, 3H), 1.52 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 195.4, 166.7, 151.8,
151.5, 141.6, 137.2, 134.6, 130.0, 127.6, 127.4, 127.0, 126.3, 113.9, 108.4, 60.9, 56.3,
56.2, 30.1; IR (Neat Film, NaCl) 2969, 2935, 1674, 1645, 1589, 1514, 1447, 1360, 1331,








Purified by flash chromatography (SiO2, 5:95 EtOAc/hexanes) to yield a yellow oil (73%
yield).  Rf = 0.40 (25:75 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.52 (s, 1H),
7.39 (app dd, J = 2.7, 1.0 Hz, 2H), 7.38 (dd, J = 5.9, 1.5 Hz, 1H), 7.29 (t, J = 3.7 Hz, 1H),
7.00 (s, 1H), 6.05 (d, J = 9.5 Hz, 2H), 1.50 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 195.2,
166.1, 150.8, 150.4, 141.7, 137.1, 136.8, 129.9, 127.7, 127.1, 126.1, 111.6, 105.9, 102.4,
60.9, 30.0; IR (Neat Film, NaCl) 2973, 2909, 1679, 1645, 1608, 1593, 1483, 1448, 1373,
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1332, 1282, 1187, 1037 cm-1; HRMS (FAB+) m/z calc’d for C19H17NO4 [M+H]+:
324.1230, found 324.1241.
6.4.2.7 Representative Procedure for the Three-Component Synthesis of















A flame-dried 15 mL round bottomed flask with a magnetic stir bar was charged with
TBAT (0.607 g, 1.124 mmol, 2.0 equiv) and THF (3 mL).  To this solution was added
methyl propiolate (452 ) (0.05 mL, 0.562 mmol), 2-(trimethylsilyl)phenyl
trifluoromethanesulfonate (71) (0.204 mL, 0.843 mmol, 1.5 equiv), and tert-
butylisocyanide (670) (0.095 mL, 0.843 mmol, 1.5 equiv), each via syringe.  The reaction
was heated to 40 °C under argon for 12 h, at which point TLC analysis showed complete
consumption of aryne precursor.  The reaction was cooled to room temperature, and then
concentrated on celite.  The crude suspension was purified by flash chromatography over
silica gel.
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Purified by flash chromatography (SiO2, 5:95 EtOAc/hexanes) to yield a yellow solid
(88% yield).  Rf = 0.66 (20:80 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.65 (dt, J
= 7.6, 1.0 Hz, 1H), 7.49 (d, J = 1.0 Hz, 1H), 7.48 (dd, J = 2.0, 1.0 Hz, 1H), 7.39 (ddd, J =
8.3, 5.1, 3.2 Hz, 1H), 7.12 (dd, J = 8.3, 7.3 Hz, 2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.92
(dd, J = 8.8, 1.2 Hz, 2H), 1.97 (s, 3H), 1.43 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 153.8,
152.7, 143.6, 136.6, 132.9, 131.4, 130.1, 129.1, 128.3, 124.4, 123.4, 122.8, 122.3, 110.6,
54.1, 30.4, 26.3; IR (Neat Film, NaCl) 2968, 1778, 1704, 1662, 1490, 1215, 1114 cm–1;





Purified by flash chromatography (SiO2, 10:90 EtOAc/hexanes) to yield a white solid
(83% yield).  Rf = 0.38 (30:70 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.65 (dt, J
= 7.6, 1.0 Hz, 1H), 7.49 (d, J = 1.0 Hz, 1H), 7.48 (dd, J = 2.0, 1.0 Hz, 1H), 7.39 (ddd, J =
8.3, 5.1, 3.2 Hz, 1H), 7.12 (dd, J = 8.3, 7.3 Hz, 2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.92
(dd, J = 8.8, 1.2 Hz, 2H), 1.97 (s, 3H), 1.43 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 153.8,
152.7, 143.6, 136.6, 132.9, 131.4, 130.1, 129.1, 128.3, 124.4, 123.4, 122.8, 122.3, 110.6,
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54.1, 30.4, 26.3; IR (Neat Film, NaCl) 2968, 1778, 1704, 1662, 1490, 1215, 1114






Purified by flash chromatography (SiO2, 15:85 EtOAc/hexanes) to yield a yellow oil
(66% yield).  Rf = 0.39 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.18 (d, J
= 8.75 Hz, 2H), 7.56-7.50 (m, 3H), 7.35 (d, J = 7.24 Hz, 1H), 7.28 (t, J = 7.83 Hz, 1H),
7.19 (t, J = 7.24 Hz, 1H), 7.02 (d, J = 7.24 Hz, 1H) 4.53 (t, J = 5.85 Hz, 1H), 3.79 (s, 3H),
3.29 (s, 6H), 2.97 (d, J = 5.85); 13C NMR (125 MHz, CDCl3) δ 153.00, 149.04, 147.04,
135.96, 131.79, 130.88, 129.21, 128.64, 127.99, 126.96, 126.02, 118.65, 104.82, 85.55,
77.74, 53.74, 53.11, 35.85; IR (Neat Film, NaCl) 2968, 1778, 1704, 1662, 1490, 1215,







Purified by flash chromatography (SiO2, 15:85 EtOAc/hexanes) to yield a yellow solid
(91% yield).  Rf = 0.57 (20:80 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.94 (d, J
= 6.51 Hz, 1H), 7.68-7.61 (m, 3H), 7.31 (d, J = 7.50 Hz, 1H), 7.26 (t, J = 6.51 Hz, 2H)
7.11 (t, J = 6.93 Hz, 1H), 4.62 (t, J = 4.98, 1H), 3.79 (s, 3H), 3.59 (s, 3H), 3.31 (s, 3H),
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3.30 (s, 3H), 3.04 (t, J = 7.07 Hz, 2H; 13C NMR (125 MHz, CDCl3) δ 153.8, 152.7,
143.6, 136.6, 132.9, 131.4, 130.1, 129.1, 128.3, 124.4, 123.4, 122.8, 122.3, 110.6, 54.1,
30.4, 26.3; IR (Neat Film, NaCl) 2939, 2832, 1722, 1598, 1489, 1435, 1337, 1281, 1258,






Purified by flash chromatography (SiO2, 15:85 EtOAc/hexanes) to yield a yellow oil
(66% yield).  Rf = 0.41 (30:70 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.56 (d, J
= 7.97 Hz, 1H), 7.54 (s, 1H), 7.37 (t, J = 7.97 Hz, 1H), 6.98 (d, J = 7.97 Hz, 1H), 3.88 (s,
3H), 3.86 (s, 3H), 1.50 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 159.63, 153.55, 144.13,
139.43, 129.31, 119.96, 116.74, 111.76, 87.92, 78.63, 57.75, 55.35, 53.14, 29.61; IR
(Neat Film, NaCl) 2969, 215, 1720, 1602, 1576, 1486, 1466, 1433, 1362, 1275, 1252,
1206, 1175, 1043, 983, 914, 879, 790, 748 cm–1; HRMS (FAB+) m/z calc’d for
C16H19NO3 [M+H]+: 274.1365, found 274.1454






Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(79% yield).  Rf = 0.41 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.65 (dt, J
= 7.6, 1.0 Hz, 1H), 7.49 (d, J = 1.0 Hz, 1H), 7.48 (dd, J = 2.0, 1.0 Hz, 1H), 7.39 (ddd, J =
8.3, 5.1, 3.2 Hz, 1H), 7.12 (dd, J = 8.3, 7.3 Hz, 2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.92
(dd, J = 8.8, 1.2 Hz, 2H), 1.97 (s, 3H), 1.43 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 153.8,
152.7, 143.6, 136.6, 132.9, 131.4, 130.1, 129.1, 128.3, 124.4, 123.4, 122.8, 122.3, 110.6,
54.1, 30.4, 26.3; IR (Neat Film, NaCl) 2968, 1778, 1704, 1662, 1490, 1215, 1114 cm-1;






Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a colorless oil
(54% yield).  Rf = 0.22 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.65 (dt, J
= 7.6, 1.0 Hz, 1H), 7.49 (d, J = 1.0 Hz, 1H), 7.48 (dd, J = 2.0, 1.0 Hz, 1H), 7.39 (ddd, J =
8.3, 5.1, 3.2 Hz, 1H), 7.12 (dd, J = 8.3, 7.3 Hz, 2H), 6.97 (tt, J = 7.3, 1.2 Hz, 1H), 6.92
(dd, J = 8.8, 1.2 Hz, 2H), 1.97 (s, 3H), 1.43 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 153.8,
152.7, 143.6, 136.6, 132.9, 131.4, 130.1, 129.1, 128.3, 124.4, 123.4, 122.8, 122.3, 110.6,
54.1, 30.4, 26.3; IR (Neat Film, NaCl) 2968, 1778, 1704, 1662, 1490, 1215, 1114 cm-1;
HRMS (FAB+) m/z calc’d for C17H21NO4 [M+H]+: 304.1471, found 304.1552.






Purified by flash chromatography (SiO2, 10:90 EtOAc/hexanes) to yield a white solid
(56% yield).  Rf = 0.46 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.52 (s,
1H), 7.51 (d, J = 8.3 Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H), 6.00 (s, 2H), 3.88 (s, 3H), 1.48 (s,
9H); 13C NMR (125 MHz, CDCl3) δ 149.9, 148.0, 143.3, 132.9, 122.6, 110.0, 107.7,
106.7, 101.5, 87.7, 78.3, 57.4, 53.1, 29.7; IR (Neat Film, NaCl) 2697, 2217, 1718, 1576,
1504, 1488, 1444, 1362, 1275, 1257, 1207, 1117, 1039, 980, 937, 918, 812, 748 cm-1;
HRMS (FAB+) m/z calc’d for C16H17NO4 [M+H]+: 288.1158, found 288.1227.
6.4.2.9 Representative Procedure for the Three-Component Synthesis of



















A flame-dried 1.5 dram vial with a magnetic stir bar was charged with TBAT (0.162
g, 0.300 mmol, 2.0 equiv), 1,4-benzoquinone (706) (0.0165g, 0.153 mmol) and THF (1.5
mL).  To this solution was added 2-(trimethylsilyl)phenyl trifluoromethanesulfonate (71)
(0.073 mL, 0.301 mmol, 2.0 equiv) and tert-butylisocyanide (670) (0.034 mL, 0.301
mmol, 2.0 equiv), each via syringe.  The reaction was stirred at 23 °C under argon for 20
h, at which point TLC analysis showed complete consumption of benzoquinone.  The
reaction was then passed over a plug of silica (3 cm diam. x 3 cm length) eluting with
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25:75 EtOAc/hexanes in order to remove excess TBAT from solution.  The solvents
were removed under reduced pressure and the crude residue was purified by flash
chromatography over silica gel.





Reaction performed at 23 °C.  Purified by flash chromatography (SiO2, 5:95 → 15:85
EtOAc/hexanes) to yield a pale yellow solid (60% yield).  R f = 0.13 (25:75
EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 7.85 (ddd, J = 6.1, 2.7, 0.7 Hz, 1H),
7.52–7.46 (comp m, 2H), 7,13 (ddd, J = 6.1, 2.7, 0.7 Hz, 1H), 6.69 (dd, J = 8.1, 2.0 Hz,
2H), 6.35 (dd, J = 8.1, 2.0 Hz, 2H), 1.42 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 184.9,
153.4, 146.2, 142.1, 132.3, 131.8, 129.9, 128.7, 124.7, 121.7, 82.2, 54.3, 30.0; IR (Neat
Film, NaCl) 2967, 1696, 1672, 1635, 1463, 1285, 1214, 1062 cm-1; HRMS (MM:
ESI–APCI) m/z calc’d for C17H17NO2 [M–H]–: 266.1187, found 266.1183.





Reaction performed at 23 °C.  Purified by flash chromatography (SiO2, 2:98
EtOAc/hexanes) to yield a yellow solid (57% yield).  Rf = 0.43 (15:85 EtOAc/hexanes);
1H NMR (500 MHz, CDCl3) δ 8.20 (dd, J = 7.6, 1.7 Hz, 1H), 7.89 (dd, J = 6.6, 1.0 Hz,
1H), 7.49 (dd, J = 6.6, 2.0 Hz, 1H), 7.48 (dd, J = 6.1, 1.7 Hz, 1H), 7.45 (dd, J = 7.3, 1.0
Hz, 1H), 7.39 (td, J = 7.57, 1.2 Hz, 1H), 7.06 (dd, J = 7.1, 2.0 Hz, 1H), 6.91 (dd, J = 7.6,
0.7 Hz, 1H), 6.82 (d, J = 10.0 Hz, 1H), 6.53 (d, J = 10.3 Hz, 1H), 1.45 (s, 9H); 13C NMR
(125 MHz, CDCl3) δ 184.1, 154.4, 146.6, 145.8, 141.8, 133.4, 131.9, 131.5, 129.9, 129.4,
128.8, 128.6, 126.8, 126.7, 124.4, 121.9, 83.4, 54.2, 30.0; IR (Neat Film, NaCl) 2966,
1701, 1672, 1601, 1457, 1298, 1286, 1214, 1076 cm-1; HRMS (MM: ESI–APCI) m/z





Purified by flash chromatography (SiO2, 2:98 EtOAc/hexanes) to yield a yellow solid
(83% yield).  Rf = 0.20 (15:85 EtOAc/hexanes); 1H NMR (500 MHz, CDCl3) δ 8.10 (d, J
= 7.8 Hz, 1H), 8.01 (d, J = 7.3 Hz, 1H), 7.94 (dd, J = 7.8, 1.2 Hz, 1H), 7.87 (d, J = 7.6
Hz, 1H), 7.78 (ddd, J = 8.1, 7.3, 1.5 Hz, 1H), 7.46 (ddd, J = 7.6, 1.7, 1.0 Hz, 1H), 7.45
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(ddd, J = 7.3, 1.7, 1.2 Hz, 1H), 7.37 (dd, J = 7.8, 1.5 Hz, 1H), 7.34 (dd, J = 7.3, 1.2
Hz, 1H), 7.32 (dd, J = 7.6, 1.5 Hz, 1H), 7.16 (app td, J = 7.6, 1.2 Hz, 1H), 6.75 (dd, J =
7.8, 1.0 Hz, 1H), 1.61 (s, 9H); 13C NMR (125 MHz, CDCl3) δ 193.8, 155.2, 144.6, 137.6,
137.2, 135.5, 131.2, 130.4, 129.8, 129.6, 129.3, 129.2, 128.9, 128.7, 128.6, 126.0, 124.8,
124.6, 123.4, 120.9, 91.3, 54.4, 30.0; IR (Neat Film, NaCl) 2966, 1708, 1601, 1451,
1360, 1270, 1214, 1065 cm-1; HRMS (MM: ESI–APCI) m/z calc’d for C25H21NO2
[M+H]: 368.1645, found 368.1639.
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However, the authors noted that quinones ix–xi failed to react under their










(65) Peña, D.; Pérez, D.; Guitián, E.; Castedo, L.  J. Am. Chem. Soc. 1999, 121,
5827–5828.
(66) Tadross, P. M.; Gilmore, C. D.; Bugga, P.; Virgil, S. C.; Stoltz, B. M.  Org. Lett.
2010, 12, 1224–1227.
(67) Liu, Z.; Zhang, X.; Larock, R. C.  J. Am. Chem. Soc. 2005, 127, 15716–15717.
(68) Tambar, U. K.; Stoltz, B. M.  J. Am. Chem. Soc. 2005, 127, 5340–5341.
(69) Peña, D.; Cobas, A.; Pérez, D; Guitián, E.  Synthesis 2002, 1454–1458.
Appendix 6 – Spectra Relevant to Chapter 6 585
APPENDIX 6
Spectra Relevant to Chapter 6:
Multicomponent Aryne Reactions



































Appendix 6 – Spectra Relevant to Chapter 6 587
Figure A6.1.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 680.
Figure A6.1.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 680.
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Figure A6.2.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683a.
Figure A6.2.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683a.
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Figure A6.3.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683b.
Figure A6.3.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683b.
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Figure A6.4.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683c.
Figure A6.4.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683c.
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Figure A6.5.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683d.
Figure A6.5.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683d.
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Figure A6.6.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683e.
Figure A6.6.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683e.
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Figure A6.7.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683f.
Figure A6.7.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683f.
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Figure A6.8.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683g.
Figure A6.8.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683g.
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Figure A6.9.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683h.
Figure A6.9.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683h.
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Figure A6.10.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683i.
Figure A6.10.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683i.
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Figure A6.11.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683j.
Figure A6.11.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683j.
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Figure A6.12.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683k.
Figure A6.12.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683k.
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Figure A6.13.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683l.
Figure A6.13.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683l.
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Figure A6.14.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683m.
Figure A6.14.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683m.
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Figure A6.15.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683n.
Figure A6.15.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683n.
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Figure A6.16.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683o.
Figure A6.16.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683o.
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Figure A6.17.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683p.
Figure A6.17.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683p.
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Figure A6.18.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683q.
Figure A6.18.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683q.
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Figure A6.19.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683r.
Figure A6.19.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683r.
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Figure A6.20.3  13C NMR (125 MHz, CDCl3) of phenoxy iminoisobenzofuran 683s.
Figure A6.20.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683s.
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Figure A6.21.3  13C NMR (125 MHz, CDCl3) of phenoxy
iminoisobenzofuran 683t.
Figure A6.21.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683t.
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Figure A6.22.3  13C NMR (125 MHz, CDCl3) of phenoxy
iminoisobenzofuran 683u.
Figure A6.22.2  Infrared spectrum (thin film/NaCl) of phenoxy
iminoisobenzofuran 683u.
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Figure A6.23.3  13C NMR (125 MHz, CDCl3) of ortho-ketobenzamide 669a.
Figure A6.23.2  Infrared spectrum (thin film/NaCl) of ortho-ketobenzamide 669a.



































Appendix 6 – Spectra Relevant to Chapter 6 633
Figure A6.24.3  13C NMR (125 MHz, CDCl3) of ortho-ketobenzamide 669b.
Figure A6.24.2  Infrared spectrum (thin film/NaCl) of ortho-ketobenzamide 669b.
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Figure A6.25.3  13C NMR (125 MHz, CDCl3) of ortho-ketobenzamide 669c.
Figure A6.25.2  Infrared spectrum (thin film/NaCl) of ortho-ketobenzamide 669c.
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Figure A6.26.3  13C NMR (125 MHz, CDCl3) of ortho-ketobenzamide 669d.
Figure A6.26.2  Infrared spectrum (thin film/NaCl) of ortho-ketobenzamide 669d.




































Appendix 6 – Spectra Relevant to Chapter 6 639
Figure A6.27.3  13C NMR (125 MHz, CDCl3) of ortho-ketobenzamide 669e.
Figure A6.27.2  Infrared spectrum (thin film/NaCl) of ortho-ketobenzamide 669e.






































































Appendix 6 – Spectra Relevant to Chapter 6 641
Figure A6.28.3  13C NMR (125 MHz, CDCl3) of 2:1 mixture of
ortho-ketobenzamide 669f and cyclic imidate 669f’.
Figure A6.28.2  Infrared spectrum (thin film/NaCl) of 2:1 mixture of
ortho-ketobenzamide 669f and cyclic imidate 669f’.
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Figure A6.29.3  13C NMR (125 MHz, CDCl3) of ortho-ketobenzamide 669g.
Figure A6.29.2  Infrared spectrum (thin film/NaCl) of ortho-ketobenzamide 669g.
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Figure A6.30.3  13C NMR (125 MHz, CDCl3) of dibenzoketocaprolactam 687a.
Figure A6.30.2  Infrared spectrum (thin film/NaCl) of dibenzoketocaprolactam 687a
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Figure A6.31.3  13C NMR (125 MHz, CDCl3) of dibenzoketocaprolactam 687b.
Figure A6.31.2  Infrared spectrum (thin film/NaCl) of dibenzoketocaprolactam 687b.



































Appendix 6 – Spectra Relevant to Chapter 6 649
Figure A6.32.3  13C NMR (125 MHz, CDCl3) of dibenzoketocaprolactam 687c.
Figure A6.32.2  Infrared spectrum (thin film/NaCl) of dibenzoketocaprolactam 687c.
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Figure A6.33.3  13C NMR (125 MHz, CDCl3) of iminoindenone 691.
Figure A6.33.2  Infrared spectrum (thin film/NaCl) of iminoindenone 691.
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Figure A6.34.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698a.
Figure A6.34.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698a.
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Figure A6.35.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698b.
Figure A6.35.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698b.






































Appendix 6 – Spectra Relevant to Chapter 6 657
Figure A6.36.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698c.
Figure A6.36.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698c.
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Figure A6.37.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698d.
Figure A6.37.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698d.
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Figure A6.38.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698e.
Figure A6.38.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698e.
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Figure A6.39.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698f.
Figure A6.39.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698f.
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Figure A6.40.3  13C NMR (125 MHz, CDCl3) of iminoindenone 698g.
Figure A6.40.2  Infrared spectrum (thin film/NaCl) of iminoindenone 698g.
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Figure A6.42.3  13C NMR (125 MHz, CDCl3) of spirocycle 707.
Figure A6.42.2  Infrared spectrum (thin film/NaCl) of spirocycle 707.
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Figure A6.43.3  13C NMR (125 MHz, CDCl3) of spirocycle 709.
Figure A6.43.2  Infrared spectrum (thin film/NaCl) of spirocycle 709.
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Figure A6.44.3  13C NMR (125 MHz, CDCl3) of spirocycle 711.
Figure A6.44.2  Infrared spectrum (thin film/NaCl) of spirocycle 711.
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APPENDIX 7
X-Ray Crystallography Reports Relevant to Appendix 6
A7.1 CRYSTAL STRUCTURE OF PHENOXY IMINOISOBENZOFURAN 683p
Figure A7.1. ORTEP drawing of phenoxy iminoisobenzofuran 683p (shown with 50% probability ellipsoids)
NOTE: Crystallographic data have been deposited in the Cambridge Database (CCDC), 12 Union Road,
Cambridge CB2 1EZ, UK, and copies can be obtained on request, free of charge, by quoting the publication
citation and the deposition number 739396.
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Crystal size 0.31 x 0.27 x 0.25 mm3
Crystal color Colorless
Data Collection
Type of diffractometer Bruker KAPPA APEX II
Wavelength 0.71073 Å MoKα
Data Collection Temperature 100(2) K
θ range for 9578 reflections used
in lattice determination 2.48 to 38.91°
Unit cell dimensions a = 8.4862(3) Å α= 77.791(2)°
b = 9.8342(3) Å β= 77.424(2)°





Density (calculated) 1.245 Mg/m3
F(000) 412
Data collection program Bruker APEX2 v2.1-0
θ range for data collection 2.14 to 39.22°
Completeness to θ = 39.22° 95.3 %
Index ranges -14 ≤ h ≤ 14, -15 ≤ k ≤ 17, -22 ≤ l ≤ 23
Data collection scan type ω scans; 18 settings
Data reduction program Bruker SAINT-Plus v7.34A
Reflections collected 51220
Independent reflections 11606 [Rint= 0.0801]
Absorption coefficient 0.081 mm-1
Absorption correction None
Max. and min. transmission 0.9800 and 0.9752
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Table A7.1. (cont.)
Structure solution and Refinement
Structure solution program SHELXS-97 (Sheldrick, 2008)
Primary solution method Direct methods
Secondary solution method Difference Fourier map
Hydrogen placement Difference Fourier map
Structure refinement program SHELXL-97 (Sheldrick, 2008)
Refinement method Full matrix least-squares on F2
Data / restraints / parameters 11606 / 0 / 362
Treatment of hydrogen atoms Unrestrained
Goodness-of-fit on F2 1.891
Final R indices [I>2σ(I),  8945 reflections] R1 = 0.0431, wR2 = 0.1014
R indices (all data) R1 = 0.0581, wR2 = 0.1036
Type of weighting scheme used Sigma
Weighting scheme used w=1/σ2(Fo2)
Max shift/error 0.001
Average shift/error 0.000
Largest diff. peak and hole 0.648 and -0.292 e.Å-3
Special Refinement Details
Crystals were mounted on a glass fiber using Paratone oil then placed on the diffractometer under a
nitrogen stream at 100K.
Refinement of F2 against ALL reflections.  The weighted R-factor (wR) and goodness of fit (S) are based
on F2, conventional R-factors (R) are based on F, with F set to zero for negative F2. The threshold expression of F2 >
2σ( F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement.
R-factors based on F2 are statistically about twice as large as those based on F, and R-factors based on ALL data will
be even larger.
All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix.
The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles;
correlations between esds in cell parameters are only used when they are defined by crystal symmetry.  An
approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
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Figure A7.2. Phenoxy iminoisobenzofuran 683p
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Table A7.2. Atomic coordinates (x 104) and equivalent isotropic displacement parameters (Å2 x 103) for
683p (CCDC 739396).  U(eq) is defined as the trace of the orthogonalized Uij tensor
________________________________________________________________________________
x y z Ueq
________________________________________________________________________________
O(1) 3472(1) 9014(1) 1779(1) 12(1)
O(2) 5165(1) 9139(1) 2930(1) 12(1)
O(3) 2639(1) 9400(1) 5108(1) 15(1)
N(1) 1898(1) 7586(1) 1261(1) 14(1)
C(1) 3544(1) 9449(1) 2754(1) 11(1)
C(2) 2329(1) 8643(1) 3583(1) 11(1)
C(3) 1846(1) 8646(1) 4671(1) 11(1)
C(4) 591(1) 7865(1) 5232(1) 13(1)
C(5) -124(1) 7092(1) 4714(1) 14(1)
C(6) 360(1) 7080(1) 3636(1) 14(1)
C(7) 1594(1) 7881(1) 3088(1) 11(1)
C(8) 2302(1) 8109(1) 1950(1) 11(1)
C(9) 3117(1) 11036(1) 2619(1) 11(1)
C(10) 1992(1) 11714(1) 1985(1) 15(1)
C(11) 1592(1) 13170(1) 1848(1) 18(1)
C(12) 2320(1) 13954(1) 2340(1) 18(1)
C(13) 3425(1) 13278(1) 2980(1) 17(1)
C(14) 3820(1) 11817(1) 3134(1) 14(1)
C(15) 5864(1) 7735(1) 3005(1) 12(1)
C(16) 6663(1) 7253(1) 2082(1) 19(1)
C(17) 7442(1) 5878(1) 2155(1) 24(1)
C(18) 7425(1) 5014(1) 3138(1) 23(1)
C(19) 6657(1) 5516(1) 4060(1) 22(1)
C(20) 5858(1) 6889(1) 3996(1) 17(1)
C(21) 2051(1) 9494(1) 6203(1) 16(1)
C(22) 2651(1) 7806(1) 125(1) 17(1)
C(23) 1637(1) 7108(1) -400(1) 32(1)
C(24) 4405(1) 7088(1) -15(1) 30(1)
C(25) 2593(1) 9360(1) -384(1) 25(1)
________________________________________________________________________________
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Table A7.4. Anisotropic displacement parameters (Å2 x 104) for 683p (CCDC 739396).  The
anisotropic displacement factor exponent takes the form: –2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ]
______________________________________________________________________________
U11 U22 U33 U23 U13 U12
______________________________________________________________________________
O(1) 130(2) 128(2) 105(2) -46(1) -1(2) -40(1)
O(2) 100(2) 105(2) 174(2) -44(2) -28(2) -3(1)
O(3) 151(2) 196(2) 119(2) -70(2) -24(2) -45(2)
N(1) 172(2) 145(2) 104(2) -52(2) -10(2) -32(2)
C(1) 102(2) 120(2) 104(2) -37(2) -15(2) -13(2)
C(2) 103(2) 109(2) 105(2) -35(2) -12(2) -7(2)
C(3) 111(2) 121(2) 107(2) -40(2) -24(2) -2(2)
C(4) 134(2) 148(2) 104(3) -33(2) -7(2) -13(2)
C(5) 145(3) 164(2) 126(3) -38(2) 8(2) -50(2)
C(6) 146(3) 146(2) 132(3) -53(2) -1(2) -49(2)
C(7) 115(2) 115(2) 105(2) -42(2) -3(2) -12(2)
C(8) 117(2) 106(2) 113(2) -39(2) -7(2) -16(2)
C(9) 113(2) 106(2) 115(3) -32(2) 1(2) -11(2)
C(10) 155(3) 133(2) 161(3) -36(2) -36(2) -1(2)
C(11) 187(3) 143(3) 177(3) -22(2) -32(2) 25(2)
C(12) 212(3) 113(2) 178(3) -39(2) 21(2) -4(2)
C(13) 200(3) 129(2) 186(3) -67(2) -2(2) -34(2)
C(14) 153(3) 135(2) 153(3) -50(2) -22(2) -17(2)
C(15) 106(2) 109(2) 159(3) -30(2) -27(2) -12(2)
C(16) 221(3) 163(3) 166(3) -53(2) -46(2) 37(2)
C(17) 273(4) 185(3) 275(4) -113(3) -93(3) 76(2)
C(18) 206(3) 129(3) 371(5) -42(3) -111(3) 10(2)
C(19) 155(3) 186(3) 280(4) 64(3) -56(3) -24(2)
C(20) 130(3) 184(3) 174(3) 6(2) -20(2) -10(2)
C(21) 174(3) 201(3) 120(3) -72(2) -38(2) -9(2)
C(22) 229(3) 178(3) 103(3) -51(2) -11(2) -49(2)
C(23) 500(6) 392(5) 148(4) -90(3) -54(4) -231(4)
C(24) 295(4) 383(4) 175(4) -97(3) 29(3) 71(3)
C(25) 369(4) 209(3) 143(3) -3(2) -26(3) -58(3)
______________________________________________________________________________
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Table A7.5. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) for
683p (CCDC 739396)
________________________________________________________________________________
x y z Uiso
________________________________________________________________________________
H(4) 195(11) 7865(9) 5989(8) 16(2)
H(5) -949(11) 6529(9) 5152(8) 19(2)
H(6) -126(12) 6554(10) 3263(9) 24(2)
H(10) 1514(12) 11163(10) 1610(9) 24(2)
H(11) 817(12) 13634(10) 1389(9) 22(2)
H(12) 2027(12) 14956(10) 2256(9) 24(2)
H(13) 3978(13) 13807(11) 3336(9) 28(3)
H(14) 4579(11) 11346(9) 3594(8) 15(2)
H(16) 6670(12) 7893(10) 1388(9) 24(2)
H(17) 7961(15) 5535(12) 1525(11) 40(3)
H(18) 8013(13) 4068(11) 3201(9) 31(3)
H(19) 6660(14) 4920(11) 4740(10) 34(3)
H(20) 5290(14) 7260(11) 4623(10) 35(3)
H(21A) 899(12) 9846(10) 6330(9) 22(2)
H(21B) 2656(12) 10148(10) 6345(8) 20(2)
H(21C) 2231(12) 8528(10) 6677(9) 24(2)
H(23A) 1742(16) 6048(13) -88(12) 51(4)
H(23B) 2069(15) 7207(12) -1187(11) 38(3)
H(23C) 467(18) 7546(13) -279(12) 58(4)
H(24A) 5072(16) 7598(13) 224(12) 51(4)
H(24B) 4858(14) 7095(11) -786(10) 37(3)
H(24C) 4511(17) 6092(14) 400(12) 55(4)
H(25A) 1484(14) 9829(11) -271(10) 37(3)
H(25B) 3018(13) 9472(10) -1169(10) 28(3)
H(25C) 3247(13) 9878(11) -80(10) 31(3)
________________________________________________________________________________
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APPENDIX 8
Notebook Cross-Reference
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NOTEBOOK CROSS-REFERENCE FOR NEW COMPOUNDS
The following notebook cross-reference has been included to facilitate access to the
original spectroscopic data obtained for the compounds presented in this thesis.  For each
compound, both hard copy and electronic characterization folders containing the original
1H NMR, 13C NMR, 19F NMR, and IR spectra have been created.  All notebooks and
spectroscopic data are stored in the Stoltz research group archive.
Table A8.1. Compounds in Chapter 2 – Orthogonal Synthesis of Indolines and Isoquinolines via
Aryne Annulation
Compound 1H NMR 13C NMR IR
167 CDGVII-93D CDGVII-93Dc CDGVII-119
170a, b CDGVII-123E CDGVII-123Dc CDGVI-225
170c CDGVII-117B CDGVII-121Bc CDGVII-117
170d CDGVI-219B CDGVII-219Bc CDGVII-065_Phe
176 CDGVII-47G CDGVII-47Gc CDGVII-47
181a CDGVI-299_char CDGVI-299c_char CDGVI-299
181b CDGVII-65 CDGVII-65c CDGVII-65
181c CDGVII-211_char CDGVII-211c_char CDGVII-211
181d CDGV-275G-2 CDGV-275G-2c CDGV-275
181e CDGVI-265E-2 CDGVI-265E-2c CDGVI-265
181f CDG-CF3_isoquin CDGVII-CF3c CDG-CF3IQ
181g KMA-X-229.2 KMA-X-229.2c KMA-X-229.2
181h CDGVII-149_char CDGVII-149c_char CDGVII-149
182a CDGVI-257E CDGVI-257Ec CDGVI-257
182b, c CDGV-287E CDGV-287Ec CDGV-287
182d CDGV-291_char CDGV-291Gc CDGVI-291_sesam
182e CDGVII-31 CDGVII-31c CDGVII-031
182f CDGVIII-57B-6 CDGVIII-57C CDGVIII-57D
187a CDGVII-221 CDGVII-221C CDGVI-273
187b KMA-X-35.4 KMA-X-35.4c KMA-IX-35.4
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187c KMA-X-175.5 KMA-X-175.5c KMA-X-175.5
A1-1 KMA-X-175.2 KMA-X-175.2c KMA-X-175.2
187d KMA-X-179.4 KMA-X-179.4c KMA-X-179.4
A1-2 KMA-X-179.1.1 KMA-X-179.1.1c KMA-X-179.1.1
187e CDGVII-243B-5 CDGVII-243B-5c CDGVII-243
187f KMA-IX-191.2 KMA-IX-191.2c KMA-IX-163.1
A1-4 KMA-IX-265.3 KMA-IX-265.3c KMA-IX-265.2
A1-5 KMA-IX-171.5 KMA-IX-171.5c KMA-IX-171.2
195 KMA-IX-261.2 KMA-IX-261.2c KMA-IX-177.2
196 KMA-IX-271.6 KMA-IX-269.2c KMA-IX-235.2
197 KMA-IX-273.5 KMA-IX-273.4c KMA-IX-255.5
202a KMA-XVII-75.1 KMA-XVII-75.1c KMA-XVII-75.1
202b KMA-XVII-57.1 KMA-XVII-57.1c KMA-XVII-57.1
209 KMA-XVI-219.2 KMA-XVI-219.2c KMA-XVI-219.1
202c KMA-XVII-95.1 KMA-XVII-95.1c KMA-XVII-95.1
Table A8.2. Compounds in Chapter 4 – A Concise Total Synthesis of (–)-Quinocarcin via Aryne
Annulation
Compound 1H NMR 13C NMR IR
syn-382 KMA-VI-135.1 KMA-VI-135.1c ERA-XIV-241.1
381 KMA-VIII-185.2 KMA-VIII-185.2c KMA-VIII-185.2
380 KMA-XVII-185.3 KMA-XVII-185.3c KMA-XVII-185.3
392 KMA-VIII-125.2 KMA-VIII-125.3c KMA-VIII-125.2
405a KMA-XIII-127.6 KMA-XIII-127.3-13C KMA-XIII-127.5
402 KMA-XIII-115.3 KMA-XIII-115.2-13C KMA-XIII-115.3
406 KMA-XIII-125.6 KMA-XIII-125.6c KMA-XIII-125.6
407 KMA-XIII-127.5 KMA-XIII-127.5c KMA-XIII-131.14
411 KMA-XIII-131.8a KMA-XIII-131.8-13C KMA-XIII-131.6
415a KMA-XIII-171.2 KMA-XIII-171.1-13C KMA-XIII-171.1
415b KMA-XIII-179.10 KMA-XIII-179.9c KMA-XIII-179.9
414 KMA-XIII-181.1 KMA-XIII-181.1c KMA-XIII-163.2
378 KMA-XIII-191.4 KMA-XIII-191.4c KMA-XIII-191.4
211 KMA-XIII-213.2-2 KMA-XIII-213.4c KMA-XIII-213.2
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Table A8.3. Compounds in Chapter 5 – Expedient Synthesis of 3-Hydroxyisoquinolines and 2-
Hydroxy-1,4-Naphthoquinones via One-Pot Aryne Acyl-Alkylation / Condensation
Compound 1H NMR 13C NMR IR
575h KMA-XIV-227.2 KMA-XIV-227.2c KMA-XIV-227.1
575i KMA-XV-63.3 KMA-XV-63.3c KMA-XV-63.1
575j KMA-XV-55.3 KMA-XV-55.3c KMA-XV-55.1
575k KMA-XV-35.3 KMA-XV-35.2c KMA-XV-35.2
569 KMA-XV-219.1 KMA-XV-219.1c KMA-XV-219.1
571a KMA-XIV-269.2 KMA-XIV-269.2c KMA-XIV-269.2
571b KMA-XIV-271.1 KMA-XV-221.2c KMA-XV-221.1
571c KMA-XIV-273.1 KMA-XIV-273.1c KMA-XV-223.1
571d KMA-XIV-275.2 KMA-XIV-275.2c KMA-XV-225.1
571e KMA-XV-227.1 KMA-XV-227.1c KMA-XV-227.1
571f KMA-XVI-31.2 KMA-XVI-31.2c KMA-XVI-31.2
576a KMA-XV-101.1 KMA-XV-101.1c KMA-XV-101.4
576b KMA-XV-99.1 KMA-XV-99.1c KMA-XV-99.1
576c KMA-XIV-291.6 KMA-XIV-291.2c KMA-XIV-291.6
576d KMA-XIV-261.3 KMA-XIV-261.3c KMA-XIV-261.3
576e KMA-XIV-263.3 KMA-XIV-263.3c KMA-XIV-263.3
576f KMA-XIV-225.2 KMA-XIV-295.2c KMA-XIV-225.2
576g KMA-XIV-217.5 KMA-XIV-217.5c KMA-XIV-217.4
576h KMA-XV-83.2 KMA-XV-83.3c KMA-XV-83.4
576i KMA-XV-169.3 KMA-XV-169.3 KMA-XV-169.1
576j KMA-XIV-243.1 KMA-XIV-243.1c KMA-XIV-243.1
576k KMA-XV-71.3 KMA-XV-71.3c KMA-XV-71.2
576l KMA-XV-61.2 KMA-XV-61.2c KMA-XV-61.2
576m KMA-XV-41.6 KMA-XV-121.2c KMA-XV-121.2
A5-1 KMA-XVI-185.1 KMA-XVI-185.1c KMA-XVI-185.1
578 KMA-XVI-191.1 KMA-XVI-191.1c KMA-XVI-191.1
579 BDHI-OTfd=2 BDHI-OTfd=2-13C BDH-I-OTf
588a KMA-XIV-303.2 KMA-XIV-303.2c KMA-XIV-303.2
588b KMA-XV-25.2 KMA-XV-25.2c KMA-XV-25.2
588c KMA-XIV-179.5 KMA-XIV-179.5c KMA-XV-49.1
588d KMA-XV-203.1 KMA-XV-203.1c KMA-XV-203.1
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588e KMA-XVI-35.2 KMA-XVI-35.2c KMA-XVI-35.1
588f KMA-XV-205.4 KMA-XV-205.4c KMA-XV-205.4
588g KMA-XV-31.2 KMA-XV-31.2c KMA-XV-31.2
588h KMA-XV-107.1 KMA-XV-107.1c KMA-XV-107.1
588i KMA-XV-33.1 KMA-XV-33.1c KMA-XV-33.1
588j KMA-XV-45.1 KMA-XV-45.1c KMA-XV-45.1
588k KMA-XV-73.2 KMA-XV-73.2c KMA-XV-73.1
Table A8.4. Compounds in Chapter 6 – Multicomponent Aryne Reactions
Compound 1H NMR 13C NMR IR
680 KMA-XI-43.3 KMA-XI-43.3c KMA-XI-187.2
683a KMA-XIV-35.2 KMA-XIV-35.2c KMA-XIV-35.2
683b KMA-XI-45.3 KMA-XI-45.3c KMA-XIV-31.2
683c KMA-XI-47.3 KMA-XI-47.3c KMA-XIII-301.4
683d KMA-XI-111.4 KMA-XI-111.4c KMA-XI-111.2
683e KMA-XIII-263.5 KMA-XIII-263.5c KMA-XIII-263.6
683f KMA-XII-27.5 KMA-XII-27.5c KMA-XII-27.3
683g KMA-XV-279.1 KMA-XV-279.1c KMA-XIV-63.1
683h KMA-XV-283.3 KMA-XV-283.1c KMA-XV-283.1
683i KMA-XII-75.2 KMA-XII-75.2c KMA-XII-75.2
683j KMA-XIV-65.2 KMA-XIV-65.5c KMA-XIV-65.2
683k KMA-XIII-271.4 KMA-XIII-271.4c KMA-XIII-271.4
683l KMA-XVI-139.3 KMA-XVI-139.4c KMA-XVI-139.4
683m KMA-XVI-137.3 KMA-XVI-137.4c KMA-XVI-137.4
683n KMA-XVI-75.3 KMA-XVI-75.1c KMA-XVI-75.3
683o KMA-XVI-77.2 KMA-XVI-77.1c KMA-XVI-77.2
683p KMA-XIV-139.1 KMA-XIV-139.1c KMA-XIV-139.1
683q KMA-XVI-41.1 KMA-XVI-41.1c KMA-XVI-41.1
683r KMA-XVI-21.7 KMA-XVI-21.7c KMA-XVI-21.7
683s KMA-XIV-117.3 KMA-XIV-117.6.c KMA-XIV-117.6
683t KMA-XIV-141.2 KMA-XIV-141.2c KMA-XIV-141.2
683u KMA-XVI-29.5 KMA-XVI-29.5c KMA-XVI-29.5
669a KMA-XVI-87.1 KMA-XVI-87.1c KMA-XVI-87.1
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669b KMA-XVI-85.1 KMA-XVI-85.1c KMA-XVI-85.1
669c KMA-XVI-145.5 KMA-XVI-145.5c KMA-XVI-145.5
669d KMA-XVI-161.7 KMA-XVI-161.7c KMA-XVI-161.7
669e KMA-XVI-57.2 KMA-XVI-57.2c KMA-XVI-57.2
669f KMA-XVI-173.6 KMA-XVI-173.6c KMA-XVI-173.6
669g KMA-XVI-175.5 KMA-XVI-175.5c KMA-XVI-175.5
687a KMA-XVI-169.1 KMA-XVI-169.1c KMA-XVI-169.1
687b KMA-XVI-179.1 KMA-XVI-179.1c KMA-XVI-179.1
687c KMA-XVI-177.1 KMA-XVI-177.1c KMA-XVI-177.1
691 CDGXV-141 CDGXV-141-C13 CDGXV-141
698a CDGXV-133 CDGXV-133-C13 CDGXV-133
698b CDGXV-127 CDGXV-127-C13 CDGXV-127
675c CDGXV-175 CDGXV-175-C13 CDGXV-175
675d CDGXV-165C CDGXV-165C-C13 CDGXV-165C
675e CDGXV-289 CDGXV-289-C13 CDGXV-289
675f CDGXV-287-hplcA-3 CDGXV-287-C13 CDGXV-287
675g CDGXV-169 CDGXV-169-C13 CDGXV-169
707 KMA-XVI-59.3 KMA-XVI-59.3c KMA-XVI-59.3
709 KMA-XVI-141.1 KMA-XVI-141.1c KMA-XVI-141.1
711 KMA-XVI-143.1 KMA-XVI-143.1c KMA-XVI-143.1
687
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